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ABSTRACT 
 
 High throughput sequencing technology and availability of this information has 
changed the way enzyme families can be studied.  Sequence information from large 
public databases such as GenBank and UniProtKB can easily retrieved for the purpose 
of identifying unique enzymatic activities.  The strategy adopted for this study is to 
identify characterized enzymes and the sequence features which give rise to their 
substrate specificity.  Homologues of these enzymes are retrieved, and any active site 
variations can be readily identified.  Cluster of Orthologous Groups (cog) 0402 is a 
family of enzymes which comprise a portion of the amidohydrolase superfamily.  This 
group catalyzes a deamination reaction, releasing free ammonia and replacing it with a 
tautomerized oxygen.  Cog0402 is most well known for guanine and cytosine 
deaminase, however other functions exist.  One such function was that of S-
adenosylhomocysteine deaminase, which was related to a large group of 
uncharacterized enzymes.  These enzymes were predicted by us to deaminate 5’-
modified adenosines.  The enzymes were physically characterized these predictions 
were confirmed and a 5’-deoxyadenosine deaminase was discovered in addition to an 
8-oxoadenine deaminase.  During this study it was noted that background isoguanine 
deaminase activity was found at appreciable rates in E. coli.  This activity was purified 
and identified using nanoLC-MS/MS and found to be caused by E. coli cytosine 
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deaminase.  E. coli cytosine deaminase itself is found in a cluster of uncharacterized 
enzymes with a single amino acid difference in the active site.  Representative enzymes 
were purified and a 5-methylcytosine deaminase was discovered.  This enzyme is 
capable of rescuing thymine auxotrophs in the presence of 5-methylcytosine, and will 
confer sensitivity to 5-fluorocytosine.  Finally, an enzyme distantly related to cytosine 
deaminase was purified and found to be a unique pterin deaminase.  It was most 
efficient for oxidized pterin rings and would accept a variety of substituents on the C6 
positions. Futhermore, it was thought to catalyze the first step of an undescribed pterin 
degradation pathway. 
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CHAPTER I 
INTRODUCTION: COG0402 OF THE AMIDOHYDROLASE SUPERFAMILY, NON-
AMIDOHYDROLASE DEAMINASES AND THE AMIDOHYDROLASES OF HUMANS 
 
The amidohydrolase superfamily (AHS) is an extraordinary set of enzymes, 
evolutionarily programmed to carry out various hydrolase activities (1,2).  A (β/α)8 TIM 
barrel forms a scaffold for a metal center, poising a nucleophilic water for attack.  While 
there are several variations on this catalytic theme, this dissertation focuses on 
research within a deaminase subgroup of the AHS known as cluster of orthologous 
groups 0402 (cog0402). 
Cog0402 is a large group of enzymes, containing over 4000 members. The active 
site consists of a single divalent transition metal in its active site in a trigonal 
bipyramidyl coordination (Figure 1.1) (3-6).  The TIM barrel scaffold can be used to 
easily pinpoint the location of certain active residues by referencing on which TIM 
barrel beta strand the residues reside.  For example the defining features of cog0402 
are a nearly universally conserved beta-strand 1 HxH motif, a strand 5 HxxE, a strand 6 
His and a strand 8 Asp.  The strand 5 Glu acts as a proton shuttle in the chemical 
mechanism while the remaining residues (and water) form the ligands to the metal 
center (7).  This system catalyzes the deamination of an imine functional group, 
releasing free ammonia and substituting a tautomerized carbonyl group (Scheme 1).  In 
all but one case, the imine functional group is found in an aromatic heterocyclic ring.  
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Because of the large size of this group, measures are taken to divide the cluster into 
smaller, manageable pieces.  To accomplish this, we construct a sequence similarity 
network diagram with the software BLAST (8) and Cytoscape (9,10).  In this diagram, 
the stringency can be changed to demonstrate how groups may cluster together (less 
stringent) or how they might separate (more stringent) based on phylogeny.  Groups 
were originally defined at an E-value stringency of 10-70, and the diagram is rendered at 
10-50 to demonstrate clustering.  The groups were arbitrarily numbered, and functions 
indicated (Figure 1.2). 
The first known activities before cog0402 was defined were guanine (11-13) and 
cytosine deaminases (3,7,14).  Both enzymes perform important functions in nucleotide 
metabolism.  The sequences and structures of homologues have been solved(3,7) 
(guanine deaminase PDB: 2UZ9), showing the conserved structural nature of the active 
site (Figure 1.3).  More importantly, this also displays the substrate binding of the imine 
functional group which will become important for function discovery.  Closely related 
to cytosine deaminase was that of a creatinine deaminase (15).  Additionally, enzymes 
closely related to cytosine deaminase and guanine deaminase were known to 
deaminate the atrazine intermediates N-isopropylammelide (N-isopropylammelide 
isopropylaminohydrolase, AtzC), melamine, and act as a chlorohydrolase for atrazine 
(16-18). 
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Figure 1.1: The active site of members of cog0402.  Various active site residues are 
located on the N-termini of the beta strands which form the TIM barrel. 
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Scheme 1.1 
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Figure 1.2: Cog0402 rendered at an E-value of 10-50.  Groups are arbitrarily numbered 
and functions are indicated. 
4  8-oxoguanine 
    Isoxanthopterin 
6 
Cytosine 
Creatinine 
Isoguanine 
5-Methylcytosine 
                  10 
N-formimino-L-glutamate 
2 Guanine 
1 
S-adenosylhomocysteine 
14 
Pterin 
18 
3 
9 
5 
7 
Aminofutalosine 
5 SsnA 
9 YahJ 
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Figure 1.3: The active site overlay of cytosine and guanine deaminase.  Due to the 
conserved nature of the active site, the imine functional group binds in an identical 
manner, aiding with function discovery. 
 
 
Function discovery in the in cog0402 began with two enzymes, HutF and SAH 
deaminase.  HutF was found in what is now labeled Group 10, and its genomic context 
suggested there to be a missing step of histidine metabolism (6).  This was tested, and 
the substrate was found to be N-formimino-L-glutamate, forming ammonia in N-
formyl-L-glutamate upon deimination.  Next, SAH deaminase was discovered to be the 
function of a gene Tm0936 from Thermatoga maritime (19).  This discovery was 
accomplished through genomic context, fragments bound in the active site structure 
and computational docking.  Tm0936 was the first enzyme found to deaminate the 
byproduct of SAM mediated methylation and radical reactions, and was in fact 
promiscuous for 5’-deoxy-5’-methylthioadenosine. 
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The final two discoveries prior to the research in this manuscript were 8-oxoguanine 
deaminase (4) and isoxanthopterin deaminase (5).  Guanine is often oxidized in DNA 
under oxidative stress (20), and can be removed by base excision repair (21).  Once this 
takes place, free 8-oxogaunine can be deaminated to form uric acid, which in turn is 
recycled by the cell.  A deaminase for this reaction was discovered active sequence 
differences compared to guanine deaminase as well as and library screening.  The 
closely related isoxanthopterin deaminase was identified by active site variations from 
the newly discovered 8-oxoguanine deaminase. 
Concurrently with this study, another function was established in menaquinone 
biosynthesis, aminofutalosine deaminase (22).  Two members in cog0402 have this 
function, even though they are distantly related.  One established the function of group 
7, while the other only consisted of a small unlabeled group.  Even with these 
numerous activities, still many genes remained unannotated and some groups in 
cog0402 had not been investigated to have promiscuous functions.  The chapters in this 
study cover the newly discovered functions in cog0402, which will be briefly discussed 
in the following paragraphs. 
The first discovery to be discussed (Chapter II) involved the dissection of Group 
1, where the activities of 5’-deoxyadenosine deaminase and 8-oxoadenine were 
discovered, along with new isoforms of adenosine and guanine deaminase (23).  Only 
two enzymes had been characterized from this group, deaminating SAM-mediated 
byproducts 5’-deoxy-5’-methylthioadenosine and S-adenosylhomocysteine.  Chapter III 
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will discuss is the promiscuous activity of E. coli cytosine deaminase to deaminate 8-
oxoadenine (isoguanine), an oxidized form of adenine (24).  This was found during 
attempts to characterize group one proteins as background activity of E. coli.  The 
structure was elucidated which provided insight into how isoguanine can effectively 
bind to the active site of cytosine deaminase.  The subject of Chapter IV are the 
homologues of E. coli cytosine deaminase how they were investigated, and a new 5-
methylcytosine deaminase was discovered.  The active site differed at a single amino 
acid found directly after the strand 8 aspartate.  This residue also matched one which 
had been mutated by other researchers to confer 5-fluorocytosine deaminase activity 
(25).  Chapter V discussesthe discovery of a promiscuous pterin deaminase in group 14 
(26).  This enzyme shares a similar active site to E. coli cytosine deaminase.  It is 
thought to initiate pterin ring degradation for photosynthetic organisms and plant 
symbiont and possibly forms part of a pathway for metabolizing oxidized pterin rings.  
Finally, Chapter VI will mention the attempts to functionally characterize E. coli genes 
YahJ and SsnA, two amidohydrolases of cog0402 with no known activity. 
Several other deaminases exist as well, outside the realm of the amidohydrolase 
superfamily.  Most non-amidohydrolase deaminases fall into what is known as the 
Cytidine deaminase-like superfamily. Members of this group includes cog0295 (cytidine 
deaminase), cog2131 (dCMP deaminase), cog0590 (tRNA adenosine deaminase, 
guanine deaminase, cytosine deaminase), cog0117 (RibG). Cog0717 (dCTP deaminase), 
while a deaminase, does not share the same active site machinery as the other families.  
 
 
9 
 
The APOBEC family also shares similarity with the cytidine deaminase superfamily, 
however this large group only has one catalytic function (deamination of DNA/RNA 
cytidine) even though there is incredible sequence diversity.  APOBEC will not be 
discussed in the context of unknown functions for this reason. 
Using the strategies discussed in the original research, it is possible to make a 
functional assessment of the uncharacterized members of these groups.  It is likely that 
several unique functions exist in sequence homologues of the aforementioned 
deaminases.  Presented is an overview of the groups with an assessment of these 
uncharacterized members. 
Cog0295 houses Zn dependent deaminases which hydrolytically deaminate 
cytidine/2’-deoxycytidine or the antibiotic blasticidin-S.  A sequence similarity network 
diagram was constructed by retrieving from NCBI the sequences annotated as 
“cog0295.”  The network diagram rendered at the E-values 10-30 are shown in Figure 
1.4.  The members share in common a zinc binding domain, although variations on this 
theme exist and are described below.  There are three well known activities in cog0295, 
each which populate a separate subgroup in the network diagram. There are 
homodimeric CDA/2dCDA (HCdd), homotetrameric CDA/2dCDA(TCdd) and Blasticidin-S 
deaminases.  An active site diagram of the 3 known functions is shown in Figure 1.5. 
Homodimeric ccd forms a small cluster of 141 members in cog0295, forming 
Group 1.  The group is mostly populated by gamma-proteobacteria, and includes 
representatives from Enterobacteria, Vibrionales, Pasteuralles and Alteromonadales.  
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Certainly the most studied cytidine deaminase from this group is that of E. coli, 
originally described in 1971 (27).  Here E. coli cdd was purified by monitoring catalytic 
activity, and the enzyme was found to be inhibited by 3,4,5,6-tetrahydrouridine, which 
forms a transition state analogue.  A purification in 1984 suggested that ccd formed a 
functional dimer in vitro (28), and this was confirmed in 1985 by crosslinking 
experiments (29). Furthermore, E. coli cdd was purified to homogeneity and found to 
efficiently deaminate cytidine, 2’-deoxycytidine and 5-methylcytidine (29). The 
structure was solved in 1994 (30), which revealed the nature of its active site. 
 
 
Figure 1.4: Network diagram of members of cog0295 rendered at a BLAST E-value of 10-
30. 
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Figure 1.5: The active site schematics of various members of cog0295.  Metal binding 
residues are in blue, the substrate in green and the ligand binding residues/catalytic 
machinery is in red. 
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A later structure was deposited in the PBD (PBD: 1CTT), where the enzyme was 
crystallized in the presence of a pro-inhibitor, zebularine, which is hydrated by the 
enzyme to  form zebularine 3,4-hydrate (ZEB—H2O) (31).  A mononuclear metal center 
is formed by Cys132, Cys139, and His102.  A fourth ligand is formed as an activated 
water to complete the tetrahedral geometry.  Cytidine is held in the active site by 
several interactions – O2 on the pyrimidine hydrogen bonds to the amide backbone on 
A103, the 3’ hydroxyl binds to both Gln 89 and Glu 91, and the 5’ hydroxyl binds across 
the dimer interface to the carbonyl backbone of Ala232.  The mechanism is thought to 
occur through a hydrophilic attack using an activated hydroxyl ion bound to Zn2+ and 
Glu104, which acts as a proton shuttle (32).  This was determined by solving the 
structure with various transition state inhibitors.   
Homotetrameric CDAs comprise most of cog0295, and several organisms from 
various domains of life have a homologue.  The characterized members form a central 
group which was labeled Group 2.  Most representatives from this group are from 
Bacillales, and lactobacillales, however mouse (PDB: 1ZAB) (33), yeast (PDB: 1R5T) (34), 
and human (PDB: 1MQ0) (35) possess homologues.  The first representative discovered 
was Bacillus subtilis in 1989 (36).  Here the 14 kDa enzyme described was cloned, found 
to form a homotetramer, and is capable of deaminating cytidine and 2’-deoxycytidine. 
5-Methylcytidine was not tested as a substrate.  The structure was solved in 2002 (PDB: 
1JTK) (37) and the active site as well as the tetrameric interface were described.  The 
Zn2+ coordinating ligands differ only by one residue, where the corresponding ligand to 
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H102 in DCdd is a Cys.  The binding of the substrate is similar to dCDA; O2 on the 
pyrimidine is hydrogen bonded to the amide backbone of Ala54, the 3’-hydroxyl bonds 
to Glu44 and Asn42, however the 5’-hydroxyl hydrogen bonds to the amide backbone 
of Tyr48 across the symmetric unit of the tetramer interface.  The mechanism of TCDA 
is believed to occur in a similar manner to DCDA, and the additional charge of the 3xCys 
(vs Cys-Cys-His in DCDA) binding domain is thought to the neutralized by helix dipoles.  
A later study showed that Arg56, located on the active site helix, neutralized the charge 
of the Zn-coordinate cysteines and conferred tetramer stability (38).  A functional 
outlier to this group is the yeast TCDA, which was found have mRNA editing activity of 
CU (34), and shared the same substrates as the APOBEC-1 family.  Although the 
structure was solved of the yeast enzyme, it remained unclear how mRNA could bind to 
the active site.  Moreover, mouse TCDA was found to have mRNA binding capacity (33). 
Blasticidin has been used as an antibiotic for rice since 1958 (39) and a 
deaminase for this compound was found in 1975 (40).  The corresponding deaminase 
from Aspergillus terreus was found to be 193 amino acids and can confer Blasticidin S 
resistance as a selectable marker in eukaryotes (41).  It forms a functional tetramer, like 
TCDAs (42) and was originally postulated to share a similar active site. However, its 
structure was solved in 2007 (43) which showed the free enzyme adopted a tetrahedral 
metal geometry, and shifted to trigonal bipyramidyl upon substrate binding.  A 
schematic of the active site can be seen in Figure 1.5.  Together, these enzymes 
populate group 5. 
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Groups 3, 4, 9, 10, 11 appear to be tetrameric cytidine deaminases.  A member 
from each group was selected for a sequence alignment, and all contain similar 
residues to those found in Group 2.  There are two minor differences. Groups 9 and 12 
have a Phe at position 48 as opposed to a tyrosine. Since this is a backbone interaction, 
this substitution is expected to have little effect.  Secondly, group 12 contains a 
histidine for the zinc binding, like the E. coli protein.  However a lack of the functionally 
mysterious C-terminus (as in group 1) leads one to believe group 12 will be tetrameric. 
Groups 6 and 8 both have slight variations and may contain new functions.  
Compared to group 2, both groups lack Asn42 (Cys in group 6, Ala in group 8) and Tyr48 
(Gly in group 6, Ala in group 8), however group 6 possesses the other binding residues.  
Group 8 lacks Glu44, however it is replaced with an Asp at this position which may fill a 
similar role.  Also, the Ala54 has been substituted with a Met; but given the backbone 
interaction utilized, this may have no effect.  Given the intact active site and varied 
substrate binding residues, these groups may catalyze an undescribed function. 
 Cog0717 is comprised of a mix between dCTP deaminases, dUTP 
nucleotidohydrolase (dUTPase) and both a combination of these activities to form 
bifunctional enzymes.  These enzymes provide dUMP for dTMP synthesis while 
minimizing the dUTP pool.  The deaminases are unique in that no metal center is 
required for deamination, only magnesium which is found bound to the triphosphate 
substrate.  Several structures have been solved to elucidate the catalytic mechanism for 
both of these functions, allowing functional predictions of enzymes to be made.  A 
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sequence similarity diagram was constructed at a BLAST E-value of 10-30 and its groups 
were arbitrarily labeled 1-7.  This diagram is rendered at 10-20 and 10-5 in Figure 1.6. 
6. 
 
 
Figure 1.6: Network diagrams of cog0717. 
 
In Group 1a, E. coli dCTP deaminase has been extensively studied and both its 
structure and mechanism have been deduced (44-46).  The crystal structure revealed a 
homotrimer, forming in total 3 active sites, each occurring at the interface of two 
subunits. 10 sidechains are found to be responsible for substrate binding and catalysis 
(45), and specifically 3 residues are found to catalyze the reaction (46).  Glu-138 
deprotonates a catalytic water, which is stabilized by the polar hydrogen on Ser-111, 
which in turn is hydrogen bonded to R115.  The resulting hydroxyl ion performs a 
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nucleophilic attack on the substrate, resulting in the release of ammonia.  This enzyme 
is unable to perform dUTPase activity, which can be explained by the lack of a catalytic 
glutamine found in Group 7 Mycobacterium tuberculousis (PDB: 1SIX) (47) as well as E. 
coli dUTPase (PDB: 1SEH) (48).  The designation of Group1a is defined as lacking this 
catalytic glutamine.  Other group1 members which populate Group1b have been 
characterized as a bifunctional dCTP deaminase/dUTPase.  Such examples include 
Ethanocaldococcuss (49) and Methanocaldococcus jannaschii (50,51).  Deamination of 
dCTP is accomplished in an identical manner to the Group1a proteins. 
Given these enzymes, it becomes possible to make substrate predictions for 
groups lacking functional annotations.  Sequence alignments were constructed for each 
group, and conserved residues were compared with E. coli dCTP deaminase (S111, 
R115, E138, Q182, D128, S112, K178, Y171, R110, R126, PDB: 1XS1) as well as the 
catalytic residues for M. tuberculosis dUTPase (Q113, PDB: 1SIX).  The active site of E. 
coli dCTP deaminase is presented in Figure 1.7, and the active residues of various 
groups in Table 1.1, with blue symbolizing metal binding residues, red for dUTPase 
residues and yellow for binding residues. 
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Figure 1.7: Active site of PDB: 1XS1. 
 
Table 1.1.  Active site residues of cog0717. 
1A 
1xs1 
S111 R115 E138 Q182 D128 S112 K178 Y171 R110 R126 A 
1B S R E Q D S R/K Y R/K Aro Q 
2 S R E Q E T K Y K P Q 
3 S R E N gap S K Y R gap Q 
4 S R Ins Q D S N Y R E R 
5 S R L E D S S H R V Q 
6 N/T A/E Hypho gap Unc E/D gap gap R Unc T 
7 S K Hypho Unc D G T/S Unc R Unc Q113 
1six 
 
 
Group 2 and Group 3 to our knowledge have not been experimentally verified, 
but reasonably can be assumed to have the function of a bifunctional dCTP 
deaminases/dUTPase.  Group 2 contains two uncharacterized pdb entries (3KM3 and 
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4DHK).  The catalytic machinery for both of these reactions remains intact.  Substrate 
binding residues also are very similar.  An Asn replaces Q182 for uracil binding in Group 
3, but many of the phosphate binding residues are conserved compared to Group 1a 
and 1b.  Finally, the catalytic Gln is present to perform the phosphohydrolase activity. 
Group 4 also has no published experimental results, although a structure exists 
(PDB: 2R9Q).  A sequence alignment predicts there to be a large insertion (>100AAs) 
centered around residues aligning to the catalytic Glu138.  However the structure 
shows 370 AAs, whereas E. coli dCTP deaminase (PDB: 1XS1) is only 193 residues.  A full 
length alignment of a duplicated 1XS1 sequence and 2R9Q reveal a 20% identity (vs. 
23% for single 1XS1), suggesting Group 4 proteins may constitute a duplicated, fused 
version of dCTP deaminase.  Figure 1.8 shows a structural comparison between 2R9Q 
(red) and a 2 subunits of 1XS1 (light gray, dark gray), and the similarity is apparent.  It is 
possible for Group 4 proteins to possess dCTP deaminase activity, but this would need 
to be experimentally verified.  
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Figure 1.8: Structural comparison of a group 4 protein and a homodimer from group 1. 
 
Group 5 shares many conserved residues with Group 1, but is unlikely to be 
capable of deaminase activity.  The most striking feature is the lack of the catalytic 
Glu138, which, like Group 7, has been replaced by a hydrophobic residue.  However, 
many substrate binding residues are intact, and most notably Group 5 shares with 
Group 7 a conserved Gln, which suggests these enzymes may be dUTPases.  Group 6 
proteins share few conserved residues with Group 1 or even Group 7, and their 
function is unknown. 
dCMP deaminase of cog2131 is found in all domains of life, including viruses.  
These enzymes deaminate dCMP, forming the product dUMP which has several 
metabolic roles.  The first activity was described by infecting E. coli with T2 
bacteriophage, suggesting that the enzyme plays a role in viral proliferation (52).  Since 
that discovery in 1960, other dCMPs have been studied including bacterial, mammalian 
1 
2 
7 
4 
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and viral.  The primary structure of human dCMP deaminase was found in 1993 (53). 
Most members of cog2131 have an allosteric site, being activated by dCTP and 
inhibited by dTTP (54,55). 
Three unique structures can be found in the PDB: Streptococcus mutans dCMP 
deaminase with inhibitors (PDB: 2HVW) (56) in Figure 1.9A, T4-bacteriophage (PDB: 
1VQ2) (57) in Figure 1.9B  and human dCMP deaminase (PDB: 2W4L).  The active sites 
of these enzymes are common, and are accomplished through a conserved Zn2+ metal 
site.  A tetrahedral Zn2+ ion is coordinated by a CXXC and HXE motif.  The conserved 
glutamate does not bind to the Zn2+ metal ion but instead functions as a proton shuttle 
for the mechanism, binding to a nucleophilic water which forms the 4th ligand on the 
Zn2+ metal ion.  The allosteric active site is displayed in Figure 1.10. 
 
 
Figure 1.9: A) Active site of 2HVW B) Active site of 1VQ2. 
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Figure 1.10:  Allosteric site of 2HVW 
 
A search in GenBank for “cog2131” retrieved 854 proteins. 99% identical 
redundancies were removed leaving only 440 sequences. At a stringency of 10-40, the 
enzymes cleanly separated into 8 groups (Figure 1.11).  The liganded active sites of 
2HVW and 1VQ2 were used as a comparison for each group.  Table 1.2 shows the 
active site residues, and Table 1.3 shows those ligands used for the allosteric site.  The 
portion shown in yellow indicates mechanistic and metal binding residues. 
Group 1 houses the structure of Streptococcus mutans (PDB: 2HVW). This group 
is mostly bacterial and is shown to cluster with groups 2, 3, and 6. The residues are 
almost universally conserved.  Enzymes found in this group undoubtedly perform the 
same catalytic activity. 
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Figure 1.11:  Cog2131. 
 
Table 1.2.  Active site residues of dCMP deaminase catalytic domain. 
2HVW H71 E73 C99 C102 C24 R26 N45 H65 C66 T69 A72 Y120 R121 
1VQ2 H104 E106 C132 C135 C19 S21 N40 -H71 -C75 E102 A105 Y153 K155 
2W4L H E C C D N N K Y V A K Y 
Group1 H E C C C R N H C T A Y R 
Group2 H E C C C R/A N Hdrph C/S A,G A Y/F - 
Group3 H E C C C R Unc E L S A - R 
Group4 H E C C D S,d N E,p,a Y T A F D,e 
Group5 H E C C D N,h,s N E,D,t Y V,t,s A,s Y E,D,unc 
Group6 H E C C C R N Y V - A Y K/R 
Group7 H E C C D S,N N P Y V A E,k S,e,q 
Group8 H E C C C,d S N -,unc unc unc A Y Unc 
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Table 1.3.  Amino acids aligning with allosteric domain residues. 
2HVW R21 Y44 G46 G47 D50 N53 N75 
1VQ2 E Y G S G N N 
2W4L R Y G M G - N 
Group1 R Y G S,g G,d,a,e H,n N 
Group2 R Y G Unc. G,unc H,n N 
Group3 R Y G A G N N 
Group4 W F G Y G - N 
Group5 R Y G Hydrph G - N 
Group6 L/N Y G T G N N 
Group7 F F,Y G L G - - 
Group8 Unc Unc E/D V Unc Unc Unc 
 
 
Group 2 shares many of the conserved residues as group 1, but seems to split 
into two subgroups. In one (with the equivalent to R26) we expect the substrate to be 
dCMP.  However, a portion of this group lacks R26 (as well as C66 and Y120), which is 
crucial to binding the 5’ phosphate group on dCMP.  It is possible there may be a 
unique function, or perhaps a deoxycytidine deaminase hidden within this group. 
Group 3 is populated by mostly clostridiales and is predicted to deaminated 
dCMP.  Although not all residues are conserved, the arginines corresponding to R26 
and R121 are. 
Group 6 also clusters with group 1. This large group is made up of various 
bacteria like 1, 2, and 3. Much like group three, variations exist, however important 
residues are still conserved.   
Groups 4, 5, and 7 cluster together and do not share many of the conserved 
active site contained in 2HVW and it is difficult to make an assessment without active 
site residues.  They certainly possess the metal binding domain as well as the Asn 
corresponding to N45, but lack many others.  Fortunately both groups 5 and 7 have 
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confirmed activities, even if the active site will remain unannotated.  Group 5 houses 
bacterial enzymes as well as mammalian, including human dCMP deaminase and its 
unliganded structure (PDB: 2W4L).  There is a confirmed activity in group 7, which was 
found to be a bifunctional dCMP/dCTP deaminase (58).  This cluster is comprised 
primarily of chlorella virus.  Group 4 (populated by gamma proteobacteria) has no 
confirmed activities. 
Group 8 is unique and could potentially have a new or additional function.  
Compared to the rest of the enzymes (~130 AAs), group 8 averages over 500 AAs.  The 
sequence corresponding to dCMP deaminase is found near the C-terminus, with the N-
terminus residues showing only similarity to other members of the group.  The 
remaining enzymes include mostly bacterial ones as well as the structure of T4-
bacteriophage. Most of cog2123 seems to have the same dCMP function, however 
groups 2 and 8 may have new functions, and 4 remains untested.  These enzymes are 
found in a wide variety of bacteria and should be experimentally verified. 
Cog0590 houses several functions as well as uncharacterized groups. The known 
activities include tRNA adenosine deaminases, guanine deaminases and cytosine 
deaminases.   Like most other non-amidohydrolase deaminases, a single Zn+2 ion is 
coordinated by 2 cysteine residues and a histidine.  A glutamate (forming an EXH motif 
with the coordinating histidine) plays a role in the chemical mechanism.  A search in 
GenBank revealed 2778 enzymes; after deleted those displaying 99% sequence identity, 
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1393 remained.  The cog cleanly separates into 9 apparent groups when visualized at 
an E-value of 10-30, shown in Figure 1.12.  
 
 
Figure 1.12: Cog0590 at 10-30 
 
The enzymes in group 1 are responsible for deaminating the wobble position on 
tRNA-34, postranscriptionally modifying the adenosine to an inosine.  In prokaryotes, 
this gene is known as tadA and forms a functional homodimer (59), whereas in 
eukaryotes a functional heterodimer  ADAT2-ADAT3 is formed (60).  The biological 
mechanism for this reaction was elucidated, and the enzyme was found to have an 
exceptionally low Km to manage the low concentrations of tRNA in the cell (61). On 
average there are 2500 acyl-tRNA molecules per E. coli cell (62).  A liganded structure 
1 3 
2 
4 
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was determined (PDB: 2B3J) (63) and the layout of the active site is presented in Figure 
1.13. A sequence alignment was constructed, but the active site residues were not 
universally conserved across group one. The metal binding, and catalytic residues, 
Lys106, and the residue corresponding to Asp104 were conserved, with the exception 
of a group with an Asn instead of Asp104. Arg44 however show poor conservation, 
including a large pool of Thr.  Asn similarly lacked conservation across the group.  It is 
possible other functions exist in group 1.  
Group 2 has one characterized activity, that of guanine deaminase (64).  
Inherently, this guanine deaminase is unrelated to the amidohydrolase guanine 
deaminase. There are two structures, one with a ligand of imidazole (PDB: 1WKQ). In 
order to determine how the liganded structure may appear, guanine was 
computationally modeled as an inhibitor and docked into the active site. This model is 
shown in Figure 1.14.  A sequence alignment revealed that the metal binding, catalytic 
and those aligning to Phe26 and N42 are well conserved; however, Y156 and D114 
appear in only half. If the modeled active site is accurate, there may be unique 
functions in group 2. 
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Figure 1.13: Active site shown in PBD: 2B3J 
 
 
Figure 1.14: Active site of 1WKQ with modelled guanine-related inhibitor 
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Figure 1.15: Active site of 1P6O 
 
Group 3 contains no known functions or structures, nor do any predicted active 
site residues align with known functions with the exception of the metal binding 
domain. It is likely there are undescribed activities within this group. 
Group 4 has been well characterized and has the function of cytosine 
deaminase. It was originally described as yeast and found to be unique compared to E. 
coli cytosine deaminase (65,66).  Cytosine deaminase in addition has been studied as a 
potential treatment to cancer, and its liganded structure was solved to assist with 
directed evolution experiments (67).  Shown in Figure 1.15 is the active site of PDB: 
1P6O.  A sequence alignment compared to the remaining group 4 shows the conserved 
Asn and Asp.  It is likely this group contains only cytosine deaminases.  
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No other functions are described in cog0590, meaning possibly additional 
enzymatic activities may be present in the smaller groups.  Several of the larger groups 
certainly contain additional functions. 
Cog0117 members are responsible for riboflavin biosynthesis and are known as 
RibD.  These bifunctional enzymes catalyze the deamination of the pyrimidine and 
reduction of the sugar of 2,5-diamino-6-oxy-4-(5'-phosphoribosylamine)pyrimidine to 
form 5-amino-2,6-dioxy-4-(5'-phosphoribitylamine)pyrimidine (68,69).  Compared to 
the other deaminase COGs mentioned, cog0117 is rather small and only seems for form 
3 groups.  Shown in the network diagram are 692 members labeled retrieved from 
GenBank as “cog0117”, and with 99% identical sequences removed (Figure 1.16).  The 
largest group contains several crystal structures, including that of E. coli RibD and the 
liganded Bacillus subtilis RibG (PDB: 4G3M) (70), which is used in this study for active 
site comparison. 
The central cluster retains the active site residues shown in Figure 1.17, which 
the exception of arginines filling in the role of lysine.  This would not be expected to 
affect substrate specificity.  The two remaining groups share similar residues, but minor 
differences exist.  The larger group uses a mixture of glutamate and aspartate to 
potentially bind to the sugar.  The smaller group substitutes an arginine, much like part 
of the main group in this COG.  Additionally, the smaller group is lacking a portion of 
the C-terminus, perhaps acting only as a monofunctional deaminase.  It seems likely 
though that all members of cog0117 share the same substrate. 
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Figure 1.16: Cog0117 at 10-60 
 
 
Figure 1.17: Active site of 4G3M 
 
While the subject of this manuscript primarily discusses amidohydrolases from 
microbial organisms, it is important to remember the amidohydrolase spans across all 
domains of life, including Homo sapiens.  Amidohydrolases in GenBank are known as 
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metallo-dependent hydrolases, and searching by name will reveal 97,671 sequences.  
The search results were filtered to those from Homo sapiens.  Redundant sequences 
and fragments were deleted and 11 amidohydrolases were identified for humans by 
this method.  Four more were identified by literature.  It is possible there are additional 
sequences not represented. 
The human genome contains two adenosine deaminases, both of which are 
characterized with crystal structures.  Adenosine deaminase I is conserved in many 
organisms but was first detected in humans in kidney tissue (71).  A recent structure 
was solved (PDB: 3IAR) however liganded structures of homologues (such as 91% 
identical bovine ADA) have been solved with ligands (PDB: 1KRM) (72).  In humans, 
ADA-1 is associated with T-cell activation (73) and deficiency results in 
immunodeficiency (74).  Adenosine build up causes apoptosis in lymphocytes (75), and 
inhibition of this enzyme with deoxycoformycin is a strategy for treating leukemia (76).  
ADA-2 is well characterized as well (PDB: 3LGG) (77) and was originally found to play an 
important role as an insect growth factor (78,79).  It was discovered this was due to 
adenosine deaminase activity (80).  In humans it is thought to induce differentiation of 
monocytes to macrophages in addition to aiding the proliferation of macrophages and 
CD4+ T cells (81). 
 Humans also possess three AMP deaminases (AMPD).  AMPD-1 is expressed at 
high levels in skeletal muscle in rat (82), and in humans a deficiency leads to muscle 
cramps and fatigue (83).  Isoform L (liver, AMPD-2) has AMPD activity (84).  In 
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Arabidopsis this gene is known as Embryonic factor 1 and is one of the earliest 
expressed genes (85).  The Arabidopsis gene is 51% identical to humans and its 
structure has been determined (PDB: 2A3L) (86).  In humans this gene is not as well 
characterized other than its in vitro function, but it is known to have several different 
transcripts involving exon shuffling and varying termini (87).  AMPD-3 is found in 
erthyrocytes and was cloned by cDNA human library (88).  Deficiencies in this enzyme 
are entirely asymptomatic in humans (89). 
 Guanine deaminase, as previously mentioned, is found in humans (90) as well as 
several other organisms.  This protein was primarily studied in mouse models, where its 
highest level of expression is in the small intestine (91).  The mouse protein was 
expressed and purified to homogeneity (12).  It is catabolic and forms an important part 
of the purine salvage pathway. 
 Humans also contain an interesting cluster of genes, including 
dihydropyrimidinase and 5 homologues which do not have described catalytic 
functions.  Dihydropyrimidinase is a well characterized function involved in pyrimidine 
metabolism, and deficiencies in this gene can sometimes be asymptomatic or cause 
dihydropyrimidinuria. Several mutations have been found (92).  The remaining 
predicted noncatalytic homologues have been phenotypically characterized, and 
renamed to collapsin response mediator proteins (CRMP) based on homology the 
chicken and rat genes (93,94).  CRMP1 (PDB: 4B3Z) has been physiologically 
characterized to mediate signal transduction of axon guidance molecules (95) and in 
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mouse models deficiencies have shown to impair learning (96).  CRMP2 is the most 
studied CRMP gene and plays a role in neuronal polarity. Its physiological function is 
characterized in a review (97) and its structure solved(PDB: 2GSE) (98).  CRMP3 has 
been studied in mouse systems and found to be localized in portions of the brain 
involved with motor skills (99).  Later this gene in mouse models was found to be 
important for neuronal plasticity, dendrite arborization and guide-posts navigation 
(100).  Its structure was solved in 2013(PDB: 4BKN).  CRMP4 was found to inhibit axon 
outgrowth, and inhibition of this protein may assist with neural regeneration after 
injury (101).  Finally CRMP5, also known as CRMP-associate molecule (CRAM) is found 
to be imnportant in growth cone development (102). Additionally it regulates neural 
growth and plasticity in cerebellar purkinje cells (103).  Its structure has been solved 
(PDB: 4B90) and its oligimerization with other CRMPs has been studied (104). 
 A gene for N-acetylglucosamine deacetylase is present in humans, however this 
gene remains uncharacterized to my knowledge. It can be found as gi:166233266 in 
GenBank. 
 Human renal dipeptidase is found in kidney tissue and had its sequenced 
deduced in 1990 (105). It is known to possess a high glycosylated C-terminus which is 
cleaved during maturation and is anchored to the membrane at Ser369 via 
glysocylphosphatidylinositol (106).  Although its role is not quite understood, it is 
known to hydrolyze cysteinyl dipeptides and some beta-lactam antibiotics (107). Its 
crystal structure has been solved (PDB: 1ITQ) (108).  Two other dipeptidases have been 
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characterized in mouse and are found as homologues in humans.  Dipeptidase 2 cleaves 
leukotriene D4 (LTD4) like Dipeptidase 1, but not cystinyl-bis-glycine.  Oppositely, 
Dipeptidase-3 cleaves cystinyl-bis-glycine but not LTD4 (109). 
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CHAPTER II 
STRUCTURE-GUIDED DISCOVERY OF NOVEL ENZYME FUNCTIONS: FUNCTIONAL 
DIVERSITY IN GROUP 1 OF COG0402* 
 
Introduction 
The rate at which new genes are being sequenced greatly exceeds our ability to 
correctly annotate the functional properties of the corresponding proteins (110).  
Annotations based primarily on sequence identity to experimentally characterized 
proteins are often misleading because closely related sequences can have different 
functions, while highly divergent sequences can have identical functions (18,111).  
Unfortunately, our understanding of the principles that dictate the catalytic properties 
of enzymes, based on protein sequence alone, is often insufficient to correctly annotate 
proteins of unknown function.  New methods must therefore be developed to define 
the sequence boundaries for a given catalytic activity and new approaches must be 
formulated to identify those proteins that are functionally distinct from their close 
sequence homologues.  To address these problems, we have developed a 
comprehensive strategy for the functional annotation of newly sequenced genes using 
a combination of structural biology, bioinformatics, computational biology, and 
molecular enzymology (4,19,112).  The power of -this multidisciplinary approach for 
                                                     
* This chapter is adapted with permission from Structure-Guided Discovery of New Deaminase Enzymes 
Daniel S. Hitchcock, Hao Fan, Jungwook Kim, Matthew Vetting, Brandan Hillerich, Ronald D. Seidel, 
Steven C. Almo, Brian K. Shoichet, Andrej Sali, and Frank M. Raushel Journal of the American Chemical 
Society 2013 135 (37), 13927-13933.  Copyright 2013 American Chemical Society. 
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discovering new reactions catalyzed by uncharacterized enzymes is being tested using 
the amidohydrolase superfamily (AHS) as a model system (2,19). 
The AHS is an ensemble of evolutionarily related enzymes capable of 
hydrolyzing amide, amine, or ester functional groups at carbon and phosphorus centers 
(1,2).  More than 24,000 unique protein sequences have been identified in this 
superfamily and they have been segregated into 24 clusters of orthologous groups 
(COG) (113).  One of these clusters, cog0402, catalyzes the deamination of nucleic acid 
bases (2,19).  Previously, we successfully predicted that Tm0936, an enzyme from 
Thermotoga maritima, would catalyze the deamination of S-adenosylhomocysteine 
(SAH) to S-inosylhomocysteine (SIH) (19).   Here we significantly expand the scope of 
these efforts by addressing the functional and specificity boundaries for more than 
1000 proteins homologous to Tm0936, resulting in the prediction and discovery of 
novel substrate profiles for neighboring enzyme subgroups.  To do so, we have 
integrated a physical library screen with the computational docking of high-energy 
reaction intermediates to homology models of fifteen previously uncharacterized 
proteins.  To identify enzymes most closely related to Tm0936, we retrieved all of the 
protein sequences that correlated with a BLAST E-value cutoff better than 10-36 (8).  
This procedure identified 1358 proteins that were further sorted into smaller 
subgroups through the construction of a sequence similarity network at a BLAST E-
value cutoff of 10-100 (Figure 2.1) (9).  The minimal sequence identity between any two 
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proteins in this network is 23% and twelve representative subgroups (sg-1a through sg-
11) were arbitrarily defined, colored-coded, and numbered. 
The three-dimensional structure of Tm0936 (from sg-8) was previously 
determined in the presence of the product SIH.  The most salient structural features for 
substrate recognition include Glu-84, Arg-136, Arg-148 and His-173 (Figure 2.2).  These 
residues form electrostatic interactions with the 2’- and 3’-hydroxyls from the ribose 
sugar, the α-carboxylate of the homocysteine moiety, and N3 of the purine ring (19).  
The catalytic machinery is composed of a zinc ion that is coordinated by three histidine 
residues (His-55, His-57, His-173) and an aspartate (Asp-279), while proton transfer 
reactions are facilitated by Glu-203 and His-228.  The six residues required for metal 
binding and proton transfers are fully conserved in all 1358 proteins (Figure 2.1).  
However, only those proteins within sg-8 fully conserve the four residues that are 
utilized in the recognition of SIH; sg-1 through sg-7 lack one or both of the carboxylate-
binding arginine residues, while sg-9, sg-10, and sg-11 lack the two adenine/ribose 
recognition residues, histidine and glutamate.  All of these proteins are therefore 
anticipated to contain unique substrate profiles and to catalyze the deamination of 
unanticipated substrates. 
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Figure 2.1: Sequence similarity network for proteins related to Tm0936 from 
Thermotoga maritima.  A node (dot) represents an enzyme from a bacterial species and 
an edge (a connecting line) indicates that the two proteins are related by a BLAST E-
value of 10-100 or better.  Proteins sharing sequence similarity with Tm0936 cluster into 
apparent subgroups and 12 of these have been arbitrarily numbered and color-coded 
based on the network diagram.  Subgroups are predicted to be functionally similar, and 
representatives from each subgroup, denoted by the letters a-p, were selected for 
purification and functional characterization. 
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Figure 2.2: The active site of Tm0936.  The crystal structure of Tm0936 (PDB id: 2PLM) 
in the presence of S-inosylhomocysteine (green) highlights the four residues (dark gray) 
that are important for substrate binding.  Arg-148 and Arg-136 bind to the carboxylate 
moiety of SAH; His-173 and Glu-84 interact with N3 of the purine ring and the 2’, 3’ 
hydroxyls of the ribose moiety, respectively.  Faded residues denote the six residues 
that bind the zinc or facilitate proton transfer reactions during the catalytic 
transformations.  These residues are conserved in all of the proteins depicted in Figure 
2.1. 
 
 
Methods 
Cloning and Purification of Mm2279, Spn3210, Moth1224, Avi5431, Tvn0515 
Caur1903, and Cthe1199.  The genes for Mm2279, Spn3210, Moth1224, Avi5431, and 
Tvn0515 were cloned into a pET-30a expression vector with C-terminal 6x His-tags.  
Caur1903 was cloned into pET-42a with an N-terminal GST tag.  Cthe1199 was cloned 
into pET-30a without a His-tag.  The E. coli BL-21 DE3 cells were transformed with the 
plasmids and plated onto LB-agarose containing 50 μg/mL kanamycin.  1 L cultures (LB 
broth, kanamycin 50 μg/mL) were inoculated from the resulting colonies and grown at 
37 °C until the optical density at 600 nm reached 0.6.  Protein expression was induced 
with 1 mM IPTG, and the cultures were shaken for 20 hours at 25 °C.  The cultures were 
centrifuged at 7000 RPM for 15 minutes and the cell pellets were disrupted by 
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sonication in 35 mL of running buffer and PMSF.  DNA was precipitated by protamine 
sulfate.  Proteins with a 6x His-tag were loaded onto a 5 mL HisTrap column (GE 
HEALTHCARE, USA) with running buffer (20 mM HEPES, 250 mM NaCl, 250 mM NH4SO4, 
20 mM imidazole, pH 7.5) and eluted with a linear gradient of elution buffer (20 mM 
HEPES, 250 mM NaCl, 250 mM NH4SO4, 500 mM imidazole, pH 7.5).   
Caur1903 was loaded onto a 5 mL GSTrap column (GE HEALTHCARE, USA) with 
running buffer (20 mM HEPES, 10% [w/v] glycerol, 200 mM NaCl, 200 mM NH4SO4, pH 
8.0) and eluted with a gradient of elution buffer (20 mM HEPES, 10% [w/v] glycerol, 200 
mM NaCl, 200 mM NH4SO4, 10 mM reduced glutathione, pH 8.0).  Cthe1199 was 
precipitated with 70% saturation NH4SO4 and the pellet resuspended in 4 mL of 50 mM 
HEPES, pH 7.5.  The solution was loaded onto a HiLoad 26/60 Superdex 200 gel 
filtration column.  Active fractions were loaded onto an anion exchange column with 
binding buffer (20 mM HEPES, pH 7.5), and eluted with a gradient of 20 mM HEPES, 1 M 
NaCl, pH 7.5.  All proteins were concentrated with a 10 kDa molecular weight cutoff 
filter.  Moth1224 and Mm2279 were almost entirely insoluble.  Both proteins were 
verified by N-terminal sequencing. 
Cloning and Purification of Cv1032, Pfl4080, Ef1223, Cpf1475, Dvu1825, and 
Bc1793.  The genes for these proteins were PCR amplified and ligated into pSGX3, a 
derivative of pET26b (114), yielding a protein with Met-Ser-Leu followed by the PCR 
product and a C-terminal hexa-histidine tag.  BL21 (DE3)-Condon 1 RIL (Invitrogen) cells 
were transformed with these plasmids and selenomethionine-labeled protein was 
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expressed in 3 L of HY media with 50 μg/mL of kanamycin and 35 μg/mL of 
chloramphenicol.  Expression was induced with 0.4 mM IPTG at an OD 600 of 1.0 and 
grown for 21 hours whereupon the cells were pelleted by centrifugation.  Cells were 
resuspended in 3x the volume with 20 mM Tris-HCl pH 8.0, 500 mM NaCl, 25 mM 
imidizole, 0.1% (v/v) Tween20, lysed by sonication, and clarified by centrifugation at 4° 
C.  The supernatant was applied to a 5-mL HisTrapHP column (GE HEALTHCARE, USA) 
pre-equilbrated with 20 mM Tris-HCl pH 8.0, 500 mM NaCl, 25 mM imidizole, 10% (w/v) 
glycerol.  The column was washed with 10 column volumes (CV) of 20 mM Tris–HCl pH 
8.0, 500 mM NaCl, 10% (w/v) glycerol, and 40 mM imidazole, and subsequently step-
eluted with 2 CV of same buffer with an imidazole concentration of 250 mM.  
Concentrated fractions were pooled and subsequently passed over a 120-mL Superdex 
200 column (GE HEALTHCARE, USA) equilibrated with 10 mM HEPES pH 7.5, 150 mM 
NaCl, 10% (w/v) glycerol, and 5 mM DTT.  Proteins exhibiting purity on SDS-GELS 
greater than 95% were pooled and concentrated to > 10 mg/mL using AMICON 
centrifugal filters.  Samples were snap-cooled in liquid N2, and stored at -80 °C.  
Cloning and Purification of Pa3170 and Xcc2270.  The genes for Pa3170 and 
Xcc2270 were amplified from their respective genomic DNA using primers that included 
a ligation independent cloning sequence and the N- and C-terminal sequences of each 
respective gene.  In general, PCR was performed using KOD Hot Start DNA Polymerase 
(NOVAGEN).  The amplified fragments for Pa3170, and Xcc2270 were cloned into the C-
terminal TEV cleavable StrepII-6x-His-tag containing vector CHS30, a derivative of 
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pET30 by ligation-independent cloning (115).  BL21 (DE3)-Condon 1 RIL (Invitrogen) 
cells were transformed with the resulting plasmids and protein was expressed by 
autoinduction in 2 L of ZYP-5052 media with 50 μg/mL of kanamycin and 35 μg/mL of 
chloramphenicol.  Cells were grown at 37 °C to an OD of 2-4 and then reduced to 22 °C 
for a period of 12-16 hours whereupon the cells were pelleted by centrifugation.  Cells 
were resuspended in 3x the volume with 50 mM Hepes, pH 7.5, 150 mM NaCl, 10% 
(w/v) glycerol, 20 mM imidazole, lysed by sonication, and clarified by centrifugation at 
4 °C.  The supernatant was applied to a 1-mL HisTrapHP column (GE HEALTHCARE) pre-
equilbrated with 50 mM Hepes, pH 7.5, 150 mM NaCl, 25 mM imidizole, 10% (w/v) 
glycerol.  The column was washed with 10 column volumes of 50 mM Hepes, pH 7.5, 
150 mM NaCl, 10% (w/v) glycerol, 25 mM imidazole and subsequently step-eluted with 
the same buffer with an imidazole concentration of 250 mM directly onto a 120-mL 
Superdex 200 column (GE HEALTHCARE) equilibrated with 10 mM HEPES pH 7.5, 150 
mM NaCl, 10% (v/v) glycerol, and 5 mM DTT (protein storage buffer).  Proteins 
exhibiting purity on SDS-GELS greater than 95% were pooled, concentrated to >10 
mg/mL using AMICON centrifugal filters.  Samples were snap-cooled in liquid N2, and 
stored at -80 °C. 
Substrate Characterization.  Substrate screening was performed by monitoring 
the UV-vis spectral change from 235 to 320 nm.  Potential substrates at a concentration 
of 100 μM were incubated overnight in a 96-well quartz plate with 1 M enzyme in 50 
mM HEPES, pH 7.5.  Those showing a spectral change were subjected to more detailed 
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kinetic assays.  The kinetic constants were determined in 20 mM HEPES buffer at pH 7.5 
by a direct UV assay at 30 °C.  Deamination of adenosine, 5’-dAdo, MTA, SAH and S-
adenosylthiopropylamine (TPA) were monitored at 263 nm (∆ε = 7900 M-1 cm-1) or 274 
nm (∆ε = 2600 M-1 cm-1), depending on the concentration of substrate.  Non-adenosine 
compounds were as follows: guanine (245 nm, ∆ε = 5200 M-1 cm-1), 2-hydroxyadenine 
(∆ε = 294 nm, 6600 M-1 cm-1), 8-oxoadenine (∆ε = 272 nm, 3700 M-1 cm-1).  Values of kcat 
and kcat /Km were determined by fitting the data to equation 2.1 using SigmaPlot 11, 
where v is the initial velocity, Et is enzyme concentration, and A is the substrate 
concentration.  
 
v/Et = kcat Ka/ (A + Ka)                                                        (Equation 2.1) 
 
 Homology Modeling.  Two structures (PDB code: 2PLM and 1P1M) have been 
solved for Tm0936 from Thermotoga maritima in the ligand-bound (holo) and ligand-
free (apo) states, respectively.  The holo structure of Tm0936 was used as a template to 
build homology models for 15 proteins from 11 subgroups.  Because Moth1224 from 
sg-9 has a sequence identity similar to that of guanine deaminase (PDB code: 2UZ9) as 
it does to Tm0936, the structure of guanine deaminase was also used as template for 
Moth1224.  For each target-template pair, the same procedure of homology modeling 
was applied.  First, the sequence alignment was computed by MUSCLE (Multiple 
Sequence Comparison by Log-Expectation).  Second, a total of 500 homology models 
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were generated with the standard “automodel” class in MODELLER (116), and the 
model with the best DOPE (117) score was selected to begin the model refinement.  
Third, side chains of active site residues that are within a distance of 5 Å from the 
bound ligand in the template structure, were optimized using the “side chain prediction” 
protocol in PLOP (118), resulting in one representative model.  The bound ligand from 
the template structure was included in the second step for construction of the initial 
homology model, but was removed in the model refinement.  
Virtual Screening. The high-energy intermediate (HEI) library (119,120) that 
contains 57,672 different intermediate forms of 6440 KEGG (Kyoto Encyclopedia of 
Genes and Genomes) (121,122) molecules was screened against the crystal structure of 
Tm0936 and each of the refined homology models using the docking program DOCK 3.6 
(123).  The computed poses were subjected to a distance cutoff to make sure that the 
O– of the HEI portion of the molecule is found within 4 Å of the metal ions in the active 
site.  Of the molecules that satisfied this constraint, the top 500 compounds ranked by 
DOCK score (consisting of van der Waals, Poisson–Boltzmann electrostatic, and ligand 
desolvation penalty terms) were inspected visually to ensure the compatibility of the 
pose with the amidohydrolase reaction mechanism.  The details of the HEI docking 
library preparation, the molecular docking procedure, and the docking results analysis 
have been previously described (119,120,124,125). 
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Results 
Target Selection and Structure Determination.  Representative examples from 
each of the twelve major subgroups contained within the sequence similarity network 
of proteins (Figure 2.1) related to the initial protein target, Tm0936, were selected for 
interrogation (Table 2.1).  Proteins from sg-1a (Cthe1199), sg-1b (Mm2279), sg-2 
(Cv1032, Pfl4080, Xcc2270, and Pa3170), sg-3 (Ef1223 and Cpf1475), sg-4 (Bc1793), sg-5 
(Spn13210), sg-6 (Dvu1825), sg-7 (Caur1903), sg-8 (Tm0936), sg-9 (Moth1224), sg-10 
(Avi5431), and sg-11 (Tvn0515) were purified to homogeneity and the three-
dimensional structures of three proteins were determined (Table 2.2).  The structure of 
Cv1032 was determined in the presence of inosine (PDB id: 4F0S) and also with 5’-
methylthioadenosine (MTA) in an unproductive complex (PDB id: 4F0R).  The structures 
of Xcc2270 (PDB id: 4DZH) and Pa3170 (PDB id: 4DYK) were determined with zinc 
bound in the active site.  
Predictions of Enzyme Function.  Homology models were constructed for each 
of the purified proteins using the X-ray structure of Tm0936 (PDB id: 2PLM) as the 
initial structural template (126).  A virtual library of 57,672 high-energy reaction 
intermediates (HEI) was screened against the homology models, as well as the X-ray 
structure of Tm0936 (112).  For the thirteen targets from sg-1 through sg-8, analogues 
of adenosine (5’-deoxyadenosine, adenosine, 5’-methylthioadenosine, and SAH) were 
predicted as the most probable substrates (Table 2.3). 
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Table 2.1: Amidohydrolase selected from cog0402 for purification. 
Subgroup  Organism gi Locus tag Sequence 
identity to 
Tm0936 
1a Clostridium thermocellum ATCC 27405 125973714 Cthe_1199 42% 
1b Methanosarcina mazei Go1 21228381 MM_2279 40% 
2 Chromobacterium violaceum ATCC 12472 34496487 CV_1032 32% 
2 Pseudomonas fluorescens Pf0-1 77460301 Pfl01_4080 34% 
2 Xanthomonas campestris pv. campestris str. ATCC 
33913 
21231708 
XCC2270 34% 
2 Pseudomonas aeruginosa PAO1 15598366 PA3170 33% 
3 Clostridium perfringens ATCC 13124 110799822 CPF_1475 31% 
3 Enterococcus faecalis V583 29375796 EF1223 28% 
4 Bacillus cereus ATCC 14579 29895480 BC1793 36% 
5 Streptococcus pneumoniae ATCC 700669 221232098 SPN23F_13210 33% 
6 Desulfovibrio vulgaris str. Hildenborough 46580235 Dvu1825 36% 
7 Chloroflexus aurantiacus J-10-fl 163847463 Caur_1903 32% 
8 Thermotoga maritima MSB8 15643698 Tm0936 100% 
9 Moorella thermoacetica ATCC 39073 
 
83590072 
Moth_1224 
32% 
10 Agrobacterium vitis S4 222106480 Avi_5431 31% 
11 Thermoplasma volcanium GSS1 13541346 TVN0515 30% 
 
 
The histidine residue that interacts with N3 from the purine ring of SAH in the 
structure of Tm0936 is conserved in all of the proteins except for the enzymes from sg-
9 (Moth1224), sg-10 (Avi5431), and sg-11 (Tvn0515).  In Moth1224 (sg-9), this histidine 
residue is replaced by an arginine (Arg-192), which has previously been observed in the 
active site of guanine deaminase (4).  The sequence identity (33%) between Moth1224 
and Tm0936 is similar to that between Moth1224 and human guanine deaminase (31%) 
(PDB id: 2UZ9).  Therefore, a homology model was constructed for Moth1224 based on 
each one of these two templates separately.  For the model based on Tm0936, the 
docking hits were predominantly adenosine analogues (Table 2.3).  However, for the 
model based on guanine deaminase, the primary docking hits were analogues of 
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guanine.  The highest ranking of these compounds included guanine (rank 10), 8-
oxoguanine (rank 29), and thioguanine (rank 35). 
In Avi5431 (sg-10) the sequence alignment predicts that a glutamate (Glu-189) 
replaces the histidine that interacts with N3 of the adenine moiety in the Tm0936 
template.  However, in the modeled active site of Avi5431, His-190 occupies the same 
physical position as His-173 in Tm0936, while the side chain of Lys-308 is located on the 
other side of the pocket, which has no available space for the binding of the ribose 
moiety of adenosine-like compounds.  The primary docking hits for Avi5431 included 
small aromatic amines that are not attached to a ribose group.  Among the best ranking 
compounds are mercarzole (rank 3), 6-hydroxymethyl 7,8-dihydropterin (rank 6), 8-
oxoadenine (rank 21), melamine (rank 22), and guanine (rank 28). 
Tvn0515 from sg-11 is unusual as proteins within this subgroup have a 
conserved glutamine in place of the histidine that binds to N3 of the adenine moiety in 
Tm0936.  Originally, it was hypothesized that this substitution would enable the binding 
of 2-oxoadenosine in a manner similar to the way the homologous carbonyl group 
binds in cytosine, pterin, and guanine deaminases (26).  However, virtual screening 
against the homology model of Tvn0515 suggested adenosine analogues as the most 
probable substrates; SAH was ranked higher than adenosine, MTA, and 5’-dAdo (Table 
2.3). 
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Table 2.2.  Crystallization data.    
DATASET STATISTICSa 
Cv_1032  
(Zn-INOSINE) 
Cv_1032  
(Zn-MTA) 
XCC2270 (ZN) PA3170 (ZN) 
Space Group P41212 P41212 C2 P212121 
Unit Cell (Å , ) a=b=101.1 c=88.0 a=b=101.1 c=88.6 
a=133.6 b=51.2 
c=67.4 β=106.5 
a=73.9 b=98.7 
c=119.8 
Resolution (Å) 50-1.85 (1.88-1.85) 50-1.8 (1.83-1.8) 50-1.53 (1.65-1.55) 50-2.0 (2.03-2.0) 
Completeness (%) 98.1 (98.6) 99.2 (100.0) 99.6 (100.0) 99.6 (98.9) 
Redundancy 11.4 (11.4) 6.1 (5.8) 3.7 (3.7) 5.2 (4.7) 
Mean(I)/sd(I) 21.9 (4.3) 23.2 (2.3) 18.9 (2.8) 11.2 (2.7) 
Rsym  0.140 (0.870) 0.102 (0.799) 0.068 (0.527) 0.068 (0.753) 
STRUCTURE STATISTICS     
Resolution (Å) 40.3-1.85 (1.90-1.85) 50-1.80 (1.85-1.80) 50-1.53 (1.57-1.55) 50-2.0 (2.05-2.0) 
Unique reflections 39008 (2648) 41034 (2892) 65346 (2581) 55862 (3609) 
Rcryst (%) 15.7 (16.2) 16.3 (19.0) 20.8 (31.6) 17.6 (27.6) 
Rfree (%, 5% of data) 18.5 (19.2) 19.9 (22.2) 23.3 (36.8) 22.4 (35.4) 
Contents of model (Native Range)b 1-439 1-439 1-449 1-444 
 Observed residues A5-438 A5-440 A9-447 A6-442, B6-442 
 Waters 299 325 247 309 
 Atoms total 3674 3646 3673 7035 
Average B-factor (Å2)     
 TLS groups (#) 0 0 2 8 
 Protein/Waters/Ligand/Zn 18.6/26.1/19.1/- 20.2/30.8/28.7/15.2 25.8/17.6/-/32.3 45.4/43.4/-/33.5 
RMSD     
 Bond lengths (Å)  /Angles () 0.007/1.082 0.015/1.338 0.024/1.508 0.008/1.103 
MOLPROBITY STATISTICS     
 Ramachandran 
 Favored / Outliers (%)  
97.0 (0.23) 97.0 (0.23) 96.3 (0.23) 96.3 (0.3) 
 Rotamer Outliers (%) 0.0 0.29 1.2 2.0 
 Clashscore d 4.36 (98th pctl) 5.87 (94th pctl) 5.25 (92nd pctl) 7.99 (90th pctl) 
 Overall scored 1.39 (97th pctl) 1.49 (94th pctl) 1.57 (83rd pctl) 1.91 (80th pctl) 
PDB ID 4F0S 4F0R 4DZH 4DYK 
a Statistics in parenthesis are for the highest resolution bin 
b numbering outside of listed native range are polyhistidine tags or cloning artifacts 
c Scores are ranked according to structures of similar resolution as formulated in MOLPROBITY 
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Table 2.3  Enzyme kinetic constants at pH 7.5, 30 oC, and docking ranks. 
Protein Substrate 
kcat/Km (M-1 s-1) 
Label Subgroup Locus Tag 5’-dAdo Ado MTA SAH 
(a) 1a Cthe1199 5.0 x 104 
(6) 
1.6 x 104 
(5) 
2.9 x 106 
(9) 
1.4 x 107 
(1) 
(b) 1b Mm2279 1.2 x 107 
(16) 
2.2 x 105 
(12) 
1.7 x 107 
(10) 
1.3 x 107 
(11) 
(c) 2 Cv1032 3.4 x 106 
(26) 
6.6 x 106 
(13) 
1.2 x 106 
(20) 
<10 
(80) 
(d) 2 Pfl014080 8.9 x 106 
(13) 
4.6 x 105 
(5) 
1.3 x 107 
(2) 
<10 
(316) 
(e) 2 Xcc2270 4.7 x 106 
(16) 
3.4 x 106 
(10) 
6.8 x 106 
(4) 
<10 
(60) 
(f) 2 Pa3170 4.5 x 107 
(23) 
9.6 x 106 
(9) 
8.2 x 107 
(19) 
<10 
(361) 
(g) 3 Cpf1475 <10 
(66) 
<10 
(50) 
<10 
(135) 
<10 
(212) 
(h) 3 Ef1223 <10 
(82) 
<10 
(44) 
<10 
(37) 
<10 
(373) 
(i) 4 Bc1793 3.6 x 105 
(12) 
3.7 x 105 
(6) 
3.4 x 101 
(32) 
<10 
(na)a 
(j) 5 Spn13210 1.5 x 107 
(34) 
7.2 x 106 
(23) 
<10 
(52) 
<10 
(334) 
(k) 6 Dvu1825 1.2 x 107 
(10) 
2.6 x 105 
(5) 
6.2 x 102 
(12) 
<10 
(na) 
(l) 7 Caur1903 2.6 x 105 
(6) 
2.6 x 105 
(3) 
<10 
(12) 
<10 
(14) 
(m) 8 Tm0936 3.7 x 104 
(6) 
9.2 x 103 
(3) 
1.5 x 106 
(2) 
1.1 x 107 
(1) 
(n) 9 Moth1224 <10 
(na) 
<10 
(na) 
<10 
(na) 
<10 
(na) 
(o) 10 Avi5431 <10 
(na) 
<10 
(na) 
<10 
(na) 
<10 
(na) 
(p) 11 Tvn0515 <10 
(175) 
<10 
(131) 
<10 
(106) 
2.6 x 105 
(28) 
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Physical Library Screen and Kinetic Assays.  A physical library of more than 100 
potential substrates was assembled and tested for catalytic activity using the 16 
enzymes isolated for this investigation by monitoring the change in absorbance from 
240-300 nm of the following compounds: The following compounds were tested for 
deamination with all purified enzymes: melamine, cytosine, thioguanine, guanine, 
adenine, 7-methylguanine, cytidine, 2’-deoxycytidine, pterin, biopterin, neopterin, 
guanosine, adenosine, 8-mercaptoguanine, 2,6-diaminopurine, xanthine, 8-oxoguanine, 
urate, 9-methylguanine, 6-chloropurine, 8-oxoadenine, isopentenyladenine, N6-
methyladenine, 1-methyladenine, cis-zeatin, trans-zeatin, benzyladenine, 2-amino-6-
benzylthiopurine, N-ethenopurine, N6-acyladenine, kinetin, N-dimethyladenine, N-
butyladenine, isoguanine, 2-amino-6-methoxypurine, 6-methylthiopurine, 2-
chloroadenine, 6-methoxyadenine, 6-mercaptopurine, 7-methyladenine, 2-
dimethylaminoadenine, 3-iminisoindolinone, acycloguanosine, 2’-deoxyguanosine, 
xanthosine, 2’-deoxyadenosine, 3’-deoxyadenosine, 5’-deoxyadenosine, 2’,5’-
dideoxyadenosine, 5’-amino-5’-deoxyadenosine, 5’-chloro-5’-deoxyadenosine, 5’-
deoxy-5’-methylthioadenosine, S-adenosylhomocysteine, S-adenosylthiopropylamine 
N6-methyl-2’-deoxyadenosine, isoguanine, 2’-deoxyisoguanine, cytosine-β-D-
arabinofuranose, N-methylcytidine, 5-methyl-2’-deoxycytidine, 5-
hydroxymethylcytidine, 2,4-diaminopyrimidine, 4,6-diaminopyrimidine, 4-amino-2,6-
dihydroxypyrimidine, 2-amino-4,6-dihydroxypyrimidine, 5-methlcytosine, 5-
hydroxymethylcytosine, 5-carboxycytosine, 5-aminocytosine, 5-fluorocytosine, 5-
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chlorocytosine, 4-hydroxy-2,5,6-triaminopyrimidine, N-methylcytosine, 3-
methylcytosine, 2,6-diaminopyrimidine, 2,4,6-triaminopyrimidine, uracil, 5-aminouracil, 
5-formyluracil, 5-fluorouracil, 3-oxauracil, 5-hydroxymethyluracil, 6-
hydroxyaminouracil, thiamine, 2-aminopyrimidine, 4-aminopyrimidine, toxopyrimidine, 
sulfamonomethoxine, 4-thiouracil, 2-thiouracil, thymine, 5-azacytosine, ammeline, 
ammelide, cyanuric acid, 2-amino-4-hydroxy-6-chlorotriazine, cyromazin, N-
ethylammeline, desethylatrazine, 6-azacytosine, 2-aminopyridine, 2,6-diaminopyridine, 
4,6-diamino-2-hydroxpyridine, 4-aminopyridine, 4-dimethylaminopyridine, creatinine, 
5-amino-4-imidazolecarboxyamide, 5-hydantoin acetic acid, 3-amino-5-mercapto-1,2,4-
triazole, 3-amino-5-carboxy-1,2,4-triazole, dihydrouracil, dihydrothymine, and 
dihydroorotate.  The structures of the best substrates are provided in Figure 2.3.  
Compounds that exhibited catalytic activity with any of the 16 proteins were subjected 
to detailed kinetic assays using a direct spectrophotometric assay.  Analogues of 
adenosine, including 5’-dAdo, MTA, and SAH, were deaminated by proteins from sg-1a, 
sg-1b, sg-2, sg-4 through sg-8, and sg-11.  For most targets, the substrates with the 
highest activity had kcat/Km values that ranged from 105 - 107 M-1 s-1, except for Cpf1475 
and Ef1223 from sg-3 for which no substrates could be identified.  The proteins from 
sg-1a, sg-1b, sg-8, and sg-11 preferentially deaminated SAH.  MTA was deaminated by 
proteins from sg-1 and sg-8, but not from sg-11.  The four proteins purified from sg-2 
deaminated MTA, 5’-dAdo, and adenosine, but not SAH.  The proteins purified from sg-
4 through sg-7 preferentially deaminated adenosine and 5’-dAdo; MTA is either not a 
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substrate or it is deaminated 4-orders of magnitude less efficiently.  For the proteins 
purified from sg-4, sg-5, and sg-7, adenosine and 5’-dAdo are equally good substrates, 
whereas for Dvu1825 from sg-6, 5’-dAdo is a substantially better substrate than is 
adenosine.  The values of kcat/Km for adenosine, 5-dAdo, MTA, and SAH are presented in 
Table 2.3 and the values of Km and kcat are provided in Table 2.4. 
Moth1224 (sg-9) and Avi5431 (sg-10) were subjected to more extensive library 
screening because these proteins lacked many of the conserved residues found in 
Tm0936.  Guanine was the only substrate identified for Moth1124 with values of 
kcat/Km and kcat of 1.2 x 105 M-1 s-1 and 0.48 s-1, respectively.  Avi5431 deaminated two 
adenine related compounds, 8-oxoadenine and 2-oxoadenine, with values of kcat/Km of 
1.8 x 105 and 2.3 x 104 M-1 s-1, respectively.  The values of kcat for these two compounds 
are 3.4 and 13 s-1.  This enzyme did not deaminate adenine. 
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Figure 2.3: The structures of substrates for the enzymes related to Tm0936. 
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Table 2.4.  Kinetic constants of adenosine deaminating enzymes. 
Locus Tag Subgroup 5dAdo Ado MTA SAH TPA 
  kcat 
(s-1) 
Km 
(μM) 
kcat/Km 
(M-1s-1) 
kcat 
(s-1) 
Km 
(μM) 
kcat/Km 
(M-1s-1) 
kcat 
(s-1) 
Km 
(μM) 
kcat/Km  
(M-1s-1) 
kcat 
(s-1) 
Km 
(μM) 
kcat/Km 
(M-1s-1) 
kcat 
(s-1) 
Km 
(μM) 
kcat/Km 
(M-1s-1) 
Cthe1199 1a 3.9  0.1 78 ± 7 5.0 (0.3) x 104 2.6 ± 0.1 160 ± 20 1.6 (0.1) x 104 25 ± 2 9 ± 1 2.9 (0.6) x 106 25.6 ± 0.5 1.8 ± 0.2 1.4 (0.1) x 107 23 ± 1 4.4 ± 0.7 5.2 (0.5) x 106 
MM2279 1b 27 ± 2 2.3 ± 0.4 1.2 (0.1) x 107 7.9 ± .7 36 ± 8 2.2 (0.3) x 105 16 ± 1 0.9 ± 0.3 1.7 (0.4) x 107 34 ± 3 2.7 ± 0.6 13 (2) x 107 16 ± 1 2.1 ± 0.4 7.6 (1) x 106 
Cv1032 2 105 ± 3 31 ± 3 3.4 (0.3) x 106 107 ± 4 16 ± 3 6.6 (1) x 106 18.2 ± 0.3 16 ± 1 1.2 (0.1) x 106 ND ND <100 ND ND <100 
Pf1014080 2 119 ± 3 13 ± 1 8.9 (0.6) x 106 40 ± 1 90 ± 10 4.6 (0.2) x 105 57 ± 2 4 ± 1 1.3 (0.1) x 107 ND ND <100 ND ND <100 
XCC2270 2 67 ± 1 14 ± 1 4.7 (0.2) x 106 80 ± 2 24 ± 2 3.4 (0.1) x 106 74 ± 2 11 ± 1 6.8 (0.4) x 106 ND ND <100 ND ND <100 
PA3170 2 180 ± 3 4.0 ± 0.3 4.5 (0.2) x 107 131 ± 9 14 ± 3 9.6 (1.3) x 106 155 ± 3 1.9 ± 0.2 8.2 (0.8) x 107 ND ND <100 ND ND <100 
Bc1793 4 41 ± 1 130 ± 20 3.6 (0.3) x 105 46 ± 2 120 ± 10 3.7 (1) x 105 ND ND <100 ND ND <100 ND ND <100 
SPN23F13210 5 850 ± 60 60 ± 10 15 (2) x 106 660 ± 40 90 ± 10 7.2 (0.4) x 106 ND ND <100 ND ND <100 ND ND <100 
Dvu1825 6 38.7 ± 0.5 3.3 ± 0.2 1.2 (0.1) x 107 43 ± 3 170 ± 20 2.6 (0.2) x 105 ND ND 620 ± 40 ND ND <100 ND ND <100 
Caur1903 7 2.58 ± 0.05 11 ±1 2.3 (0.1) x 105 1.44 ± 0.04 5.6 ± 0.7 2.6 (0.3) x 105 ND ND <100 ND ND <100 ND ND <100 
Tm0936 8 1.4 ± 0.1 39 ± 7 3.8 (0.5) x 104 2.2 ± 0.2 13 ± 4 1.7 (0.3) x 105 6.0 ± 0.3 4.0 ± 0.3 1.5 (0.1) x 106 7.1 ± 0.4 0.6 ± 0.2 1.1 (0.3) x 106 17 ± 1 9 ± 2 1.9 (0.2) x 106 
TVN0515 11 ND ND <100 ND ND <100 ND ND <100 2.77 ± 0.05 11 ± 1 2.6 (0.2) x 105 ND ND <100 
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Discussion 
Substrate Profiles.  In this investigation we have successfully characterized 
fifteen proteins related in sequence to the first enzyme (Tm0936) found capable of 
deaminating SAH to SIH.  Using a combination of homology modeling, virtual screening 
and physical library screening, six unique substrate profiles were established for twelve 
subgroups of proteins homologous to Tm0936.  Tvn0515 (sg-11) deaminates only SAH, 
while enzymes from three subgroups (sg-1a, sg-1b, and sg-8) efficiently deaminate both 
SAH and MTA.  Enzymes from sg-2 deaminate MTA, adenosine, and 5’-dAdo equally 
well, whereas proteins from sg-4, sg-5, and sg-7 cannot deaminate MTA but will 
deaminate adenosine and 5’-dAdo equally well.  Enzymes from sg-6 deaminate 5’-dAdo 
about 100 times faster than adenosine.  All of these substrates are linked to the 
recycling of reaction products from the utilization of S-adenosylmethionine in the cell.   
Not only was the correct family of substrates identified for these enzymes from full 
library screens, but much of the specificity among the adenosine analogues was also 
predicted, at least by relative rank.  The substrate specificities for the 1000 proteins 
contained within sg-1 through sg-11 are provided in Appendix A. 
Two of the subgroups that are closely related to Tm0936 deaminate quite 
different substrates.  Moth1224 (sg-9) deaminates guanine while Avi5431 (sg-10) 
deaminates 8-oxoadenine.  Avi5431 is the first enzyme ever reported to deaminate 
oxidatively damaged adenine.  In addition, Dvu1825 (sg-6) is the first protein found 
capable of deaminating 5’-deoxyadenosine.    
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Deamination of SAH.  In the crystal structure of Tm0936, the carboxylate of the 
homocysteine moiety of SAH interacts with two arginine residues, Arg-136 and Arg-148 
(Figure 2.2).  For Cthe1199 from sg-1a, the first arginine residue is conserved (Arg-147), 
while the second arginine is replaced with an aspartate (Asp-159).  In the modeled 
active site of Cthe1199, these two residues interact with the carboxylate and amino 
groups of the homocysteine moiety of SAH, respectively (Figure 2.4).  For Mm2279 (sg-
1b), the two arginine residues are substituted with histidine (His-169) and aspartate 
(Asp-183), respectively.  In the modeled active site of Mm2279, the amino group of the 
homocysteine moiety of SAH interacts with His-169 and Asp-183 (Figure 2.5).  
Sequence alignments for the remaining proteins in sg-1a and sg-1b suggest that 
catalytic activity with SAH is a consequence of an arginine (or lysine) residue aligned to 
Arg-136 in Tm0936, and a charged residue (Arg, Lys, Asp, Glu) aligned to Arg-148 in 
Tm0936.   For proteins from sg-1b there is usually a tyrosine or histidine at residue 
position 136 and a glutamate or aspartate at residue position 148 from Tm0936. 
This sequence-structure-activity relationship is not adequate to explain the SAH 
specificity for all of the proteins examined in this investigation.  Bc1793 from sg-4 
preserves the arginine (Arg-150) in the position aligned to Arg-136 in Tm0936, but SAH 
was not prioritized by docking against the homology model and not active in 
subsequent biochemical assays.  The lack of SAH activity can be rationalized by the 
modeled active site of Bc1793, where an inserted loop from residue 126-129 prevents 
Arg-150 from interacting with potential substrates (Figure 2.6).   
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Figure 2.4: Modeled active site of Cthe_1199.  In the modeled active sites of Cthe_1199 
(cyan cartoon, green stick), the carboxylate and the amino groups of the homocysteine 
moiety of the docked SAH (yellow stick) interact with Arg-147 and Asp-159. 
 
 
In Tvn0515 from sg-11, the two critical arginine residues from Tm0936 are 
replaced by the nonpolar residues Trp-140 and Pro-154.  Surprisingly, SAH ranked high 
in docking to the homology model of Tvn0515 and this compound was efficiently 
deaminated.  The carboxylate group from the homocysteine moiety of SAH apparently 
forms a hydrogen bond with the side chain from Lys-145 in the model of Tvn0515, 
while the amino group from the homocysteine moiety is exposed to the protein surface 
and forms a cation-π interaction with the side chain from Phe-85 (Figure 2.7).  
Uniquely, catalytic activity for Tvn0515 could not be detected with any compound 
other than SAH.  
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Figure 2.5: Modeled active site of MM_2279.  In the modeled active sites of MM_2279 
(cyan cartoon, green stick), the amino group of the homocysteine moiety of the docked 
SAH (yellow stick) interacts with His-169 and Asp-183. 
 
 
 
Figure 2.6: Modeled active site of BC1793.  In the modeled active sites of BC1793 (cyan 
cartoon, green stick), the inserted loop (red cartoon) from residue positions 126-129 
prevents the conserved Arg-150 from interacting with bound substrates. 
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Figure 2.7: Modeled active site of TVN0515.  In the modeled active sites of TVN0515 
(cyan cartoon, green stick), the carboxylate group in the homocysteine moiety of the 
docked SAH (yellow stick) forms a hydrogen bond with the sidechain from Lys-145, 
while the amino group in the homocysteine moiety of the docked SAH was exposed to 
the protein surface and formed cation-π interaction with the sidechain from Phe-85. 
 
 
Deamination of MTA.  The four enzymes from sg-2 can deaminate MTA but not 
SAH.  In the modeled active site of Pa3170, the methylthio group of the docked MTA 
resides in a hydrophobic pocket surrounded by Met-132, Tyr-133, Phe-134, Pro-155, 
Leu-157 and His-194.  This model is consistent with the crystal structure of Pa3170 
determined in the presence of 5’-methylthiocoformycin, an analogue of MTA (127).  A 
superposition of the homology model for Cv1032 from sg-2 and the two x-ray 
structures of this protein are presented in Figure 2.8A.  The modeled active site 
occupied by the HEI form of adenosine has an all-atom RMSD of 1.8 Å with respect to 
the crystal structure complexed with inosine, while the docking pose of adenosine is 
nearly identical to the crystal structure of inosine with a RMSD of 0.8 Å (Figure 2.8B).   
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Figure 2.8: Comparison of the crystallographic and modeled structures of Cv1032.  (A) 
The crystal structure of Cv1032 (PDB: 4F0S) in a catalytically productive state (white 
ribbon), the crystal structure of Cv1032 (PDB: 4F0R) in a catalytically unproductive state 
(cyan ribbon), and the homology model of Cv1032 based on the X-ray structure of 
Tm0936 (PDB: 2PLM) (yellow ribbon).  The inosine bound in the active site of Cv1032 
(PDB: 4F0S) is highlighted (white stick).  (B) The crystal structure of inosine (white stick) 
in the active site of Cv1032 (transparent white stick), and the docking pose of 
adenosine (yellow stick) in the modeled active site (transparent green stick) composed 
of the same set of residues as the active site. 
 
 
Deamination of Ado and 5’-dAdo.  The enzymes from sg-4 through sg-7 catalyze 
the deamination of adenosine and 5’-deoxyadenosine, but not MTA and SAH.  The 
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exclusion of MTA from the active sites of enzymes from these subgroups is likely the 
result of a hydrophobic amino acid residue found directly after β-strand 3 (Figure 2.9).  
In Tm0936, Val-139 is positioned near the C5’-carbon of the ribose moiety.  This residue 
apparently permits Tm0936 and all proteins within sg-1a and sg-1b (Ile, Val) and sg-2 
(Leu, Ile) to accommodate the thiomethyl substituent.  In sg-4, sg-5, and sg-6 the 
residue equivalent to Val-139 is replaced with a bulky phenylalanine and in sg-7 this 
residue is replaced with methionine.  These changes likely restrict the binding of only 
adenosine or 5’-dAdo within the active site.  The lack of adenosine binding in the active 
site of Dvu1825 (sg-6) is less obvious, but it may be related to the residue 
corresponding to Gly-137 in Tm0936.  In sg-4, sg-5, and sg-7 a conserved threonine is at 
this position.  The crystal structure of Cv1032 (sg-2) suggests that a hydrogen bond is 
formed between this residue (Ser-153) and the 5’-hydroxyl of the bound inosine (PDB 
id: 4F0S).  Dvu1825 contains an alanine (Ala-152) at this residue position and thus a 
hydrogen bond is not possible. 
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Figure 2.9: Interaction of Phe-153 in BC1793. In the modeled active sites of BC1793 
(cyan cartoon, green stick), the 5’-hydroxyl group of the docked adenosine forms a 
hydrogen bond with the sidechain of the conserved Thr-151. The neighboring Phe-153 
could prevent the binding of MTA 
 
 
 
Convergent Evolution of Guanine Deaminase.  Moth1224 from sg-9 was active 
as a deaminase only for guanine.  The observed substrate specificity can be rationalized 
by the identity of the conserved residues located within the active site of this enzyme.  
Arg-192 and Gln-68 from Moth1224 align with residues Arg-213 and Gln-68 in human 
guanine deaminase (GuaD), which form critical hydrogen bonds to the substrate in the 
active site.  The docking pose of guanine in the active site of Moth1224 (based on the 
GuaD structure) is presented in Figure 2.10.  Although the protein is more similar to the 
entire group of enzymes related to Tm0936, the active site of Moth1224 bears the 
hallmark of the GuaD family.   This example of convergent evolution underscores the 
importance of observing conservation of active site residues when predicting enzyme 
functions based on homology. 
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Figure 2.10: The binding pose of guanine in the homology model of Moth1224.  The 
docking pose of guanine in a high-energy intermediate state (yellow stick) in the 
modeled active site of Moth1224 (transparent white stick) is presented. 
 
 
8-Oxoadenine Deaminase.  Avi5431 from sg-10 was able to deaminate only two 
substrates, 2-oxoadenine and 8-oxoadenine.  To the best of our knowledge this is the 
first time that an enzyme has been identified that can deaminate these compounds.  
Both of these substrates are oxidatively damaged adenine within DNA (128,129).  The 
deaminated products, 8-oxohypoxanthine and xanthine, can be further metabolized to 
uric acid (130).  We had earlier identified the first enzyme capable of deaminating 8-
oxoguanine (4).  In the docking pose of 8-oxoadenine to the modeled Avi5431 active 
site, the N3 nitrogen and the C8 carbonyl oxygen from the purine ring interact with the 
side chains of His-190 and Lys-308, respectively (Figure 2.11). 
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Figure 2.11: Modeled active site of Avi_5431.  In the modeled active sites of Avi_5431 
(transparent cyan cartoon, solid green stick), the N3 nitrogen and the C8 carbonyl 
oxygen from the purine ring of the docked 8-oxoadenine interact with His-190 and Lys-
308. 
 
 
Functional Annotation.  Using a combination of bioinformatics, homology 
modeling, computational docking, structural biology, and molecular enzymology, we 
have interrogated the catalytic properties of a large cluster of proteins homologous to 
Tm0936, a protein from Thermotoga maritima, which was previously shown to 
deaminate S-adenosyl homocyteine to S-inosyl homocysteine.  Subsets of enzymes 
were found to deaminate the catabolic metabolites of S-adenosyl methionine, including 
S-adenosyl homocyteine, methylthioadenosine, adenosine, and 5’-deoxy-adenosine.  
Not only were all of the actual substrates ranked within the top 100 of the metabolites 
in the virtual library, but the overall substrate specificities were also captured.  We did 
not anticipate this level of agreement between prediction and experiment given the 
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well-known complexities of docking.  Remarkably, these predictions were based on 
homology models of the targets, often templated at the limit of reliable primary 
sequence alignments.  These results support the feasibility of prioritizing substrates and 
substrate-specificity from large library docking screens against homology models and 
presage large-scale functional annotation efforts that will significantly expand the range 
of metabolic diversity present in nature.  
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CHAPTER III 
RESCUE OF THE ORPHAN ENZYME ISOGUANINE DEAMINASE* 
 
Introduction 
 A major challenge for all aerobic organisms is the prevention and management 
of oxidative damage to DNA (131). In bacteria such as Escherichia coli there are specific 
repair enzymes for the removal of modified bases from damaged DNA (20,132-134).  
This class of repair enzymes includes MutM for excising 8-oxoguanine (8-oxoG), 8-
oxoadenine (8-oxoA) and formamidopyrimidines (FAPY) from DNA (134-136). MutT 
catalyzes the hydrolysis of 2’-deoxy-8-oxoguanosine triphosphate to the 
monophosphate (137). The removal of mismatched A and isoguanine (2-oxoadenine) 
from DNA is catalyzed by MutY (138). 
Isoguanine is mutagenic to E. coli (129,139).  This base promotes A to C, G, and T 
transversions in addition to base substitutions and deletions (140).  The formation of 
isoguanine in DNA occurs when 2’-deoxyATP is oxidized to 2’-deoxy-2-oxoadenosine 
triphosphate and then this modified base is incorporated into DNA by DNA polymerase 
III opposite guanine.  To a lesser extent, adenine moieties in DNA can be oxidized 
directly to isoguanine (141). 
                                                     
*Part of this chapter is adapted with permission from Rescue of the Orphan Enzyme Isoguanine 
Deaminase Daniel S. Hitchcock, Alexander A. Fedorov, Elena V. Fedorov, Lawrence J. Dangott, Steven C. 
Almo, and Frank M. Raushel Biochemistry 2011 50 (25), 5555-5557.  Copyright 2011 American Chemical 
Society. 
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A bacterial enzyme has recently been discovered that catalyzes the deamination 
of 8-oxoG to urate (4).  This discovery suggests that other oxidized nucleotides may be 
metabolized in a similar manner.  However, to the best of our knowledge, an enzyme 
that is able to catabolize isoguanine has not been identified and characterized. The 
recently discovered 8-oxoguanine deaminase (8-OGD) was found in cog0402 within the 
amidohydrolase superfamily (AHS). This superfamily also contains enzymes known to 
deaminate guanine, cytosine, S-adenosyl homocysteine (SAH) and adenosine (2,4-
6,14,17,19). 
Results and Discussion 
A sequence similarity network for cog0402 is presented in Figure 1.2 at an E-
value cutoff of 10-70 (10).  We postulated that there may be a subset of enzymes within 
cog0402 that is able to deaminate isoguanine to xanthine as shown in Scheme 3.1. The 
most likely candidate for this activity was originally predicted to be in a group of 
enzymes related to S-adenosylhomocysteine deaminase in Group 1 of Figure 1.2, prior 
to its characterization in Chapter II.  Group 1 is the largest and most diverse group of 
enzymes within cog0402.  SAH deaminase utilizes a conserved histidine residue (His-
137) to hydrogen bond with N3 of the adenine moiety of SAH for substrate recognition 
(6).  This particular histidine residue is fully conserved across all Group 1 enzymes of 
cog0402 except for three small subgroups, one of which contains a glutamine at this 
position.  It was initially hypothesized that the carboxamide moiety of the glutamine 
side chain could be positioned in the active site of these enzymes to hydrogen bond 
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with the C2/N3 carbamoyl group of isoguanine, although this subgroup was ultimately 
found to specifically deaminate S-adenosylhomocysteine.  From this small subgroup of 
enzymes, an uncharacterized protein from Picrophilus torridus was selected for 
purification and characterization.  Since the DNA from this extremophilic archaeon was 
not commercially available, we purchased the codon-optimized gene (gi|48477797) 
from GenScript and then attempted to express the protein in an E. coli host.  
 
Scheme 3.1 
 
The target protein was largely insoluble when expressed from either a pET-28 or 
GenScript PGS-21a vector in E. coli BL21.  However, an isoguanine deaminase activity 
was detected in cell extracts after centrifugation.  The enzymatic activity was not 
thermostable and we were unable to isolate the protein using standard nickel affinity 
or GST columns, as would be expected for the recombinant protein with GST and 
polyhistidine tags.  These results suggested that E. coli contained a native isoguanine 
deaminase.  In E. coli there are two uncharacterized putative deaminases from cog0402 
within the AHS.  These proteins are YahJ (gi|16128309; Group 9) and SsnA 
(gi|33347706; Group 5), and the subject of Chapter VI.  Both of these proteins were 
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purified to homogeneity, but no isoguanine deaminase activity could be detected with 
either enzyme.  We therefore attempted to identify the specific enzyme responsible for 
the isoguanine deaminase activity in E. coli through classical purification methods. 
E. coli BL21 (DE3) cells were grown in an LB medium to stationary phase and 
harvested.  The isoguanine deaminase activity was determined at each step of the 
purification scheme by monitoring the decrease in absorbance at 300 nm using a Δɛ = -
5.0 x 103 M-1cm-1 for the conversion to xanthine.  The cells were lysed by sonication and 
the DNA was removed through precipitation with protamine sulfate.  Ammonium 
sulfate (40% - 50% of saturation) was used to fractionally precipitate the protein 
mixture.  The pellet was redissolved in 50 mM HEPES, pH 7.7, and then loaded onto a 
HiLoad 26/60 Supderdex 200 gel filtration column.  The active fractions from the gel 
filtration chromatography were pooled and loaded onto a ResourceQ anion exchange 
column.  A 10% SDS-PAGE gel stained with Coomassie Blue revealed three bands, two 
of which correlated with the activity profile of the ResourceQ fractions with molecular 
weights of ~50 and ~70 kDa.  The specific activity of isoguanine deaminase increased by 
approximately 1000-fold, relative to the initial cell lysate.  The purification results are 
summarized in Table 3.1. 
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Table 3.1.  Purification scheme for isoguanine deaminase.a 
Step volume 
(mL) 
units 
(U) 
protein 
(mg) 
U/mg 
lysate 75 8.6 490 0.018 
protamine sulfate 147 6.2 130 0.048 
(NH4)2SO4 5 5.4 10 0.53 
gel filtration 17 2.2 0.63 3.4 
anion exchange 4.5 0.97 0.11 14 
aA Unit (U) is defined as 1.0 μmol/min. 
 
 
Table 3.2.  Fragments from nanoLC Electrospray MSMS. 
Position Observed mass Actual Mass 
3-14 1317.26 (+2) 1315.25 
15-30 1822.05 (+3) 1819.02 
31-46 1647.20 (+2) 1645.18 
95-103 1012.60 (+2) 1010.59 
112-122 1323.68 (+2) 1321.67 
193-201 1062.06 (+2) 1060.04 
227-236 1059.00 (+2) 1056.96 
244-262 2058.06 (+3) 2055.04 
375-391 1817.46 (+3) 1814.43 
405-427 2570.04 (+3) 2567.02 
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NanoLC electrospray MS/MS analysis was employed to identify the partially 
purified protein with the ability to catalyze the deamination of isoguanine.  The gel 
from the SDS-PAGE separation was submitted to the Protein Chemistry Laboratory at 
Texas A&M University for trypsin digestion and analysis.  The 70 kDa band was 
identified as catalase, and the 50 kDa band was identified as cytosine deaminase from 
E. coli (gi|16128322).  The specific peptides that were identified in the mass spectrum 
are listed in Table 3.2. 
 
 
Figure 3.1: Absorption spectra of the reaction mixtures before and after the addition of 
purified cytosine deaminase to either isoguanine (top panel) or cytosine (bottom panel) 
at pH 7.7.  Isoguanine and cytosine (spectra in blue) were incubated with 1.6 µM CDA 
for 1.5 hours in 45 mM HEPES, pH 7.7.  After the reaction was complete, the UV spectra 
(shown in red) were collected.  The red spectrum in the top panel is consistent with the 
formation of xanthine (λmax = 272 nm) from isoguanine (λmax = 286 nm).  The red 
spectrum in the bottom panel is consistent with formation of uracil (λmax = 260 nm) 
from cytosine (λmax = 267 nm). 
 
 
 
Cytosine deaminase (CDA) from E. coli was cloned and inserted into a pET30 
expression vector using standard protocols.  The CDA transformed cells were grown in 
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the presence of 90 µM dipyridyl supplemented with 1.0 mM Zn2+ to diminish the 
incorporation of iron in the active site (124).  To ascertain whether CDA is able to 
catalyze the deamination of isoguanine, 1.6 μM of the purified protein was incubated 
with 100 μM cytosine or isoguanine and the UV spectra were obtained before and after 
addition of the enzyme.  The spectra matched that of the two expected products, uracil 
and xanthine, as illustrated in Figure 3.1.  Also, an activity profile from anion exchange 
showed the activities for cytosine and isoguanine deaminase coeluted.  A structural 
comparison of cytosine and isoguanine is presented in Scheme 3.1. 
The kinetic constants for the deamination of isoguanine and cytosine with the 
purified CDA were determined with a direct spectrophotometric assay at 294 and 255 
nm using values for Δɛ of -6.6 x 103 M-1 cm-1 and +2.6 x 103 M-1 cm-1, respectively.  The 
kinetic constants for the deamination of isoguanine by CDA are 49 ± 2 s-1, 72 ± 5 μM, 
and 6.7 (± 0.3) x 105 M-1 s-1 for the values of kcat, Km, and kcat/Km, respectively. Under 
identical reaction conditions the kinetic constants for the deamination of cytosine are 
45 ± 4 s-1, 302 ± 44 µM and 1.5 (± 0.1) x 105 M-1 s-1 for the values of kcat, Km, and kcat/Km, 
respectively, at pH 7.7.  The values of kcat are nearly identical for the two substrates but 
kcat/Km for the deamination of isoguanine is more than 4-fold greater than for the 
deamination of cytosine. 
 To further confirm that CDA is the only enzyme within E. coli that is capable of 
deaminating isoguanine we obtained a strain of this bacterium from the KEIO collection 
containing a knockout of the gene for cytosine deaminase (ΔcodA) (142).  The ΔcodA E. 
 
 
73 
 
coli cells were grown to stationary phase and lysed.  The rate of deamination of 
isoguanine was measured by following the decrease in absorbance at 300 nm.  Those 
cells lacking CDA had less than 1% of the isoguanine deaminase activity as the wild type 
strain. 
The three-dimensional structure of cytosine deaminase (PDB code: 1K70) has 
previously been determined in the presence of an inhibitor that mimics the putative 
tetrahedral intermediate during the deamination of cytosine (3).  In this structure, His-
246 and Asp-313 are poised to serve as general acid/base groups to activate the metal-
bound water molecule and the amino leaving group.  In addition, Glu-217 is positioned 
to deliver a proton to N3 of the pyrimidine ring.  The carbamoyl moiety at N1/C2 is 
recognized via hydrogen bonding interactions with the side chain of Gln-156.  The 
crystal structure of CDA bound with isoguanine was determined and the molecular 
interactions with isoguanine are shown in Figure 3.2 (PDB code: 3RN6). The orientation 
of isoguanine is nearly identical to that of the cytosine mimic in the previous structure.   
However, an additional interaction to the substrate is formed via a hydrogen bond 
between Asp-314 and N7 of the purine ring.  The adenine deaminase from cog1816 of 
the amidohydrolase superfamily (PDB code: 3PAN) also possess an Asp-Asp motif at the 
end of β-strand 8 within the (β/α)8-barrel structure that forms a hydrogen bond with 
N7 of the purine ring. 
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Figure 3.2: The structure of isoguanine (in green) bound in the active site of cytosine 
deaminase. 
 
We were initially surprised to find that there were no reports of CDA from any 
source being able to deaminate isoguanine.  However, a comprehensive literature 
search identified a single reference for the deamination of isoguanine by crude extracts 
of E. coli (143).  The specific enzyme that was responsible for this transformation has 
not (until now) been identified in the 60 years since this initial discovery.  We have now 
rescued the orphan isoguanine deaminase and have demonstrated that this enzyme 
also catalyzes the deamination of the structurally related base, cytosine.  It is of interest 
to note that the value of kcat/Km for the deamination of isoguanine by CDA is greater 
than for the deamination of cytosine.  Therefore, in E. coli the mutagenic base, 
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isoguanine, can be recycled via the formation of xanthine.  It is likely that all of the 
bacterial cytosine deaminases have the ability to deaminate isoguanine. 
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CHAPTER IV 
DISCOVERY OF A 5-METHYLCYTOSINE DEAMINASE 
Introduction 
Thymine, like other nucleobases, is essential for cell proliferation.  Most 
organisms synthesize this metabolite through methylation of 2’-
deoxyuracilmonophosphate (dUMP) by thymidylate synthase (ThyA) creating thymine 
in the form of 2’-deoxythymidinemonophosphate (dTMP) (Scheme 4.1) (144), where it 
is further phosphorylated to 2’-deoxythymidinetriphosphate (dTTP).  Thymine 
starvation, however, differs from other nucleotide starvation.  Not only is cell growth 
stalled, but cell death is induced (145).  This phenomenon occurs in all organism, 
ranging from E. coli to cancer cells. 
This strategy has been used in a very successful cancer drug, 5-fluorouracil (5FU) 
(146).  The drug is received by cancer patients, where is phosphoribosylated to its 
active form, 2’-deoxy-5-fluorouridinemonophosphate (FdUMP).  FdUMP is an 
irreversible mechanism based inhibitor of ThyA, and causes thymineless death.  Rapidly 
dividing cancer cells are susceptible to this drug on account of rapid thymine depletion, 
yet healthy human cells are still killed in the process.  One strategy being developed to 
reduce toxicity to healthy human cells is to utilize the relatively non-toxic 5-
fluorocytosine (5FC) as a pro drug (147).  This compound is not rapidly deaminated by 
any human genes products to form 5FU. Cancer cells could be specifically transfected 
with a 5FC deaminase, which in turn will form 5FU only in tumors. 
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5FC deaminase activity is minimal in any characterized enzyme, therefore 5FC 
deaminases have been engineered by directed evolution starting with E. coli cytosine 
deaminase (b0337) (25).  It was found that a single active site mutation could confer 
5FC deaminase activity.  This engineered cytosine deaminase was capable of killing E. 
coli cells with 5FC, and since then more robust mutants mutants have been developed 
and effectively kill cancer cells by this strategy (148). 
 
 
Scheme 4.1 
 
Cytosine deaminase (CDA) itself is an integral enzyme in pyrimidine recycling 
and degradation (Scheme 4.1) (149,150).  It is a member of the amidohydrolase 
superfamily, which use a TIM-barrel and a metal center to perform a nucleophilic attack 
from a coordinated water molecule (1,2).  CDA is a member of cluster of orthologous 
groups 0402 (cog0402), along with guanine deaminase (90), S-adenosylhomocysteine 
deaminase (19) and 8-oxoguanine deaminase (4).  These enzymes accomplish the 
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deamination reaction through a mononuclear metal center which is conserved across 
the entire cog.  With b0337 having a well characterized structure and slight 
promiscuous activity for 5FC, it provided an excellent target for mutagenesis (3).  The 
first round of mutants to confer 5FC deaminase activity involved modifications at the 
D314 position—most notably D314S, D314A, and D314G (Figure 4.1). 
Upon closer inspection of the CDA family, it was found that this mutation 
already exists.  Members were found to possess a Ser or Cys at the position 
corresponding to D314 in b0337.  CDA homologues from Klebsielle pneuominae 
(KPN_00632) and Rhodobacter sphaeroides (RSP_0341) were cloned and purified and 
found to deaminate, in addition to cytosine, 5-methylcytosine (5MC) and 5FC.  
Furthermore, KPN_00632 was found to perform these activities in vivo in E. coli host 
cells, either killing them in the presence of 5FC or rescuing thymine auxotrophs in the 
presence of 5MC.  The activity for 5MC deaminase could be physiologically relevant.  
Furthermore, these genes could provide new starting points on directed evolution to 
evolve more efficient 5FC deaminase for cancer gene therapy. 
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Figure 4.1: Active site of CDA. A) WT CDA bound to inhibitor.  B) D314S mutant bound 
to 5-fluorouracil analogue, 
 
Materials and Methods 
Cloning and Purification of NCGl0075, KPN_00632, RSP_0341, and b0337.  The 
genes for NCGl0075, KPN_00632, RSP_0341 were cloned into pET28 with a 6x C-
terminal His tag using standard cloning practices.  The plasmids were transformed into 
E. coli BL-21 DE3 cells and plated onto LB-agarose containing 50 μg/mL kanamycin.  1 L 
cultures (LB broth, kanamycin 50 μg/mL) were inoculated from the resulting colonies 
and grown at 37 °C until the optical density at 600 nm reached 0.6.  Protein expression 
was induced with 1 mM IPTG, and the cultures were shaken for 20 hours at 25 °C.  The 
cultures were centrifuged at 7000 RPM for 15 minutes and the cell pellets were 
disrupted by sonication in 35 mL of running buffer and PMSF.  DNA was precipitated by 
protamine sulfate.  Proteins with a 6x His-tag were loaded onto a 5 mL HisTrap column 
(GE HEAL/THCARE, USA) with running buffer (20 mM HEPES, 250 mM NaCl, 250 mM 
NH4SO4, 20 mM imidazole, pH 7.5) and eluted with a linear gradient of elution buffer 
(20 mM HEPES, 250 mM NaCl, 250 mM NH4SO4, 500 mM imidazole, pH 7.5).   
A B 
Gln156 
T66 
D314 
Gln156 
T66 
D314
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The gene for b0337 was cloned into pBAD322C.  E. coli (CGSC# 9145) (151) cells 
were transformed with the plasmid and plated onto LB-agarose containing 25 μg/mL 
chloramphenicol.  A 1 L culture (LB broth, chloramphenicol 25 μg/mL) was inoculated 
from the resulting colonies and grown at 37 °C until the optical density at 600 nm 
reached 0.6.  Protein expression was induced with 1 mM L-arabinose, and the culture 
was shaken for 20 hours at 25 °C.  The culture were centrifuged at 7000 RPM for 15 
minutes and the cell pellets was disrupted by sonication in 35 mL of running buffer and 
PMSF.  DNA was precipitated by protamine sulfate.  The protein were precipitated with 
70% saturation NH4SO4 and the pellet resuspended in 4 mL of 50 mM HEPES, pH 7.5.  
The solution was loaded onto a HiLoad 26/60 Superdex 200 gel filtration column.  
Fractions were pooled and concentrated. 
Cloning of KPN_00632, RSP_0341, and b0337-D314A for in vivo Assays.  The 
genes for KPN_00632, RSP_0341 were cloned into pBAD322C using standard cloning 
practices.  The b0337 D314S mutant was constructed using site directed mutagenesis 
by primer overlap extension from the pBAD322C-b0337 plasmid. 
Activity Screen and Kinetic Constant Determination.  1 µM purified enzyme 
was incubated in 50 mM HEPES buffer pH 7.5 at 25 degrees C for 1 hr in a 96-well UV-
Vis quartz plate. The spectrum was monitored from 240-350 nm and any spectral shifts 
were noted as deaminase activity.  The library included cytosine, 5-methylcytosine, 5-
hydroxymethylcytosine, 5-fluorocytosine, 5-aminocytosine, creatinine, isoguanine, 
cytosine-5-carboxylate, N-methylcytosine, and cytosine-5-formylcytosine. 
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 Positive hits were subjected to kinetic assays.  Initial reaction velocities were 
measured by a UV-Vis direct assay in a 96-well quartz plate for various 
enzyme/substrate combinations.  Substrate concentration was varied while enzyme 
concentration was held constant.  Product formation was monitored at the following 
wavelengths with experimentally derived molar extinction coefficients for the tested 
substrates: cytosine (255 nm, Δε = 2600 M-1 cm-1), 5-methylcytosine (262 nm, Δε = 3700 
M-1 cm-1), creatinine (240 nm, Δε = 6100 M-1 cm-1), isoguanine (294 nm, Δε = -6600 M-1 
cm-1), 5-fluorocytosine (262 nm, Δε = 3200 M-1 cm-1), 5-aminocytosine (235 nm, Δε = -
2000 M-1 cm-1), 5-hydroxymethylcytosine (258 nm, Δε = 3700 M-1 cm-1). 
5-Fluorocytosine in vivo Deaminase Assay.  E. coli pyrimidine auxotrophs 
(CGSC# 9145) cells were transformed with pBAD322C and the constructs containing the 
genes b0337, KPN_00326, and b0337-D314A, and grown on LB-agar plates with 25 
µg/mL chloramphenicol.  Single colonies were picked and overnight 5 mL cultures were 
grown in selection media plus 150 µM cytosine and 25 µg/mL chloramphenicol.  
Selection media consisted of:  1X M9 minimal salts, 1.96 g/L Yeast Synthetic Dropout 
Medium without uracil, 0.1% glycerol, 100 µM CaCl2, 1 mM MgSO4, and 1X trace 
elements.  5000x trace elements was created with 95 mL H2O, 5 g citric acid, 5 g 
ZnSO4*7H2O, 4.75 g FeSO4*7H2O, 1g Fe(NH4)2(SO4)2*6H2O, 250 mg CuSO4*H2O, 50 mg 
MnSO4*H2O, Na2MoO4*2H2O.  Yeast synthetic dropout with cytosine and glycerol was 
autoclaved separately from M9, CaCl2 and MgSO4 were sterile filtered and trace 
elements 5000x was autoclaved before all were combined.  The culture was grown for 
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14 hrs.  25 mL cultures of selection media + 150 µM cytosine + 25 µg/mL + 100 µM 
MnSO4 + 100 µM zinc acetate + chloramphenicol were prepared in 100 mL flasks with 
the following experimental conditions:  1) no modification, 2) 100 µM arabinose 
(Induced), 3) 50 µM 5-FC + 100 µM arabinose, 4) 110 µM 5-FC + 100 µM arabinose, 5) 
320 µM 5-FC + 100 µM arabinose, 6) 500 µM 5-FC + 100 µM arabinose, 7) 1 µM 5FU + 
100 µM arabinose, 8) 5 µM 5FU + 100 µM arabinose.  The cultures were inoculated 
with 25 µL of the overnight cultures and shaken at 200 rpm for 12 hrs at 37 degrees C.  
OD600 was measured every 2 hrs in a 96-well UV-Vis plate with 250 uL of the culture, 
pathlength of 0.63 cm.   
Culture Activity Measurement.  5 mL of the active cultures was centrifuged at 
6000 RPM for 10 minutes.  The pellets were resuspended in Bugbuster 1x and 50 mM 
HEPES pH 7.5.  The resuspended cultures were incubated at 25 degrees C on a while 
rotating for 30 minutes.  The resulting suspension was centrifuged at 14000 RPM for 10 
minutes.  5 µL of the resulting supernatant was combined with 200 µM of the 
appropriate substrate in a 250 µL reaction in a 96-well UV-Vis quartz plate, and reaction 
was monitored at the appropriate wavelength.  If necessary, the supernatant was 
diluted in 50 mM HEPES pH 7.5 to allow measurement of initial velocity.  All values 
were adjusted for extinction coefficient and cell density.   
5-Methylcytosine in vivo Deaminase Assay.  E. coli thymine auxotrophs 
(CGSC#: 4091) were transformed with pBAD322C and the constructs containing b0337, 
KPN_00326, and RSP_0341 and plated on to LB-Agar chloramphenicol (25 µg/mL) 
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plates supplemented with 200 µM thymine.  Single colonies were picked and 5 mL 
cultures of LB + 100 µM thymine + 25 µg/mL were grown for 14 hours.  25 mL cultures 
of selection media + 100 µM MnSO4 + 100 µM zinc acetate + 25 µg/mL 
chloramphenicol were prepared in 100 mL flasks with the following experimental 
conditions:  1) no modification, 2) 500 µM 5FC, 3) 100 µM arabinose (Induced), 4) 100 
µM thymine + 100 µM arabinose, 5) 100 µM 5MC + 100 µM arabinose, 6) 100 µM 5MC 
+ 100 µM arabinose.  The cultures were inoculated with 25 µL of the overnight cultures 
and shaken at 200 rpm for 12 hrs at 37 degrees C.  OD600 was measured every 2 hrs in 
a 96-well UV-Vis plate with 250 µL of the culture, pathlength of 0.63 cm.   
Results 
 Phylogeny of the Cytosine Deaminase Group.  A BLAST search was conducted 
using the sequence of E. coli cytosine deaminase was submitted, and 1377 homologues 
were found.  An All-by-All BLAST was conducted with the enzymes, and over 4 groups 
formed at an E-value stringency of 10-140, which were arbitrarily labeled subgroups (sg) 
1-4 (Figure 4.2).  A sequence alignment was performed and one striking feature was 
the variation of a residue found directly after the strand 8 metal binding Asp.  This 
residue (D314 in E. coli CDA) corresponds to that which was mutated to engineer a 5-
fluorocytosine deaminase.  Sg1 perserves this Asp, however sg2 posesses a Ser, sg3 a 
Cys, and sg4 a Ser.  Four representatives were selected for cloning and purification:  
b0337, sg1, E. coli cytosine deaminase; sg2, KPN_00632, Klebsiella pneumonia; sg3, 
RSP_0341, Rhodobacter sphaeroides 2.4.1; sg4, NCGl0075, Corynebacterium 
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glutamicum ATCC 13032 creatinine deaminase.  Despite their location in separate 
subgroups, sequence identity was high (Table 4.1). Additionally, the b0337 D314A 
mutant was constructed by primer overlap extension from the pBAD322C-b0337 
plasmid. 
 
 
Figure 4.2: Sequence similarity network diagram of CDA homologues a BLAST E-value 
cutoff 10-140. Proteins characterized in this study are: a) b0037, b) KPN_00632, c) 
RSP_0341, d)NCGl0057. 
 
Table 4.1.  Percent identity between protein sequences. 
 RSP_0341 NCGl0075 b0037 
NCGl0075 35%   
b0037 40% 42%  
KPN_00632     42% 48% 58% 
 
 
Sg1 
Sg3 
Sg2 
Sg4 
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Enzymatic Characterization.  The targets were cloned into pBAD322C, 
expressed in E. coli and purified via gel filtration. B0337 contained 0.68 eq Zn and 0.18 
eq Fe.  KPN_00326 contained 0.33 eq Fe, 0.20 eq Zn, and 0.15 eq Mn.  RSP_0341 
contained 0.49 eq Fe, 0.35 eq of Zn, and 0.21 eq Mn.  NCGl0075 contained 0.52 eq Fe, 
0.19 eq Cu, 0.18 eq Mn, and 0.17 Zn. 
 B0337 has been previously characterized, however the kinetic constants were 
redetermined in the buffer conditions used in this experiment.  The kinetic constants 
are summarized in Table 4.2.  B0337 was found to deaminate only cytosine and 
isoguanine at appreciable rates.  5-methylcytosine deaminase activity was barely 
detectable (22 M-1s-1) and 5-fluorocytosine demainase activity somewhat higher (250 
M-1s-1).  KPN_00632 was found to deaminate 5-methylcytosine the most efficiently (the 
first recorded instance of this activity), followed by promiscuous activity for cytosine 
and isoguanine and 5-fluorocytosine.  RSP_0341 was found to have a similar profile for 
as KPN_00632 except for it preferentially deaminates cytosine over methylcytosine.  
NCGl0075 was found to have creatinine as its best substrate. D314A activity. 
5-Fluorocytosine Toxicity Assay.  The empty vector as well as plasmid 
constructs containing b0337, D314A, and KPN_00632 transformed into E. coli CGSC #: 
9145, and the constructs were tested for their ability to deaminate 5-fluorocytosine in 
vivo, which would cause cell death or slow growth from inhibition of ThyA (Figure 4.3).  
All constructs, including the empty vector, showed no growth in 1 and 10 µM 5-
fluorouracil in 12 hrs.  The empty vector showed slowed growth for 5-fluorocytosine, 
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whereas the effects for 5-fluorocytosine were more pronounced in other cultures.  Only 
KPN_00632 showed no growth at 500 µM 5-fluorocytosine, suggesting it most potently 
produced 5-fluorouracil in this system.  5-fluorocytosine, 5-methylcytosine and cytosine 
deaminase activity were measured at 10 hrs for the induced culture and for the 50 µM 
5FC culture (Figure 4.4). 
5-Methylcytosine Deaminase Rescues Thymine Auxotrophs.  The empty vector 
as well as plasmid constructs containing b0337, KPN_00632, and RSP_0341 were 
transformed into E. coli CGSC#: 4091 to test their ability to rescue the thymine 
autotroph by in vivo deamination of 5-methylcytosine (Figure 4.5).  All strains were 
capable of growth when supplemented with 100 µM thymine.  Neither the empty 
vector nor b0337 were capable of rescuing growth, even when supplemented with 400 
µM 5-methylcytosine.  Both KPN_00632 and RSP_0341 showed growth when the gene 
was induced in addition to 400 µM 5-methylcytosine, and to a lesser extent 100 µM 5-
methylcytosine. 
 
 
87 
 
Table 4.2  Kinetic constants of the CDA homologues with various substrates. 
kcat (s-1) 
Km (µM) 
Kcat/Km (M-1s-1) 
Cytosine 5MC Creatinine Isoguanine 5FC 5AC N-MCyt HMC 
b0337 33 (7) 
400 (100) 
8.4 (0.9) x 104 
 
 
 
22 (1) 
0.11 (.03)  
830 (250) 
1.3 (0.1) x 102 
3.9 (0.1) 
36 (4) 
1.1 (0.1) x 105 
 
 
250 (50) 
 
 
8.0 (0.5) x 103 
.0017 (.0001) 
43 (8) 
40. (5) 
 
 
<10 M-1s-1 
KPN_00632 13 (2) 
440 (110) 
2.9 (0.2) x 104 
8.4 (1) 
25 (7) 
3.3 (0.6) x 105 
 
 
6.8 (1.3)x 103 
4.5 (0.5) 
116 (26) 
3.8 (0.5) x 104 
6.5 (0.2) 
56 (3) 
1.15 (0.05)x 105 
160 (10) 
280 (30) 
5.8 (0.3) x 105 
 
 
<10 M-1s-1 
 
 
2.2 (0.2) x 103 
RSP_0341 30. (5) 
210 (60) 
1.4 (0.2) x 105 
4.8 (.8) 
245 (81) 
2.0 (0.3) x 104 
 
 
131 (5) 
.035 (.003) 
240 (30) 
1.4 (0.1) x 102 
25 ± 3 
370 ± 70  
 6.8 (0.5) x 104 
 
 
<10 M-1s-1 
 
 
<10 M-1s-1 
 
 
<10 M-1s-1 
NCGl0075 0.35 (.05) 
300 (90) 
1.1 (0.2) x103 
1.3 (0.2) 
900 (200) 
1.5 (0.1) x 103 
32 (4) 
510 (90) 
6.3 (0.3) x 104 
0.23 (0.04) 
380 (90) 
5.9 (0.3) x 102 
0.055 (0.005) 
270 (50) 
2.0 (0.2) x 102 
 
 
1.0 (0.1) x 103 
 
 
<10 M-1s-1 
 
 
<10 M-1s-1 
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Figure 4.3: Toxicity of 5FC to E. coli with various cytosine deaminases. The experiment conditions are induced with 100 µM 
arabinose (IND) ( ), IND + 50 µM 5FC ( ), IND + 500 µM 5FC( ), and IND + 5 µM 5-FU ( ). A)  KPN_00632 B) 
b0337, C) b0337 D314A, D) Empty pBAD322C 
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Figure 4.4.  Activity for cytosine deaminase in cultures for 5-fluorocytosine toxicity test.  
Activity for cytosine ( ), 5MC( ) and 5FC( ) was measured in the induced culture and 
induced culture with 50 µM 5FC added.  A) KPN_00326, B) b0337, C) D314A, 
D)pBAD322C. 
  
A B C D 
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Figure 4.5:  Growth of E. coli thymine auxotrophs supplemented with 5MC and various cytosine deaminases.  E. coli 
expressing various deaminases had their growth monitored. Experimental conditions are: no addition ( ), 400 µM 5MC (
), 100 µM Arabinose (IND) ( ), IND + 100 µM thymine ( ), IND + 100 µM 5MC ( ), IND + 400 µM 5MC( ). 
A)  KPN_00632 B) b0337, C) RSP_0341, D) Empty pBAD322C 
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Discussion 
 Substrate Profiles and Structural Assessment.  B0337 has several structures 
with various ligands and even mutants.  Given the high sequence similarity between 
these homologues studied, it is clear a determining factor is the residue corresponding 
to Asp314.  The D314S mutant is capable of binding to 5-fluorouracil, the CDA 
homologues in this study can be reasoned to have their various activities based on this 
evidence.  The D314S mutant creates a larger pocket for a polar substitution atC5 on 
the pyrimidine substrate and the structure determined (PDB: 1rak) reflects this.  
Likewise, the D314G mutant similarly creates a larger pocket for lower steric energy.  It 
remains unclear how b0337 is capable to binding isoguanine, but not the smaller 5-
methylcytosine. 
 KPN_00632 possesses a Ser at this position.  Presumably this allows for a bulky 
methyl group on the C5 position of the substrate.  This serine is hydrogen bonded to an 
Asp corresponding to Asp317 in b0337.  Likewise, RSP_0341 utilizes a Cys at this 
positions.  Their substrate profiles are similar, however RSP_0341 is less efficient for 5-
methylcytosine, was incapable of catalyzing the deamination of 5-aminocytosine, which 
is not known to be a naturally occurring compound. 
 NCGl0075 striking feature is its specificity for creatinine.  This enzyme has 
previously been characterized as a creatinine deaminase.  While the enzyme possesses 
a Ser at the corresponding 314 position, other sequence features may  create a 
preference for smaller substrates.  In all other homologues mentioned, the 314 residue 
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is bonded to Asp317, which in turn is hydrogen bonded to Thr66.  This threonine is 
conserved except in the creatinine deaminase, where a Tyr occupies this position.  
Aside from potentially disrupting this hydrogen boding network and altering the 
backbone structure, Tyr could be capable of filling the active site and interfering with 
larger substrates such as 5-methylcytosine or isoguanine. 
The Deamination of 5-Methylcytosine.  While 5-methylcytidine deaminase 
activity has been observed by cytidine deaminase, deamination of the free pyrimidine 
has never been observed.  The direct deamination of this compound results in thymine.  
Thymine is unique of the nucletodies in that starvation not only stalls cell growth, but 
actively induces cell death.  Given the abililty of KPN_00632 and RSP_0341 to 
deaminate 5-methylcytosine at physiologically relevant rates, it was of importance to 
see if this reaction could rescue thymine auxotrophs and if this reaction could be 
physiologically relevant.  BothRSP_0341 and KPN_00632 were capable of deaminating 
exogenous 5MC and supporting cell growth.  B0337 has a very low kcat/Km for 
methylcytosine, and this is apparent in in vivo where cell growth does not occur with 
5MC.  Similarly, no growth is observed from the empty vector.  In this case it is possible 
in KPN_00632 that this reaction is relevant. 
Klebsiella pneumoniae additionally possesses a cytosine deaminase homologue 
which clusters with sg1 in the diagram.  This cytosine deaminase would be expected to 
deaminate cytosine in a similar manner as b0337.  KPN_00632 however in its operon 
contains codB which is a characteristic gene found in group 1 cytosine deaminases.  
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This gene encodes a cytosine membrane transport, suggesting that KPN_00632 could 
physiologically deaminated cytosine in addition to 5MC.  It is unclear why there would 
be two deaminases. 
The Deamination of 5-Fluorocytosine.  The only known instance of the 
deamination of 5-fluorocytosine is from directed evolution experiments.  No naturally 
occurring enzyme is found to have appreciable activity for this substrate, with the 
exception of low activity for b0337.  The KPN_00632 is roughly 400 times faster than 
b0337.  The test this deamination in vivo, a similar experiment was performed with 
pyrmidine auxotrophs (ΔpyrF) which are forced to use the pyrimidine salvage pathway 
and phosphoribosylate pyrimidines.  If 5FU is formed as the deamination product of 5-
fluorocytosine, it will be converted to 2’-deoxy-5-fluorouracil (d5FUMP) and stall 
growth or kill cells by inhibition of thymidylate synthase.  The empty vector was found 
to not confer 5FC sensitivity, and slowed growth is presumably caused by incorporation 
of 5FC into DNA.  However like b0337 and D314G, KPN_00632 slowed growth of E. coli, 
and at 500 µM 5FC did not allow any growth in 12 hrs.  b0337 still slowed growth, and 
its activity was measured to account for expression levels.  The higher expression of 
b0337 allowed for appreciable rates of 5FC deaminase in vivo, being expressed orders 
of magnitude higher than KPN_00632 (Figure 4.4). 
Conclusion 
Here is the first described described deamination of 5-methylcytosine, and 
additionally the first naturally occurring enzyme found which can catalyze the 
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deamination of 5FC.  KPN_00632 as well as RSP_0341 may provide promising starting 
points for additional directed evolution experiments, owing to the already favorable 
ratios of 5FC/cytosine deamination.  Additionally, the discovery of activity for 5-
methylcytosine may provide an alternative route for organisms to procure thymine. 
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CHAPTER V 
ASSIGNMENT OF PTERIN DEAMINASE ACTIVITY TO AN ENZYME OF UNKNOWN 
FUNCTION GUIDED BY HOMOLOGY MODELING AND DOCKING* 
Introduction 
With increasing availability of genomic sequences, a pressing challenge in 
biology is a reliable assignment of function to the proteins encoded by these genomes. 
Functional annotation of an uncharacterized protein can be conveniently accomplished 
by matching its sequence to that of a characterized protein (152,153).  However, this 
strategy is often inaccurate and imprecise (154,155).  Conservatively, over 50% of the 
sequences in the public databases have uncertain, unknown, or incorrectly annotated 
functions (156).  Annotation of enzymes in functionally diverse superfamilies is 
particularly challenging (110).  
A promising approach to functional assignment is the identification of the 
substrate by docking potential substrates against the binding site of an experimentally 
determined enzyme structure (111,157).  This approach was used to predict the 
substrates of Tm0936 from Thermotoga maritima (120).  High-energy intermediate 
forms of thousands of candidate metabolites were docked to the X-ray structure of 
Tm0936, and those highly ranked by docking energy score were tested experimentally, 
                                                     
*This chapter is adapted with permission from Assignment of Pterin Deaminase Activity to an Enzyme of 
Unknown Function Guided by Homology Modeling and Docking Hao Fan, Daniel S. Hitchcock, Ronald D. 
Seidel, II, Brandan Hillerich, Henry Lin, Steven C. Almo, Andrej Sali, Brian K. Shoichet, and Frank M. 
RaushelJournal of the American Chemical Society 2013 135 (2), 795-803. Copyright 2013 American 
Chemical Society. 
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confirming a high deaminase activity against S-adenosylhomocysteine (SAH).  This 
approach has been subsequently prosecuted against three other enzymes for activity 
determination (158-160).  These studies suggest that structure-based docking might be 
a useful tool for enzyme function annotation, when an experimentally determined 
atomic structure of the enzyme is available.  
Often, however, an enzyme of unknown function has no experimentally 
determined three-dimensional structure.  In such situations, a three-dimensional model 
of the target sequence can be computed by homology modeling if a template structure 
of a related protein is known (161).  Currently, the total fraction of protein sequences in 
a typical genome for which reliable homology models can be obtained varies from 20-
75%, increasing the number of structurally characterized protein sequences by more 
than two orders of magnitude relative to the PDB (162).  Therefore, homology models 
can, in principle, greatly extend the applicability of virtual screening for ligand discovery 
(126,163-167).  For example, this strategy was successfully employed, in the prediction 
of function for Bc0371 from Bacillus cereus as an N-succinyl arginine/lysine racemase 
by docking dipeptides and N-succinyl amino acids to a homology model of Bc0371 
based on the X-ray structure of the closest structural homologue, L-alanine-D/L-
glutamate epimerase (168). 
The accuracy of a homology model can be estimated from the target-template 
sequence identity.  Generally, when the sequence identity exceeds 30%, a reliable 
alignment can be constructed, and the resulting models are often useful for virtual 
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screening.  When the sequence identity decreases much below 30%, the target 
structure often deviates significantly from that of the template, resulting in large errors 
in side chain packing, loop conformations, core backbone conformations, alignment, 
and even fold assignment. Unfortunately, for many proteins from newly sequenced 
genomes, only distantly related template structures are available. Hence, it is of 
pressing interest to develop modeling and docking methods that account for backbone 
variation between homologues, so that homology models based on distant templates 
can be used for annotation of protein function.   
The functionally diverse amidohydrolase superfamily (AHS) of enzymes provides 
an ideal test case for developing robust computational methods for function 
identification of uncharacterized enzymes.  Enzymes within this superfamily possess a 
mononuclear or binuclear metal center embedded within a (β/α)8-barrel structural fold 
(1), and catalyze diverse reactions, including ester and amide hydrolysis, nucleic acid 
deamination, double bond hydration, carbohydrate isomerization, and decarboxylation 
(2).  To date, more than 24,000 unique bacterial proteins have been annotated to this 
superfamily, segregated into 24 clusters of orthologous groups (COGs) (113,169). 
One of these COGs, cog0402, contains approximately 1400 distinct proteins. 
At an E-value of 10-70, cog0402 can be divided into 14 major groups of similar sequences
(9,10)(Figure 5.1).  Although 40% of the proteins in cog0402 can be reliably annotated as 
catalyzing the deamination of an aromatic base or a similar functional group 
(3,5,11,12,149,159,170), the rest remain uncharacterized. Here, we have attempted to 
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predict the substrate profile for enzymes of unknown function represented by Group 
14 of cog0402, containing approximately 140 proteins. In particular, Arad3529 from 
Agrobacterium radiobacter K84 was cloned, expressed, and purified to homogeneity.  
Substrates of Arad3529 were predicted by docking high-energy intermediate forms of 
candidate metabolites to the homology models constructed for Arad3529.  High-
ranking predictions were acquired and tested as candidate substrates by enzymology.  
The sequence identity between Arad3529 and its closest structurally characterized 
homologue, cytosine deaminase from E. coli, is only 26%, making the construction of 
the homology model and subsequent computational docking highly challenging. 
Materials and Methods 
General. All chemicals were obtained from Sigma-Aldrich unless otherwise 
specified.  7,8-Dihydro-L-biopterin was purchased from Santa Cruz Biotechnology.  
Formylpterin, pterin-7-carboxylate, hydroxymethylpterin, xanthopterin, 7,8-
dihydrohydroxymethylpterin, and 7,8-dihydroneopterin were purchased from Schirks 
Laboratories. 
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Figure 5.1.  Sequence Similarity Network for cog0402.  Protein sequences for cog0402 
were retrieved from NCBI, subjected to an All-by-All BLAST to determine overall 
sequence similarity to all of the other proteins within this network(10). Each dot (node) 
represents an enzyme, and each connection between two nodes (an edge) represents 
those enzyme pairs that are more closely related than the arbitrary E-value cutoff (10-
70). Groups are arbitrarily numbered; those groups with experimentally determined 
substrate profiles are as follows: (1) S-adenosylhomocysteine/5’-deoxy-5’-
methylthioadenosine deaminase; (2) guanine deaminase; (4) 8-
oxoguanine/isoxanthopterin deaminase; (6) cytosine deaminase; and (8), N-formimino-
L-glutamate deiminase. 
 
 
Cloning, Expression, and Purification of Arad3529.  The gene for Arad3529 was 
amplified from Agrobacterium radiobacter Strain K84 genomic DNA using 5’-
TTAAGAAGGAGATATACCATGTCATACAGTTTCATGTCCCCGCC-3’ as the forward primer 
and 5’-GATTGGAAGTAGAGGTTCTCTGCTGCGCCAATCACGGTGTCCAG-3’ as the reverse 
primer.  PCR was performed using KOD Hot Start DNA Polymerase (Novagen).  The 
amplified fragment was cloned into the C-terminal TEV cleavable StrepII-6x-His-tag 
containing vector, CHS30, by ligation-independent cloning (171). 
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 The Arad3529-CHS30 vector was transformed into BL21(DE3) E. coli 
containing the pRIL plasmid (Stratagene) and used to inoculate a 5 mL 2xYT culture 
containing 25 µg/mL kanamycin and 34 µg/mL chloramphenicol.  The culture was 
allowed to grow overnight at 37°C in a shaking incubator.  The overnight culture was 
used to inoculate 1 L of PASM-5052 auto-induction media (172) containing 150 mM 2-
2-bipyridyl, 1.0 mM ZnCl2, and 1.0 mM MnCl2.  The culture was placed in a LEX48 airlift 
fermenter and incubated at 37 °C for 5 hours and then at 22 °C overnight.  The culture 
was harvested and pelleted by centrifugation. 
 Cells were resuspended in lysis buffer (20 mM HEPES pH 7.5, 500 mM NaCl, 20 
mM imidazole, and 10% glycerol) and lysed by sonication.  The lysate was clarified by 
centrifugation at 35,000 x g for 30 minutes.  The clarified lysate was loaded onto a 5 mL 
Strep-Tactin column (IBA), washed with 5 column volumes of lysis buffer, and then 
eluted in StrepB buffer (20 mM HEPES pH 7.5, 500 mM NaCl, 20 mM imidazole, 10% 
glycerol, and 2.5 mM desthiobiotin).  The eluent was loaded onto a 1.0 mL HisTrap FF 
column (GE Healthcare), washed with 10 column volumes of lysis buffer, and eluted in 
buffer containing 20 mM HEPES pH 7.5, 500 mM NaCl, 500 mM imidazole, and 10% 
glycerol.  The purified sample was loaded onto a HiLoad S200 16/60 PR gel filtration 
column which was equilibrated with SECB buffer (20 mM HEPES pH7.5, 150 mM NaCl, 
10% glycerol, and 5 mM DTT).  Peak fractions were collected, analyzed by SDS-PAGE, 
snap frozen in liquid nitrogen, and stored at -80 °C.  The purified protein was submitted 
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to ICP-MS for metal content analysis and found to contain 0.8 eq Mn, 0.1 eq Fe, 0.1 eq 
Ni, and 0.1 eq Zn. 
Homology Modeling of Arad3529.  The amino acid sequence of Arad3529 from 
Agrobacterium radiobacter K84 (gi|222086854) was retrieved from the Structure 
Function Linked Database (SFLD) (173).  Homology models of Arad3529 were generated 
in four steps.  First, the primary sequence was submitted to the PSI-BLAST server at 
NCBI to search for suitable template structures (174).  Cytosine deaminase (CDA) from 
E. coli (PDB id: 1K70) is the most closely related sequence of known structure.  Cytosine 
deaminase is from group 6 of cog0402 and shares a 26% sequence identity to Arad3529 
(Figure 5.1).  In the PDB file, the enzyme is complexed with a mechanism-based 
inhibitor, 4-(S)-hydroxyl-3,4-dihydropyrimidine.  Second, a sequence alignment 
between Arad3529 and cystosine deaminase was computed by MUSCLE (175) (Multiple 
Sequence Comparison by Log-Expectation).  Third, 500 homology models were 
generated with the standard “automodel” class in MODELLER (116), and the model 
with the best DOPE (117) score was selected (Model-1) (Figure 5.2).  Finally, two loop 
regions (residues 83-89, 174-186) in Model-1 were refined with the “loopmodel” class 
in MODELLER, resulting in Models-2, 3, and 4 (Figure 5.3).  The “loopmodel” class in 
MODELLER includes several loop optimization methods, which all rely on scoring 
functions and optimization protocols adapted for loop modeling (176).  Side chains in 
these two loops were optimized using the “side chain prediction” protocol in PLOP 
(118).  The Fe2+ ion was included in all modeling steps.  The cocrystallized inhibitor from 
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the template structure was included in the third step for the construction of the initial 
homology model, but was removed from the modeled active site in the last step. 
Docking Screen Against Arad3529.  A high-energy intermediate (HEI) library 
(119,177) that contains ~22,500 different stereoisomers of 4207 KEGG (Kyoto 
Encyclopedia of Genes and Genomes) molecules (121,122) was screened against the X-
ray structure of the cytosine deaminase template (PDB id: 1K70) as a control, and each 
of the four homology models of Arad3529 using DOCK 3.5.54 (178).  The computed 
poses were subjected to a distance cutoff to ensure that the O– moiety of the HEI 
portion of the molecule is found within 4 Å of the metal ion in the active site.  The top 
500 compounds ranked by the docking score (the sum of van der Waals, Poisson–
Boltzmann electrostatic, and ligand desolvation penalty terms) were inspected visually 
to ensure the compatibility of the pose with the amidohydrolase reaction mechanism.  
The details of the HEI docking library preparation, the molecular docking procedure, 
and the protocol for analyzing docking results have been previously described 
(120,124,125,179). 
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Figure 5.2.  The active site of E. coli CDA and residues predicted to be important for 
Arad3529.  Residues drawn in white are conserved across all members of cog0402. Thr-
66, Gln-156, and Asp-314 in CDA, displayed in green, differed significantly in the 
sequence of Arad3529 and may be important for substrate binding.  Thr-66 
corresponds to Lys-85, Gln-156 corresponds to Leu-177, and Asp-314 corresponds to 
Asn-332. In the X-ray structure of CDA, Gln-156 forms hydrogen bonds with the bound 
inhibitor; Asp-304 is found within 4 Å of the CDA inhibitor but only forms steric 
interactions with it; Thr-66 is more distant from the active site. The conversion of a 
large lysine in Arad3529 suggests that the Lys-85 may reach into the active site and play 
a role in substrate binding. 
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Figure 5.3.  The active site conformations of 4 representative models of Arad3529 used 
in virtual screening.  Model-1 is ranked the best by DOPE score among 500 homology 
models generated automatically by MODELLER.  Model-2, Model-3 and Model-4 are 
different from Model1 in Loop-1, Loop-2, and both Loop-1 and Loop-2, respectively.   
 
 
Chemoinformatic Analysis of the Docking Hit-Lists.  The top 200 highest ranked 
compounds for each model were combined into ligand sets and used to calculate self-
consistency expectation values (E-value) within each set using the Similarity Ensemble 
Approach (SEA) (180,181).  Briefly, each ligand was broken into molecular fingerprints, 
here ChemAxon path fingerprints.  The similarity between molecules is quantified by 
the number of bits they have in common divided by the total number of bits using the 
Tanimoto coefficient (Tc). The sum of all pairwise Tc values over a defined cutoff is 
calculated and compared to what is expected at random between two ligand sets of the 
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same size.  The ratio of the calculated sum of Tc values over the sum of Tc values 
expected at random is divided by the standard deviation of the random similarity to 
give a Z-score and plotted against an extreme value distribution to yield an E-value.  
The self-similarity between the ligands of the same set provides a metric to how diverse 
or similar the ligands are based on the E-value.  The more significant is the E-value 
(lower), the tighter the chemical space is in the ligand set with likely fewer numbers of 
distinct chemotypes.  Each docking model’s self-consistency E-value was then 
compared to the number of true substrates found from each ligand set. 
Physical Library Screening.  The initial screen of catalytic activity monitored 
changes in the UV–visible spectrum from 240 to 400 nm after the addition of 1.0 μM 
Arad3529 to a solution containing 100 μM of the target compound in 20 mM HEPES, pH 
7.7 in a 96-well quartz plate using a Molecular Devices Spectramax 384 Plus 
spectrophotometer.  The compounds that exhibited observable spectral change were 
subjected to more quantitative kinetic assays.  On the basis of the docking ranks and 
compound availability, 11 compounds prioritized by docking were tested as potential 
substrates, including melamine, cytosine, thioguanine, guanine, adenine, 7-
methylguanine, cytidine, 2′-deoxycytidine, pterin, biopterin, and neopterin. In addition, 
104 compounds that were substrates of annotated amidohydrolases were tested as 
potential substrates:  guanosine, adenosine, 8-mercaptoguanine, 2,6-diaminopurine, 
xanthine, 8-oxoguanine, urate, 9-methylguanine, 6-chloropurine, 8-oxoadenine, 
isopentenyladenine, N6-methyladenine, 1-methyladenine, cis-zeatin, trans-zeatin, 
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benzyladenine, 2-amino-6-benzylthiopurine, N-ethenopurine, N6-acyladenine, kinetin, 
N-dimethyladenine, N-butyladenine, isoguanine, 2-amino-6-methoxypurine, 6-
methylthiopurine, 2-chloroadenine, 6-methoxyadenine, 6-mercaptopurine, 7-
methyladenine, 2-dimethylaminoadenine, 3-iminisoindolinone, acycloguanosine, 2’-
deoxyguanosine, xanthosine, 2’-deoxyadenosine, 3’-deoxyadenosine, 5’-
deoxyadenosine, 2’,5’-dideoxyadenosine, 5’-amino-5’-deoxyadenosine, 5’-chloro-5’-
deoxyadenosine, 5’-deoxy-5’-methylthioadenosine, S-adenosylhomocysteine, N6-
methyl-2’-deoxyadenosine, isoguanine, 2’-deoxyisoguanine, cytosine-β-D-
arabinofuranose, N-methylcytidine, 5-methyl-2’-deoxycytidine, 5-
hydroxymethylcytidine, 2,4-diaminopyrimidine, 4,6-diaminopyrimidine, 4-amino-2,6-
dihydroxypyrimidine, 2-amino-4,6-dihydroxypyrimidine, 5-methlcytosine, 5-
hydroxymethylcytosine, 5-carboxycytosine, 5-aminocytosine, 5-fluorocytosine, 5-
chlorocytosine, 4-hydroxy-2,5,6-triaminopyrimidine, N-methylcytosine, 3-
methylcytosine, 2,6-diaminopyrimidine, 2,4,6-triaminopyrimidine, uracil, 5-aminouracil, 
5-formyluracil, 5-fluorouracil, 3-oxauracil, 5-hydroxymethyluracil, 6-
hydroxyaminouracil, thiamine, 2-aminopyrimidine, 4-aminopyrimidine, toxopyrimidine, 
sulfamonomethoxine, 4-thiouracil, 2-thiouracil, thymine, 5-azacytosine, ammeline, 
ammelide, cyanuric acid, 2-amino-4-hydroxy-6-chlorotriazine, cyromazin, N-
ethylammeline, desethylatrazine, 6-azacytosine, 2-aminopyridine, 2,6-diaminopyridine, 
4,6-diamino-2-hydroxpyridine, 4-aminopyridine, 4-dimethylaminopyridine, creatinine, 
5-amino-4-imidazolecarboxyamide, 5-hydantoin acetic acid, 3-amino-5-mercapto-1,2,4-
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triazole, 3-amino-5-carboxy-1,2,4-triazole, dihydrouracil, dihydrothymine, and 
dihydroorotate. 
After the pterins were identified as substrates, 11 compounds composed of a 
pteridine ring were added to the screening: 2,4-diamino-6-hydroxymethylpteridine, 
isoxanthopterin, pterin-6-carboxylate, sepiapterin, folate, formylpterin, pterin-7-
carboxylate, hydroxymethylpterin, xanthopterin, 7,8-dihydrohydroxymethylpterin, and 
7,8-dihydroneopterin. 
Determination of Kinetic Constants.  Once candidate substrates had been 
identified in parallel by docking and plate-based screening, quantitative kcat and kcat/Km 
were determined in 20 mM HEPES buffer at pH 7.7.  For each compound, the change in 
the extinction coefficient between the substrate and the deaminated product was 
determined experimentally by subtraction of the absorbance spectrum of the product 
from the spectrum of the substrate.  The wavelengths (nm) and the differential 
extinction coefficients, Δε (M-1 cm-1) for each of the compounds utilized in this 
investigation are as a follows:  pterin-6-carboxylate (271 nm, 6211 M-1 cm-1); pterin 
(255 and 314 nm, 7021 and 1877 M-1 cm-1); biopterin (260 nm, 6527 M-1 cm-1); D-
neopterin (320 nm, 4431 M-1 cm-1); isoxanthopterin (350 nm, 2223 M-1 cm-1); 
sepiapterin (260 nm, 3137 M-1 cm-1); folate (364 nm, 4312 M-1 cm-1); formylpterin (316 
nm, 2963 M-1 cm-1), pterin-7-carboxylate (264 nm, 3706 M-1 cm-1); hydroxymethylpterin 
(264 nm, 7356 M-1 cm-1); xanthopterin (282 nm, 9704 M-1 cm-1); 7,8-
dihydrohydroxymethylpterin (536 nm, 3220 M-1 cm-1); 7,8-dihydroneopterin (282 nm, 
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9424 M-1 cm-1); and 7,8-dihydrobiopterin (262 nm, 3254 M-1 cm-1).  The values of kcat 
and Km were determined by fitting the parameters in Equation 5.1 to the experimental 
data, using SigmaPlot 11, where v is the initial velocity, Et is enzyme concentration, and 
A is the substrate concentration. 
                                                         v/Et = kcat A / (A + Ka)                                     (Equation 5.1) 
 
Confirmation of Product Formation.  100 μM pterin-6-carboxylate was 
incubated with 150 nM Arad3529 in 50 mM NH4CO3H for 1 h at 25 °C.  The reaction 
mixture was filtered with a 30,000 MW cutoff spin column, and the flow-through was 
collected.  This flow-through and a sample of 100 μM pterin-6-carboxylate was 
submitted to ESI–mass spectrometry at the Texas A&M Laboratory for biological mass 
spectrometry.  The reaction showed an m/z change from 206.04 to 207.02, consistent 
with the product 2,4-dihydroxypteridine-6-carboxylate from the deamination of pterin-
6-carboxylate. 
Results 
Sequence Comparison of Arad3529 with Cytosine Deaminase from E. coli.  
Cytosine deaminase from E. coli is currently the closest structurally characterized 
protein to Arad3529.  The four metal binding residues in cytosine deaminase (H61, H63, 
H214, and D313) align well with H80, H82, H231, and D331 from Arad3529, along with 
two additional residues (H246 and E217 aligned with H263 and E234 in Arad3529, 
respectively) that function as proton shuttles in cytosine deaminase.  Because these 
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active site residues to perform a deamination were all intact in Arad3529, it is very 
likely also a deaminase.  However, in Arad3529 there are three notable changes in the 
amino acid sequence, relative to that found in most other cytosine deaminases from 
cog0402. In Arad3529, Thr66, Gln156, and Asp314 from CDA are replaced by Lys85, 
Leu177, and Asn332, respectively (Figure 5.2).  In CDA from E. coli, Thr66 located near 
the active site does not appear to hydrogen bond with cytosine.  Conversely, Gln156 
forms a pair of hydrogen bonds to the carbamoyl moiety of cytosine, while Asp314 is 
located immediately after the invariant Asp313 and within 4 Å of the bound inhibitor in 
the CDA structure.  The substitutions to the active site residues thus suggest that 
Arad3529 deaminates a substrate different from cytosine. 
 Molecular Docking.  In the initial homology model of Arad3529 (Model-1), 
which overall adopts the same backbone conformation as the template, changes are 
located in two unstructured loop regions that help define the active site (Loop-1, 
residues 83–89; Loop-2, residues 174–186).  Therefore, Loop-1 and Loop-2 were 
remodeled separately, resulting in Model-2 and Model-3 (Figure 5.3).  Finally, the Loop-
1 conformation in Model-2 and the Loop-2 conformation in Model-3 were combined in 
Model-4.  Thus, four homology models were obtained that are distinct from each other 
in their active site conformations. 
Because homology models are constructed from template structures, the 
models often share some structural features with the templates, and thus recognize 
similar ligands.  Here, however, small molecules that are highly ranked by the template 
 
 
110 
 
structure (PDB id: 1K70) are unlikely to be the true substrate of the remote homologue.  
Therefore, before targeting the homology models of Arad3529, the template 
structure 1K70 was docked against as a negative control.  57,672 high-energy 
intermediates (HEI) were docked into the template structure.  As expected, cytosine, 
the natural substrate of the template, was ranked highly (10th out of 57 672), as were 
several other nucleosides (Table 5.2).  These molecules were deprioritized for testing 
against Arad3529; we instead looked for molecules with high differential ranks 
between the models and the template docking screens. 
The same HEI database was docked to each of the four homology models of 
Arad3529.  From each model, putative substrates were selected from the top 500 
scored molecules (Table 5.1).  The compound sets selected using different homology 
models are overlapping but distinct. For Model-1, the docking hits were dominated by 
relatively small compounds with a 1,3,5-triazine skeleton.  This pattern is also observed 
in the docking hits from Model-2. However, compounds composed of the purine or 
pteridine ring were also favored by Model-2. For Model-3, the 1,3,5-triazine skeleton 
completely disappeared, and the docking hits were dominated by compounds 
composed of the pteridine ring. Model-4 shared the pteridine pattern with Model-3, 
but also favored nucleosides having a ribose group. 
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Table 5.1.  Virtual screening of the HEI database against four homology models of 
Arad3529* 
Name KEGG ID Docking rank 
Model-1 Model-2 Model-3 Model-4 
melamine C08737 10    
cyclopropylmelamine C14147 13 18   
diethylatrazine  C06559 28 32   
Diisopropylatrazine C06556 29 33   
Diisopropylhydroxyatrazine C06557 31    
cytosine  C00380 52 45 185 126 
2-amino-4-hydroxy-6-hydroxymethyl-
7,8-dihydropteridine  
C01300 108 (N1) 135 (N1) 10 (N1) 12 (N3) 
thioguanine C07648  11   
Guanine C00242  20   
pterin C00715  31 (N3) 27 (N1) 102 (N3) 
127 (N1) 
phenazopyridine C07429  50   
biopterin  C06313  66 (N3) 14 (N1) 51 (N1) 
71 (N3) 
adenine C00147  99   
neopterin C05926   15 (N1) 143 (N1) 
7-methylguanine C02242    23 
deoxycytidine  C00881    49 
cytidine  C00475    75 
5'-deoxy-5’-fluorocytidine  C16635    132 
2-aminoadenosine  C00939    206 
*The names of three molecules that were found in the control are written in italic. The 
2-aminopteridine-4(3H)-one and the 2-aminopteridine-4(1H)-one tautomers were 
attacked by the hydroxide from the re-face and the si-face, and have the N-1 ring 
nitrogen and N-3 ring nitrogen protonated by Glu234, resulting in two intermediates 
named as N1 and N3, respectively.  
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Table 5.2.  Virtual screening of the HEI database against the template structure 1K70 
Name KEGG ID Rank 
cytosine C00380 10 
creatinine C00791 32 
5-methylcytosine C02376 48 
adenine C00147 50 
N6-methyladenine C08434 59 
2’-deoxycytosine C02026 73 
guanine C00242 77 
toxopyrimidine C01279 126 
 
 
Chemoinformatic Analysis of the Docking Hit-Lists.  On the basis of docking 
energies alone, it is difficult to prioritize one of these overall hit-lists over another, 
although the geometry of the interactions does provide guidance (below).  One can, 
however, pose extra-thermodynamic criteria to judge among them.  One such is to 
expect that in a well-behaved docking hit-list, the highly ranked molecules will 
resemble one another, and thus the hit-list will resemble itself by chemical similarity.  
We therefore compared the top-ranked 200 molecules for each of the four models of 
Arad3529 against themselves using the Similarity Ensemble Approach (SEA) (180,181).  
This was quantified by an expectation value (E-value) of the likelihood the self-similarity 
of each hit-list would occur at random.  Of the four models, Model-3 and Model-4 had 
more self-consistent hit-lists (SEA E-value 1.5 × 10–100 and 4.9 × 10–98, respectively) as 
compared to Model-1 and Model-2 (SEA E-value 2.7 × 10–89 and 1.2 × 10–85, 
 
 
113 
 
respectively).  Comfortingly, the structures of what turned out to be the true pterin 
substrates of the enzyme were docked in catalytically competent geometries in Model-
3 and Model-4.  Naturally, this criterion has nothing to recommend it other than 
consistency, but it may merit further study as a metric to select multiple possible hit-
lists for targets adopting different structures. 
Substrate Profile for Arad3529.  On the basis of commercial availability, eight 
compounds predicted to be potential substrates for Arad3529 were tested as enzyme 
substrates, as were three “negative control” nucleosides that also ranked well against 
the CDA template (Table 5.1).  Arad3529 was found to deaminate three of the eight: 
pterin, biopterin, and neopterin with kcat/Km values of greater than 106 M–1s–1.  We 
docked the ground states of three substrates, pterin, biopterin, and neopterin, to 
Model-3.  The docking scores of these ground states (−19.29, −27.30, and −23.08, 
respectively) were substantially higher (worse) than the corresponding HEI states 
(−53.83, −58.45, and −58.26, respectively), consistent with the catalytic mechanism.  
The pterin deaminase (PDA) reaction is illustrated in Scheme 5.1.  To investigate the 
mechanism further, the enzyme was screened with other substituted pterins and was 
found to deaminate several pterins (Scheme 5.2).  Various substitutions on C6 of the 
pteridine ring are allowed (Table 5.3), and with the exception of sepiapterin, the fully 
aromatic pteridine ring is preferred.  7,8-Dihydroneopterin and 7,8-dihydrobiopterin 
were deaminated very slowly, and the deamination of dihydrofolate or 
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tetrahydrofolate could not be measured (<0.0008 s–1).  2,4-Diamino-6-
hydroxymethylpteridine was not deaminated. 
 
 
Scheme 5.1 
 
 
 
Scheme 5.2 
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Variations on Binding Orientation of Pterin.  In all of the structurally 
characterized members of the amidohydrolase superfamily, the re-face of the carbonyl 
group of amide and ester substrates is presented to the attacking hydroxide; the same 
orientation was observed for the amidine or guanidine moieties of substrates in the 
deamination reactions. In docking screens against Arad3529, we observed two chiral 
intermediates of pterin (named as N1 and N3), that were generated by hydroxide re- 
and si-face attacking two pterin tautomers 2-aminopteridin-4(3H)-one and 2-
aminopteridin-4(1H)-one, and by Glu234 protonating the N-1 and N-3 nitrogen in the 
pteridine ring, respectively (Scheme 5.3).  In particular, N3 was selected by Model-2, N1 
was selected by Model-3, and both intermediates were selected by Model-4 (Table 
5.1).  In Model-2, the docking pose of N3 had a stranded C-4 carbonyl group, which in 
N1 forms hydrogen bonds with Asn332 in Model-3 (Figure 5.4).  This C-4 carbonyl group 
and the N-5 ring nitrogen in N1 also hydrogen bonded with Lys85 in Model-3.  
Furthermore, it is known that the 2-aminopteridin-4(1H)-one tautomer is less stable 
than the 2-aminopteridin-4(3H)-one tautomer (in ab initio and free energy perturbation 
calculations the ratio is 1:6 (182)).  It is clear that the N1 orientation is the true binding 
motif, and that an important feature for recognition of a pterin deaminase is the DN 
dyad (D331, N332) found on β-strand 8 and the Lys85 found on β-strand 1.  
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Table 5.3.  Catalytic constants for substrates of Arad3529 
Substrate kcat/Km (M-1 s-1) kcat (s-1) Km (μM) 
Docking 
rank* 
formylpterin 5.2 (0.5) x 106 64 ± 12 12 ± 2  
pterin-6-carboxylate 4.0 (0.2) x 106 110 ± 3 27 ± 2  
pterin-7-carboxylate 3.7 (0.2) x 106 48 ± 2 13 ± 1  
pterin 3.3 (0.3) x 106 131 ± 4 39 ± 4 27 
hydroxymethylpterin 1.2 (0.1) x 106 28 ± 1 23 ± 3  
biopterin 1.0 (0.1) x 106 46 ± 4 47 ± 9 14 
D-(+)-neopterin 3.1 (0.1) x 105 19 ± 1 61 ± 7 15 
isoxanthopterin 2.8 (0.2) x 105 1.6 ± .03 5.7 ± .5  
sepiapterin 1.3 (0.4) x 105 2.9 ± .3 22 ± 9  
folate 1.3 (0.2) x 105 6.4 ± .5 50 ± 10  
xanthopterin 1.17 (.08) x 105 0.46 ± 0.01 40.0 ± 0.4  
7,8-dihydro-
hydroxymethylpterin 
3.3 (0.4) x 104 1.23 ± 0.09 37 ± 7 
 
7,8-dihydroneopterin 2.6 (0.3) x 102 0.036 ± 0.008 200 ± 100  
7,8-dihydrobiopterin          -- ~0.01      --  
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Scheme 5.3 
 
Discussion 
Three techniques were crucial for what turned out to be the correct prediction 
of pterin deaminase, activity for Arad3529.  First, to leverage a distantly-related 
template, detailed modeling of two active-site loops was required to find models that 
were at once structurally sensible and catalytically competent, and that could 
discriminate new substrates from these precedential from the template.  Second, the 
selectivity of models was enhanced by negative control docking screens against the 
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template structure; we sought substrates ranked highly by the models and poorly by 
the template.  Finally, a close cycle of bioinformatics, biophysical modeling, and 
enzymology made this approach pragmatic. Moreover, identifying substrates for 
Arad3529 allows the functional annotation of about 140 previously uncharacterized 
amidohydrolase enzymes in Group 14 of cog0402.  These proteins may be used by 
bacteria to salvage oxidized pterins, and form the pterin degradation pathway with 
neighboring genes.  
Enzyme Specificity Recapitulated by Loop Modeling.  The substrate specificity 
of enzymes comes from the corresponding compositions of binding-site residues. 
Remarkable changes in the binding-site residues between two enzyme sequences lead 
to differences in their binding-site structures.  However, a homology model tends to 
inherit the backbone conformations of aligned regions from the template.  Therefore, a 
homology model of the target enzyme often contains errors in the packing of side 
chains, and backbone conformations of structurally undefined regions (loops), 
especially when computed based a remote template.  Accurate substrate prediction by 
docking against homology models of unknown enzymes requires precise positioning of 
the binding site residues that interact with the new substrates. In this study, we 
attempted to recapitulate binding-site features in the native structure of Arad3529, by 
remodeling two binding-site loops in the initial homology model. Because no target 
ligand is known, three new models that are structurally diverse were selected and 
docked against independently, followed by combining the screening results.  True 
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substrates of the target enzyme Arad3529, pterins, were not captured by the initial 
homology model but these remodeled, demonstrating the necessity of the directed 
refinement of binding-site loops that contain residues different from the template.  
Docking Against Template as a Negative Control.  Given the definition of 
structure-based docking screens, the highly ranked compounds can be seen as 
fingerprint of the protein structure that was docked against. When a homology model 
of the target enzyme is computed based a distantly related template structure, on one 
side, the target enzyme very likely have different substrates from those of the 
template; on the other side, however, the homology model of the target even after 
refinement could still share some structural features with the template and thus 
prioritize similar compounds as the template structure in docking screens.  In this 
study, we first generated the docking fingerprint of the template structure, and then 
compared to what the homology models of the target enzyme Arad3529 predicted.  
Several compounds, that were ranked highly by the template, were also prioritized by 
the homology models. However none of these compounds was confirmed as substrates 
of Arad3529 by enzymology testing.  This result suggests that, for enzyme substrate 
prediction by homology model-based docking, it may be useful to account for 
compounds that are recognized by the template as negative control, especially when 
there is only a remote relationship between the target and the template sequence.   
Additional Enzymes in Cog0402 that Catalyze Pterin Deamination.  Figure 5.1 
depicts 22 sequences in Group 14.  To identify a more comprehensive list of proteins in 
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the current databases that share the same substrate profile as Arad3529, a BLAST 
search was conducted with the sequence of Arad3529.  Of the top 200 hits, 165 
proteins contained the characteristic β-strand 8 “DN” dyad and a total of 139 of these 
would populate Group 14 if included in the network diagram.  The remaining 26 
sequences cluster with the currently uncharacterized Group 13.  Group 13 is closely 
related to cytosine deaminase and also possesses a mixture of enzymes that have 
either a “DN” or “NN” dyad.  While the enzymatic function of Group 13 is unknown, all 
members of Group 14 are predicted to deaminate pterins.  A list of these enzymes is 
found in Appendix B.  Of course, this remains just a prediction, because even proteins 
with high sequence identity sometimes have different activities (18).  
Biological Relevance of Substrates, Genomic Context in Agrobacterium 
radiobacter.  Pterin rings form the backbone of the coenzymes folate and 
tetrahydrobiopterin.  The 7,8-dihydro forms of hydroxymethylpterin and neopterin are 
intermediates in folate synthesis, whereas sepiapterin is an intermediate in the 
synthesis of biopterin.  During the biosynthesis of these cofactors, the pterin 
substructure remains reduced in the 7,8-dihydro form.  Fully oxidized pterins, formed 
by oxidation of 7,8-dihydropterins (183), are not known to be salvaged by reduction 
(184).  Isoxanthopterin is formed by oxygenation of pterin by xanthine dehydrogenase 
(185), while pterin-6-carboxylate, formylpterin and pterin can be formed by photolysis 
of folate (186,187).  It seems possible that Arad3529 and its orthologs are used by the 
bacteria to degrade oxidized pterins.  
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The gene for Arad3529 is situated in an apparent operon along with the genes 
TauC, GlcD and MdaB, which is flanked by TauA, TauB, LysR, and a protein from 
cog1402 (Figure 5.4).  TauA, TauB and TauC resemble ATP-cassette binding transporters 
and LysR is a transcription factor.  MdaB, GlcD and cog1402 are uncharacterized 
proteins resembling quinone oxidase, glycolate oxidase D, and creatininase, 
respectively.  MdaB is predicted to contain an NAD(P)H binding domain, GlcD is 
predicted to be a flavin dependent redox enzyme, and the cog1402 protein will likely 
catalyze the hydrolysis of an amide bond.  These enzymes may form a degradative 
pathway for catabolizing pterin rings.  To our knowledge, the only known instance for 
the degradation of a pterin ring is by the soil bacteria Alcaligenes faecalis (188).  In this 
bacterium, isoxanthopterin is deaminated to form 7-oxylumazine, which is further 
oxidized to 6,7-dioxylumazine (tetraoxypteridine).  An isomerase then cleaves the 
C6/C7 bond, and reattaches forming xanthine-8-carboxylate (189).  Xanthine-8-
carboxylate is then decarboxylated, forming xanthine (190).  Unfortunately, the 
recently sequenced genome of A. faecalis does not possess an Arad3529 homologue or 
any of its operon-related genes, and the protein that deaminates isoxanthopterin 
remains to be discovered. 
 
 
Figure 5.4.  Operon of Arad3529.  
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Certain caveats merit mentioning.  Here, homology models of Arad3529 were 
predicted from a cytosine deaminase structure in complex with a mechanism-based 
inhibitor.  This likely gave us an advantage over modeling from a ligand-free template. 
When such an apo- template is the only choice, enhanced sampling may be needed 
(166).  Inevitably, this will lead to more models. To judge among these possible 
structures, and the docked molecules to which they lead, the criterion of a self-similar 
hit-list may be useful, as we found it to be.  Admittedly, this metric remains largely 
untested, and its only theoretical virtue is that it quantifies an expectation that a well-
behaved docking calculation should find putative ligands that resemble one another. 
From a docking standpoint, we have continued to use high-energy intermediate forms 
of substrates, rather than their ground states.  This seems well-justified for 
amidohydrolases, where we have a good understanding of the structures that such 
intermediates adopt, and confidence that the chemical step is rate determining for the 
reactions the enzymes catalyze.  For other families of enzymes, our ability to anticipate 
high-energy structures, and confidence that the chemical step is rate limiting, may be 
more limited.  Finally, docking screens, in our hands, retain a human element as a final 
arbiter of which among the tens-to-hundreds of high-ranking metabolites to actually 
test experimentally.  We have argued that human inspection integrates aspects of 
docking that are captured by the experience of the trained modeler, enzymologist, or 
medicinal chemist that are difficult to fully capture algorithmically (191). 
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Conclusion 
Members of the amidohydrolase superfamily have been found in every 
sequenced genome; the functions of most of these proteins remain unknown.  Here we 
focused on one amidohydrolase, Arad3529 from Agrobacterium radiobacter K84, which 
represents proteins from Group 14 in cog0402.  Proteins in Group 14 were completely 
uncharacterized, with sequence similarity and knowledge of the mechanistically related 
chemistries within the superfamily wrongly suggesting annotations as chlorohydrolases 
or cytosine deaminases.  A multidisciplinary approach was applied to the function 
annotation of Arad3529, integrating three-dimensional protein structure prediction by 
homology modeling, virtual metabolite screening by structure-based small molecule 
docking, and physical library screening by quantitative kinetic assays.  The true 
substrates of Arad3529, a set of modified pterins, were prospectively predicted by 
homology model-based docking, and were efficiently deaminated by Arad3529 in 
quantitative kinetic assays.  On the basis of the conservation of characteristic residues 
that interact with substrates in the docked structure, about 140 other previously 
unannotated amidohydrolase enzymes from different spieces may now be assigned as 
pterin deaminases.  This approach may be useful in the discovery in vitro enzymatic and 
in vivo metabolical functions of unknown enzymes discovered in genome projects, 
especially for those targets with marginal sequence identities to template structures of 
know functions. 
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CHAPTER VI 
ATTEMPTS TO ASCERTAIN THE ENZYMATIC ACTIVITY OF E. coli GENES SSNA AND YAHJ 
 
Introduction 
E. coli possesses four enzymes from cog0402.  Two are well studied and 
characterized, and include cytosine/isoguanine deaminase (3,7,24,150) and guanine 
deaminase (11).  The other two enzymes are SsnA and YahJ.  SsnA is found in Group 5 
(Figure 1.2), where it clusters with group 1.  YahJ is found in Group 9 and is more 
closely related to Group 6, cytosine deaminase.  While the functions of these genes 
remain unknown, there are several clues which may help identify the substrates of 
these enzymes. 
Results and Discussion 
Library Screens.  A large library of compounds was screened to be deaminated 
by YahJ and SsnA using either a UV-Vis direct assay, or coupling release of ammonia to 
glutamate dehydrogenase, resulting in the oxidation of NADH (GLDH).  These 
compounds tested and their structures are presented in Appendix C. 
The SsnA Gene.  SsnA is a gene encoding a 51 kDa protein.  This enzyme 
possesses the catalytic machinery characteristic of all cog0402 members (Figure 1.1).  
Additionally it has been purified, containing 1 equivalent of manganese in its active site.  
Aside from its purification, much remains unknown about its function in vivo.  A single 
in vivo study had been performed involving the overexpression and knockout of SsnA 
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(192).  In this study it was determined that SsnA is regulated by RpoS and that 
expression is induced at early stationary phase.  Disruption of the SsnA gene resulted in 
more colony forming units forming from cultures in stationary phase than wild type.  
Constitutive expression of SsnA in an expression vector slowed cell growth when 
compared to SsnA fragments being expressed.  These results suggest that SsnA may 
play a role in the decline of cell viability during stationary phase. 
SsnA Genomic Neighborhood.  Analyzing the SsnA gene for genomic context 
reveals a set of genes which may be associated with SsnA.  The genomes of 27 
organisms containing a homologue of SsnA were compared and any homologues were 
noted.  56% of the organisms possessed a homologue of XdhA (b2866).  In E. coli, 
deletion of this gene stops production of CO2 from adenine, suggesting it may be a 
xanthine dehydrogenase (193).  The mutants also displayed an increased sensitivity to 
adenine, which was partially reversed by addition of guanosine.  A homologue of b2867 
is found in 48% of organisms, which is predicted to be the FAD binding subunit of 
b2866.  A third protein is b2867, which is predicted to be the iron sulfur cluster binding 
subunit of this complex.  It is found in 59% of organisms.  44% contain all three of these 
proteins adjacent to each other.  B2870 has been studied and a structure has been 
determined (194).  It shares homology with carbamoyltransferases, although it displays 
no activity with a variety of compounds, including amino acids. A homologue of this 
gene is found in 89% of the compared organisms.  B2871 is found in 63% of organisms 
with SsnA, and is annotated as a PLP dependent diaminopropionate ammonia lyase 
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(195).  Its structure has been determined (196).  B2872 is found in 85% of organisms, 
annotated only as a peptidase.  It shares 23% sequence identity to succinyl-
diaminopimelate desuccinylase. B3880 and b2881 are found in 44% and 59% of the 
organisms with an SsnA homologue.  They are annotated only has a 
dehydrogenase/oxidase and not much is known about them.  63% possess b2874, 
which shares 49% identity to a confirmed carbamate kinase (PDB: 1B7B).  56% possess 
a homologue of b2878, which bares only 28% identity to an uncharacterized gene 
labelled “xanthine dehydrogenase (PDB: 3ON5).”  81% of the organisms possess a 
homologue of b2873.  This enzyme has been characterized as a D-phenylhydantoinase 
(197), however d-phenylhydantoin is not known to be naturally occurring. It is possible 
its physiological function has not been discovered.  B2877, found in 56% of the 
genomes, is confirmed to catalyze molybdopterin cytidylyltransferase, forming the 
molybdopterin cytidine dinucleotide cofactor (198).  This cofactor is essential for 
xanthine dehydrogenase, which may explain its proximity to the oxidoreductases in the 
genomic neighborhood.  B2878 is found in 63% of the genomics discussed.  It is an 
uncharacterized dehydrogenase with an iron sulfur binding domain. 
SsnA Sequence and Structure.  SsnA homologues populate group 5 in cog0402.  
This group is closely related to the group 1 proteins discussed in Chapter II and even 
clusters with this group at an E-value of 10-50, however activity has never been found 
with any adenosine derivatives.  Of course this is perfectly reasonable, considering the 
specific substrate requirements of certain group 1 proteins to deaminate only guanine 
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or 8-oxoadenine and their high similarity to other group 1 proteins.  The hallmark of 
group 1 adenosine deaminases is a histidine found on beta strand 4 which binds to N3 
of the purine ring and a glutamate found on beta strand 1 which binds to the 2’ and 3’ 
hydroxyls on the ribose moiety.  In SsnA, this histidine is conserved however the 
residue corresponding to the glutamate exists as an aspartate.  Shown in Figure 6.1 is 
an active site alignment of the structure of E. coli SsnA (green) and of its closest 
liganded homologue, a group 1 methylthioadenosine deaminase (MTADA)  from 
Pseudomonas Aeruginosa Pao1 (127) (PDB: 4GBD)(cyan) and a transition state 
analogue (pink).  The active sites align well, however the positioning of the aspartate 
suggests it may play a different role, if any, in substrate binding. 
The surface also reveals some of the differences between SsnA and the group 1 
proteins.  Figure 6.2 shows an active site cavity which is open to the solvent, unlike the 
Group 1 enzymes.  The ribose binding pocket is much smaller and likely would not be 
able to fit a ribose.  A new cavity forms near the C4 position on the adenine ring, 
possibly allowing extra space for substituents on that ring position.  Of course it should 
be noted the structure could change substantially if bound to a ligand. 
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Figure 6.1: Active site of SsnA.  The active site of SsnA (green) is aligned with the 
structure of MTADA (PDB: 4GBD) (blue) along with the ligand of MTADA (pink).  
Residues are labelled according to the characterized structure MTADA.  
 
 
 
 
Figure 6.2: Surface of SsnA.  The ligand from PDB: 4GBD is included in SsnA for 
comparison.  The active site cavity is highlighted with a green line. 
Strand 4 His 
Strand 1 Asp 
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Functional Assessment of SsnA.  Even with these features of SsnA known, a 
meaningful prediction remains difficult to establish.  From its structural relationship 
with adenosine deaminases as well as the genomic context including dehydrogenases, 
carbamoyltransferases and the hydantoinase, and its expression at early stationary 
phase, it would seem this enzyme is degradative in nature and all predictions point to a 
heterocyclic imine functional group.  The molybdenum cofactor produced by b2877 
could provide an excellent starting point since little is known about its degradation. 
While most common adenosine compounds have been tested, it is possible 
SsnA is an adenosine deaminase which is very specific on its function.  This kind of 
activity is precedented by Tvn0515 , a specific group 1 SAH deaminase which would not 
deaminate any other tested adenosine compound.  It is possible that the substrate is 
not known as a metabolite.  Most predictions are based of compounds found in KEGG, 
which is continuingly being updated with newly discovered metabolites. 
 The YahJ Gene.  While YahJ is included with SsnA in this chapter, it only 
superficially resembles this enzyme in that they are both unknown deaminases in 
cog0402.  Being said, YahJ likely does not interact in any respect with SsnA.  YahJ has 
not been studied as extensively as SsnA.  YahJ encodes an amidohydrolase with a twin 
arginine translocation (TAT) peptide attached (199).  This peptide assists in transporting 
the folded protein to the cell envelope or intermembrane space.  This enzyme had 
been previously cloned and was found only to be soluble when using the 3rd 
methionine as a start codon.  It would not fold properly inside the cell if the TAT 
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peptide were included on the N-terminus.  There is no phenotype for the knockout, and 
genomic context too is limited.  E. coli has in the operon a carbamate kinase, however 
other organisms which possess a YahJ homologue do not conserve this gene. 
 There is no structure, and the closest characterized homologues are N-
isopropylammelide isopropylaminohydrolase (AtzC) (PDB: 2QT3) (29% identity) and 
cytosine deaminase (PDB: 1k70) (26% identity).  The sequence of YahJ possesses some 
similar features to that of cytosine deaminase.  Gln156 in E. coli CDA, which binds to 
the carbonyl of cytosine, is conserved in the members of YahJ.  A slight variation occurs 
on Asp314, where the YahJ equivalent exists as a Ser.  In E. coli cytosine deaminase, this 
mutation confers activity for C5 substituted cytosines such as 5-methyl and 5-
fluorocytosine (PDB: 1RAK).  Unfortunately none of these compounds are deaminated 
by YahJ.  Lys65 in AtzC aligns with Thr66 in E. coli CDA, which is conserved in YahJ.  A 
simple model of the potential active site of YahJ is present in Figure 6.3.  On this 
assessment alone, it would seem likely that that the substrate of YahJ would be a 6-
member ring.  Because of the conservation of the E. coli CDA Gln156, the substrate 
would conceivably possess a carbonyl at position C2 to form a hydrogen bond.  Also, 
there may be a polar substitute on C5 of this 6-member ring.   
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Figure 6.3:  Proposed active site model of YahJ.  White residues are from E. coli cytosine 
deaminase D314S mutant (PDB: 1RAK), bound to a transition state analogue of 5-
fluorouracil.  The blue residue is a Lys65 from AtzC (PDB: 2QT3) which aligns with Thr66 
in E. coli CDA. 
 
 An interesting consideration is YahJ has only been purified from cell pellets, and 
never tested to be excreted into the media.  It is possible, however unlikely, that YahJ 
may not be active until it is transported across the cell membrane.  When solubility of 
the TAT construct was tested, it may have only been the misfolded enzyme inside the 
cell which was analyzed and not the active protein which was able to be exported.  If 
this were the case, the full TAT construct could be expressed with a C-terminal His tag 
and purified out of the media in this manner. 
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CHAPTER VII 
CONCLUSION 
 
 The age of sequencing has opened many new scientific possibilities and allowed 
new methods in examining the structure-function relationship of enzymes.  In this 
dissertation we have explored the sequence universe of characterized enzymatic 
homologues and discovered new enzymatic function which would otherwise have 
remained unrepresented. 
 Chapter I, aside from being an introduction to chapters presented, is an 
exploration of the homologue universe of the known non-amidohydrolase family.  A 
short review was presented over cog0295 (cytidine deaminase), cog2131 (dCMP 
deaminase), cog0590 (tRNA adenosine deaminase, guanine deaminase, cytosine 
deaminase), cog0117 (RibG), and cog0717 (dCTP deaminase).  The sequences of 
members from these groups were retrieved from GenBank and isofunctional clusters of 
enzymes were identified based on known functions and conserved active site residues.  
New enzymatic activities are predicted to populate cogs 0295, 0717, 2313 and 0590.  
While the functional annotations here are only presented as unknown new function, it 
would be possible through analyses performed in the following chapters to provide 
more accurate descriptions. 
 Chapter II presents a similar strategy used in Chapter I to divide a large cluster 
of enzymes related to SAH/MTA deaminase (Tm0936) and ascertain the functional 
 
 
133 
 
boundaries as well as discovery enzymatic activities.  About 1400 homologues of 
Tm0936 were retrieved and found to not possess the same active site residues.  Most 
conspicuously absent were two arginines which bound to the homocysteine moiety on 
SAH.  Furthermore, the sequence clustered, based on sequence similarity, to at least 12 
different subgroups.  A library of compounds was constructed based on modifications 
on the 5’ end of the sugar moiety (based on the lack of arginines).  A new function was 
discovered, that of 5’-deoxyadenosine deaminase.  Also, new substrate profiles were 
discovered which contrast that of SAH deaminase.  Enzymes were discovered which 
deaminate SAH/MTA/5dAdo, MTA/5dAdo/Ado, 5dAdo/Ado, specifically 5dAdo, and 
specifically SAH.  Additional enzymes had wildly different active sites and were found to 
be 8-oxoadenine deaminases and guanine deaminase.  These studies were performed 
concurrently with docking predictions to help predict, justify binding modes and 
synergistically improve function discovery and molecular simulation.  This chapter was 
an adaptation of the published works from a 2013 JACS article (23). 
 Chapter III summarizes the work carried to discover the orphan enzyme 
isoguanine deaminase in E. coli.  This project began while studying the enzymes in 
Chapter I.  A homologue of TVN0515 from Picrophillus torridus was predicted to 
deaminate isoguanine.  When expressed in E. coli, it was found to be entirely insoluble; 
however, background activity persisted for isoguanine deaminase.  It was found that 
this background activity was from E. coli cell extract, and not from the exogenous gene.  
The activity for isoguanine activity was purified from E. coli, and the protein sequence 
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was identified by peptide mass fingerprinting by in the protein chemistry lab at Texas 
A&M by comparison to protein databases which have only become available from 
sequencing technology.  The protein was identified as cytosine deaminase, and it was 
discovered that this enzyme was in fact more efficient for isoguanine than cytosine.  
The biological relevance for this reaction is not entirely established, but isoguanine is 
an oxidative adduct of adenine and this may provide a method of detoxification and 
recycling of the purine.  This chapter was an adaptation of a 2011 Biochemistry 
publication (24). 
Chapter IV summarizes unpublished results of the dissection of the bacterial 
cytosine deaminase family.  Based on previous mutagenesis studies by a group 
attempting to develop 5-fluorocytosine deaminase activity, it was found that a single 
active site mutation (D314S) would confer this activity.  By examining the cytosine 
deaminase family in the sequence universe, it was found that the family separated into 
at least 4 groups, with almost half the groups possessing an equivalent mutation in the 
active site.  Members of each group were purified, resulting in the discovery of a novel 
5-methylcytosine deaminase.  This enzyme also had promiscuous 5-fluorocytosine 
deaminase activity.  5-methylcytosine deaminase activity was tested in vivo.  E. coli 
thymine auxotrophs were transformed by plasmids containing WT CDA, and the new 5-
methylcytosine deaminase (KPN00632) (as well as the empty vector).  The cultures 
were grown in media lacking thymine, requiring deamination of 5-methylcytosine to 
form thymine to allow growth.  The methylcytosine deaminase was capable of forming 
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thymine, while the empty vector and WT CDA were not.  The deamination of 5-
fluorocytosine was also measured in a similar experiment.  The rate of 5-fluorocytosine 
deamination was measured by growth of cultures containing 5-fluorocytosine, which 
would produce 5-fluorouracil and inhibit the gene thyA.  KPN00632 was found to be 
particularly effective at this reaction. 
Chapter V discusses the discovery of a novel promiscuous pterin deaminase as 
well as the potential for an undescribed pterin degradation pathway.  The gene product 
of Arad3529 was purified by collaboration with the EFI as part of a probe of cog0402.  
Arad3529 is found in group 14 and is distantly related to bacterial cytosine deaminase.  
Computational homology modelling provided models of the protein and allowed 
computational docking of the KEGG library.  Concurrently, this enzyme was screened 
against a physical deamination library.  Arad3529 was found to deaminate a variety of 
pterin compounds and would accept modifications on C6 of the pterin ring.  Even 
oxidized folate was capable of interacting with the enzyme.  Homologues of Arad3529 
are found in primarily cyanobacteria and plant symbionts.  It is likely that this enzyme is 
used to deaminate oxidized pterin molecules, which are formed by unintentional 
oxidation of reduced pterin rings, which are used in the production of cofactors.  
Furthermore, Arad3529 is found to be on an operon with several other enzymes which 
were suggested to be a part of a new pterin degradation pathway.  These results are 
summarized in a 2012 JACS publication(26). 
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Chapter VI is a summary of two remaining projects which we have worked on, 
which still remain uncharacterized.  These are the E. coli genes YahJ and SsnA, which 
are related to cytosine deaminase and the group 1 proteins respectively.  No activity 
has been detected for either of these gene products.  Knockout phenotypes have not 
produced any clues.  SsnA appears to have a conserved genomic neighborhood among 
other organisms which contain an SsnA homologue.  The active site of SsnA has been 
established in a structure, and the active site of YahJ can be approximated.  However 
the substrate remains elusive and is thought to be either a purine or pyrimidine ring. 
In conclusion, this research has attempted to utilize the availability of the 
sequence databases to its full extent.  With the information available to us, and it being 
so easily extractable, pockets of new functional activity can be rapidly identified.  In this 
dissertation, we have discovered a new pterin deaminase, a 5’-deoxadenosine 
deaminase, an 8-oxoadenine deaminase, an isoguanine deaminase, and a 5-
methylcytosine deaminase by exploring uncharacterized enzymes closely related to 
enzymatically established homologues.  We have postulated there to be a unique 
pterin degradation pathway and discovered an enzyme with 5-fluorocytosine 
deaminase activity which may be used in cancer gene therapy.  The sequence universe 
will continue to grow, as will the potential to identify and discovery new enzymatic 
activities. 
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APPENDIX A 
FUNCTIONAL ANNOTATIONS OF GROUP 1 PROTEINS IN CHAPTER II 
 
Organism GI Number Sg Function 
Acetonema longum DSM 6540 338814514 Sg1a SAH/MTA Deaminase 
Acidaminococcus fermentans DSM 20731 284048666 Sg1a SAH/MTA Deaminase 
Acidaminococcus intestini RyC-MR95 352684529 Sg1a SAH/MTA Deaminase 
Acidaminococcus sp. D21 227498515 Sg1a SAH/MTA Deaminase 
Acidithiobacillus caldus ATCC 51756 255021229 Sg2 MTA/5'-dAdo/Ado Deaminase 
Acidithiobacillus ferrivorans SS3 344200120 Sg2 MTA/5'-dAdo/Ado Deaminase 
Acidithiobacillus ferrooxidans ATCC 53993 198283616 Sg2 MTA/5'-dAdo/Ado Deaminase 
Acidithiobacillus thiooxidans ATCC 19377 384084622 Sg2 MTA/5'-dAdo/Ado Deaminase 
Aciduliprofundum boonei T469 254166651 Sg11 SAH Deaminase 
Aciduliprofundum boonei T469 254167272 Sg11 SAH Deaminase 
Acinetobacter lwoffii SH145 262376404 Sg10 8-Oxoadenine Deaminase 
Acinetobacter sp. HA 389704937 Sg10 8-Oxoadenine Deaminase 
Agrobacterium vitis S4 222106480 Sg10 8-Oxoadenine Deaminase 
Akkermansia muciniphila ATCC BAA-835 187736175 Sg6 5'-dAdo Deaminase 
Albugo laibachii Nc14 325189944 Sg2 MTA/5'-dAdo/Ado Deaminase 
Albugo laibachii Nc14 325189945 Sg2 MTA/5'-dAdo/Ado Deaminase 
Alcanivorax borkumensis SK2 110834613 Sg2 MTA/5'-dAdo/Ado Deaminase 
Alcanivorax dieselolei B5 407696804 Sg2 MTA/5'-dAdo/Ado Deaminase 
Alcanivorax hongdengensis A-11-3 408375135 Sg2 MTA/5'-dAdo/Ado Deaminase 
Alcanivorax pacificus W11-5 407802061 Sg2 MTA/5'-dAdo/Ado Deaminase 
Alcanivorax sp. DG881 254429653 Sg2 MTA/5'-dAdo/Ado Deaminase 
Alkalilimnicola ehrlichii MLHE-1 114320072 Sg2 MTA/5'-dAdo/Ado Deaminase 
Alkaliphilus metalliredigens QYMF 150392253 Sg9 Guanine Deaminase 
Alkaliphilus oremlandii OhILAs 158319425 Sg9 Guanine Deaminase 
Allochromatium vinosum DSM 180 288941706 Sg2 MTA/5'-dAdo/Ado Deaminase 
Alteromonas sp. S89 372267296 Sg2 MTA/5'-dAdo/Ado Deaminase 
Ammonifex degensii KC4 260892855 Sg1a SAH/MTA Deaminase 
Anaerococcus hydrogenalis ACS-025-V-Sch4 325846621 Sg1a SAH/MTA Deaminase 
Anaerococcus hydrogenalis DSM 7454 212696141 Sg1a SAH/MTA Deaminase 
Anaerococcus prevotii ACS-065-V-Col13 325479377 Sg1a SAH/MTA Deaminase 
Anaerococcus prevotii DSM 20548 257066470 Sg1a SAH/MTA Deaminase 
Anaerolinea thermophila UNI-1 320161507 Sg7 5'-dAdo/Ado Deaminase 
Archaeoglobus fulgidus DSM 4304 11498602 Sg1b SAH/MTA/5'-dAdo Deaminase 
Archaeoglobus profundus DSM 5631 284161269 Sg1b SAH/MTA/5'-dAdo Deaminase 
Archaeoglobus veneficus SNP6 327401019 Sg1b SAH/MTA/5'-dAdo Deaminase 
Aromatoleum aromaticum EbN1 56475928 Sg2 MTA/5'-dAdo/Ado Deaminase 
Azoarcus sp. BH72 119898878 Sg2 MTA/5'-dAdo/Ado Deaminase 
Azoarcus sp. KH32C 358638550 Sg2 MTA/5'-dAdo/Ado Deaminase 
Azotobacter vinelandii DJ 226943694 Sg2 MTA/5'-dAdo/Ado Deaminase 
Bacillus alcalophilus ATCC 27647 402299138 Sg1a SAH/MTA Deaminase 
Bacillus alcalophilus ATCC 27647 402299011 Sg9 Guanine Deaminase 
Bacillus anthracis str. A2012 65319185 Sg4 5'-dAdo/Ado Deaminase 
Bacillus anthracis str. Ames 30261905 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cellulosilyticus DSM 2522 317128620 Sg1a SAH/MTA Deaminase 
Bacillus cereus 03BB102 225863770 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus 03BB108 196045020 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus 172560W 229178305 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus 95/8201 229121453 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus AH1134 206970647 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus AH1271 229029603 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus AH1273 229017192 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus AH187 217959387 Sg4 5'-dAdo/Ado Deaminase 
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Bacillus cereus AH603 229059557 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus AH621 229166770 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus AH676 229043659 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus AND1407 401100969 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus ATCC 10876 229189999 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus ATCC 10987 2462117 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus ATCC 10987 42736941 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus ATCC 14579 30019935 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus ATCC 4342 229155478 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus B4264 218233043 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus BAG1X1-2 401644151 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus BAG1X1-3 401637644 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus BAG2X1-1 401649456 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus BAG2X1-2 401647728 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus BAG3X2-1 401102048 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus BAG5X1-1 401135601 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus BAG5X2-1 401140262 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus BAG6X1-1 402435656 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus BAG6X1-2 401144982 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus BDRD-Cer4 229127222 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus BDRD-ST196 229132732 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus BDRD-ST26 229138605 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus biovar anthracis str. CI 301053436 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus E33L 51977022 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus F65185 229069450 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus F837/76 376265752 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus FRI-35 402557855 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus G9241 47565590 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus G9842 218896835 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus H3081.97 206975034 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus HuA2-1 402455989 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus HuA2-4 401165478 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus HuA4-10 401170102 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus HuB1-1 402446765 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus ISP3191 401186307 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus m1293 229196109 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus m1550 229150105 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus MC67 401196778 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus MM3 229172558 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus NVH0597-99 196041244 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus Q1 222095526 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus R309803 229160865 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus Rock1-15 229109356 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus Rock1-3 229115336 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus Rock3-28 229102492 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus Rock3-42 229090873 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus Rock3-44 229084858 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus Rock4-18 229074831 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus Rock4-2 229079081 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus VD014 401217546 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus VD045 401227400 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus VD048 401224952 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus VD078 401231302 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus VD102 401241928 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus VD107 401249584 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus VD115 401253694 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus VD156 401273332 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus VD166 401275063 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus VD169 401285773 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus VD200 401294813 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus VDM022 401296447 Sg4 5'-dAdo/Ado Deaminase 
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Bacillus cereus VDM034 401303214 Sg4 5'-dAdo/Ado Deaminase 
Bacillus cereus VDM062 401307506 Sg4 5'-dAdo/Ado Deaminase 
Bacillus clausii KSM-K16 56963827 Sg1a SAH/MTA Deaminase 
Bacillus cytotoxicus NVH 391-98 152975255 Sg4 5'-dAdo/Ado Deaminase 
Bacillus halodurans C-125 15614255 Sg1a SAH/MTA Deaminase 
Bacillus halodurans C-125 162416220 Sg1a SAH/MTA Deaminase 
Bacillus halodurans C-125 15613309 Sg9 Guanine Deaminase 
Bacillus macauensis ZFHKF-1 392958953 Sg1a SAH/MTA Deaminase 
Bacillus megaterium DSM 319 295703084 Sg9 Guanine Deaminase 
Bacillus megaterium QM B1551 294497714 Sg9 Guanine Deaminase 
Bacillus megaterium WSH-002 384048466 Sg9 Guanine Deaminase 
Bacillus methanolicus PB1 387928511 Sg9 Guanine Deaminase 
Bacillus mycoides DSM 2048 229011199 Sg4 5'-dAdo/Ado Deaminase 
Bacillus mycoides Rock1-4 229007884 Sg4 5'-dAdo/Ado Deaminase 
Bacillus mycoides Rock3-17 228996976 Sg4 5'-dAdo/Ado Deaminase 
Bacillus pseudofirmus OF4 288556132 Sg1a SAH/MTA Deaminase 
Bacillus pseudomycoides DSM 12442 228990902 Sg4 5'-dAdo/Ado Deaminase 
Bacillus selenitireducens MLS10 297584388 Sg1a SAH/MTA Deaminase 
Bacillus selenitireducens MLS10 297582902 Sg9 Guanine Deaminase 
Bacillus smithii 7_3_47FAA 365158272 Sg9 Guanine Deaminase 
Bacillus sp. 1NLA3E 373858121 Sg9 Guanine Deaminase 
Bacillus sp. 2_A_57_CT2 319653145 Sg9 Guanine Deaminase 
Bacillus thuringiensis BMB171 296502493 Sg4 5'-dAdo/Ado Deaminase 
Bacillus thuringiensis HD-771 402561058 Sg4 5'-dAdo/Ado Deaminase 
Bacillus thuringiensis HD-789 401873394 Sg4 5'-dAdo/Ado Deaminase 
Bacillus thuringiensis IBL 200 228907597 Sg4 5'-dAdo/Ado Deaminase 
Bacillus thuringiensis IBL 4222 228900482 Sg4 5'-dAdo/Ado Deaminase 
Bacillus thuringiensis MC28 407704282 Sg4 5'-dAdo/Ado Deaminase 
Bacillus thuringiensis serovar andalousiensis BGSC 4AW1 228936987 Sg4 5'-dAdo/Ado Deaminase 
Bacillus thuringiensis serovar berliner ATCC 10792 228939014 Sg4 5'-dAdo/Ado Deaminase 
Bacillus thuringiensis serovar chinensis CT-43 384185807 Sg4 5'-dAdo/Ado Deaminase 
Bacillus thuringiensis serovar finitimus YBT-020 384179851 Sg4 5'-dAdo/Ado Deaminase 
Bacillus thuringiensis serovar huazhongensis BGSC 4BD1 228920608 Sg4 5'-dAdo/Ado Deaminase 
Bacillus thuringiensis serovar konkukian str. 97-27 49477409 Sg4 5'-dAdo/Ado Deaminase 
Bacillus thuringiensis serovar kurstaki str. T03a001 228952282 Sg4 5'-dAdo/Ado Deaminase 
Bacillus thuringiensis serovar pakistani str. T13001 228958183 Sg4 5'-dAdo/Ado Deaminase 
Bacillus thuringiensis serovar pondicheriensis BGSC 4BA1 228926904 Sg4 5'-dAdo/Ado Deaminase 
Bacillus thuringiensis serovar pulsiensis BGSC 4CC1 228914493 Sg4 5'-dAdo/Ado Deaminase 
Bacillus thuringiensis serovar sotto str. T04001 228964893 Sg4 5'-dAdo/Ado Deaminase 
Bacillus thuringiensis serovar tochigiensis BGSC 4Y1 228984996 Sg4 5'-dAdo/Ado Deaminase 
Bacillus thuringiensis str. Al Hakam 118477326 Sg4 5'-dAdo/Ado Deaminase 
Bacillus weihenstephanensis KBAB4 163939704 Sg4 5'-dAdo/Ado Deaminase 
Beggiatoa alba B18LD 386827021 Sg2 MTA/5'-dAdo/Ado Deaminase 
Beggiatoa sp. PS 153873847 Sg2 MTA/5'-dAdo/Ado Deaminase 
Bermanella marisrubri 94499387 Sg2 MTA/5'-dAdo/Ado Deaminase 
beta proteobacterium KB13 254467827 Sg2 MTA/5'-dAdo/Ado Deaminase 
Bilophila sp. 4_1_30 345889947 Sg9 Guanine Deaminase 
Bilophila wadsworthia 3_1_6 317487162 Sg9 Guanine Deaminase 
Blastocystis hominis 300121918 Sg2 MTA/5'-dAdo/Ado Deaminase 
Brevibacillus brevis NBRC 100599 226310925 Sg1a SAH/MTA Deaminase 
Brevibacillus brevis NBRC 100599 226312096 Sg1a SAH/MTA Deaminase 
Brevibacillus laterosporus GI-9 372457910 Sg1a SAH/MTA Deaminase 
Brevibacillus laterosporus LMG 15441 339010906 Sg1a SAH/MTA Deaminase 
Brevibacillus sp. BC25 398816055 Sg1a SAH/MTA Deaminase 
Brevibacillus sp. BC25 398816901 Sg1a SAH/MTA Deaminase 
Brevibacillus sp. CF112 399051035 Sg1a SAH/MTA Deaminase 
Brevibacillus sp. CF112 399053627 Sg1a SAH/MTA Deaminase 
Caldalkalibacillus thermarum TA2.A1 335040522 Sg4 5'-dAdo/Ado Deaminase 
Caldicellulosiruptor bescii DSM 6725 222528885 Sg1a SAH/MTA Deaminase 
Caldicellulosiruptor hydrothermalis 108 312128012 Sg1a SAH/MTA Deaminase 
Caldicellulosiruptor kristjanssonii 177R1B 312792882 Sg1a SAH/MTA Deaminase 
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Caldicellulosiruptor kronotskyensis 2002 312622825 Sg1a SAH/MTA Deaminase 
Caldicellulosiruptor lactoaceticus 6A 344996935 Sg1a SAH/MTA Deaminase 
Caldicellulosiruptor obsidiansis OB47 302871479 Sg1a SAH/MTA Deaminase 
Caldicellulosiruptor owensensis OL 312134758 Sg1a SAH/MTA Deaminase 
Caldicellulosiruptor saccharolyticus DSM 8903 146296488 Sg1a SAH/MTA Deaminase 
Caldithrix abyssi DSM 13497 373458019 Sg7 5'-dAdo/Ado Deaminase 
Caldithrix abyssi DSM 13497 373459944 Sg9 Guanine Deaminase 
Caloramator australicus RC3 397905043 Sg9 Guanine Deaminase 
Candidatus Accumulibacter phosphatis clade IIA str. UW-1 257092705 Sg2 MTA/5'-dAdo/Ado Deaminase 
Candidatus Chloracidobacterium thermophilum 157273296 Sg9 Guanine Deaminase 
Candidatus Chloracidobacterium thermophilum B 347755953 Sg9 Guanine Deaminase 
Candidatus Desulforudis audaxviator MP104C 169830835 Sg1a SAH/MTA Deaminase 
Candidatus Micrarchaeum acidiphilum ARMAN-2 255513470 Sg11 SAH Deaminase 
Carboxydothermus hydrogenoformans Z-2901 78042858 Sg1a SAH/MTA Deaminase 
Carboxydothermus hydrogenoformans Z-2901 78043497 Sg9 Guanine Deaminase 
Celeribacter baekdonensis B30 407788291 Sg10 8-Oxoadenine Deaminase 
Cellvibrio japonicus Ueda107 192359201 Sg2 MTA/5'-dAdo/Ado Deaminase 
Cellvibrio sp. BR 388257211 Sg2 MTA/5'-dAdo/Ado Deaminase 
Chloroflexus aggregans DSM 9485 219848329 Sg7 5'-dAdo/Ado Deaminase 
Chloroflexus aurantiacus J-10-fl 163847463 Sg7 5'-dAdo/Ado Deaminase 
Chondromyces apiculatus DSM 436 405354369 Sg9 Guanine Deaminase 
Chromobacterium violaceum ATCC 12472 34496487 Sg2 MTA/5'-dAdo/Ado Deaminase 
Clostridium cellulolyticum H10 220929580 Sg1a SAH/MTA Deaminase 
Clostridium clariflavum DSM 19732 374297278 Sg1a SAH/MTA Deaminase 
Clostridium papyrosolvens DSM 2782 326204458 Sg1a SAH/MTA Deaminase 
Clostridium sp. BNL1100 376261823 Sg1a SAH/MTA Deaminase 
Clostridium thermocellum ATCC 27405 125973714 Sg1a SAH/MTA Deaminase 
Congregibacter litoralis KT71 88705959 Sg2 MTA/5'-dAdo/Ado Deaminase 
Corallococcus coralloides DSM 2259 383458147 Sg9 Guanine Deaminase 
Coxiella burnetii CbuG_Q212 212212982 Sg2 MTA/5'-dAdo/Ado Deaminase 
Coxiella burnetii Dugway 5J108-111 209364106 Sg2 MTA/5'-dAdo/Ado Deaminase 
Coxiella burnetii 'MSU Goat Q177' 153207936 Sg2 MTA/5'-dAdo/Ado Deaminase 
Cycloclasticus sp. P1 407716515 Sg2 MTA/5'-dAdo/Ado Deaminase 
Dechloromonas aromatica RCB 71906868 Sg2 MTA/5'-dAdo/Ado Deaminase 
Dechlorosoma suillum PS 372488586 Sg2 MTA/5'-dAdo/Ado Deaminase 
Dehalobacter sp. DCA 410658783 Sg1a SAH/MTA Deaminase 
Desulfitobacterium dehalogenans ATCC 51507 392394730 Sg1a SAH/MTA Deaminase 
Desulfitobacterium hafniense DCB-2 219669780 Sg1a SAH/MTA Deaminase 
Desulfitobacterium hafniense DP7 361854316 Sg1a SAH/MTA Deaminase 
Desulfitobacterium hafniense Y51 89895347 Sg1a SAH/MTA Deaminase 
Desulfitobacterium metallireducens DSM 15288 354558628 Sg1a SAH/MTA Deaminase 
Desulfosporosinus acidiphilus SJ4 392426864 Sg1a SAH/MTA Deaminase 
Desulfosporosinus acidiphilus SJ4 392425377 Sg9 Guanine Deaminase 
Desulfosporosinus meridiei DSM 13257 402574100 Sg1a SAH/MTA Deaminase 
Desulfosporosinus meridiei DSM 13257 402571851 Sg9 Guanine Deaminase 
Desulfosporosinus orientis DSM 765 374997113 Sg1a SAH/MTA Deaminase 
Desulfosporosinus orientis DSM 765 374994062 Sg9 Guanine Deaminase 
Desulfosporosinus sp. OT 345859710 Sg1a SAH/MTA Deaminase 
Desulfosporosinus sp. OT 345856704 Sg9 Guanine Deaminase 
Desulfosporosinus youngiae DSM 17734 374582905 Sg1a SAH/MTA Deaminase 
Desulfosporosinus youngiae DSM 17734 374579958 Sg9 Guanine Deaminase 
Desulfotomaculum acetoxidans DSM 771 258514475 Sg1a SAH/MTA Deaminase 
Desulfotomaculum gibsoniae DSM 7213 357038764 Sg1a SAH/MTA Deaminase 
Desulfotomaculum gibsoniae DSM 7213 357038847 Sg9 Guanine Deaminase 
Desulfotomaculum kuznetsovii DSM 6115 333979669 Sg1a SAH/MTA Deaminase 
Desulfotomaculum nigrificans DSM 574 323702678 Sg1a SAH/MTA Deaminase 
Desulfotomaculum reducens MI-1 134299907 Sg1a SAH/MTA Deaminase 
Desulfotomaculum ruminis DSM 2154 334340360 Sg1a SAH/MTA Deaminase 
Desulfovibrio aespoeensis Aspo-2 317153206 Sg6 5'-dAdo Deaminase 
Desulfovibrio africanus str. Walvis Bay 374301048 Sg6 5'-dAdo Deaminase 
Desulfovibrio alaskensis G20 78356855 Sg6 5'-dAdo Deaminase 
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Desulfovibrio desulfuricans ND132 376295307 Sg6 5'-dAdo Deaminase 
Desulfovibrio desulfuricans subsp. desulfuricans str. ATCC 27774 220905193 Sg6 5'-dAdo Deaminase 
Desulfovibrio fructosovorans JJ 303247207 Sg6 5'-dAdo Deaminase 
Desulfovibrio magneticus RS-1 239907238 Sg6 5'-dAdo Deaminase 
Desulfovibrio magneticus str. Maddingley MBC34 410462003 Sg6 5'-dAdo Deaminase 
Desulfovibrio piger ATCC 29098 212702496 Sg6 5'-dAdo Deaminase 
Desulfovibrio salexigens DSM 2638 242279072 Sg6 5'-dAdo Deaminase 
Desulfovibrio sp. 3_1_syn3 303327872 Sg6 5'-dAdo Deaminase 
Desulfovibrio sp. 6_1_46AFAA 345893536 Sg6 5'-dAdo Deaminase 
Desulfovibrio sp. A2 347731243 Sg6 5'-dAdo Deaminase 
Desulfovibrio sp. FW1012B 357632585 Sg6 5'-dAdo Deaminase 
Desulfovibrio sp. U5L 386392840 Sg6 5'-dAdo Deaminase 
Desulfovibrio vulgaris DP4 120602380 Sg6 5'-dAdo Deaminase 
Desulfovibrio vulgaris str. Hildenborough 46580235 Sg6 5'-dAdo Deaminase 
Desulfovibrio vulgaris str. 'Miyazaki F' 218885652 Sg6 5'-dAdo Deaminase 
Dethiobacter alkaliphilus AHT 1 225181018 Sg1a SAH/MTA Deaminase 
Dialister microaerophilus UPII 345-E 313891988 Sg1a SAH/MTA Deaminase 
Dictyostelium discoideum AX4 66808699 Sg2 MTA/5'-dAdo/Ado Deaminase 
Dictyostelium fasciculatum 328876856 Sg2 MTA/5'-dAdo/Ado Deaminase 
Dictyostelium purpureum 330840449 Sg2 MTA/5'-dAdo/Ado Deaminase 
Ectothiorhodospira sp. PHS-1 374622997 Sg2 MTA/5'-dAdo/Ado Deaminase 
endosymbiont of Tevnia jerichonana (vent Tica) 345863456 Sg2 MTA/5'-dAdo/Ado Deaminase 
Ferroglobus placidus DSM 10642 288931156 Sg1b SAH/MTA/5'-dAdo Deaminase 
Ferroplasma acidarmanus fer1 257076627 Sg11 SAH Deaminase 
Fervidobacterium nodosum Rt17-B1 154249043 Sg8 SAH/MTA Deaminase 
Fervidobacterium pennivorans DSM 9078 383786427 Sg8 SAH/MTA Deaminase 
Filifactor alocis ATCC 35896 374307435 Sg1a SAH/MTA Deaminase 
Frankia sp. CN3 358458993 Sg10 8-Oxoadenine Deaminase 
Frankia sp. EuI1c 312198398 Sg10 8-Oxoadenine Deaminase 
Frateuria aurantia DSM 6220 383316999 Sg2 MTA/5'-dAdo/Ado Deaminase 
gamma proteobacterium BDW918 386286357 Sg2 MTA/5'-dAdo/Ado Deaminase 
gamma proteobacterium HIMB55 374619383 Sg2 MTA/5'-dAdo/Ado Deaminase 
gamma proteobacterium HTCC2207 90416544 Sg2 MTA/5'-dAdo/Ado Deaminase 
gamma proteobacterium HTCC5015 254447042 Sg2 MTA/5'-dAdo/Ado Deaminase 
gamma proteobacterium IMCC1989 331005952 Sg2 MTA/5'-dAdo/Ado Deaminase 
gamma proteobacterium IMCC3088 329894506 Sg2 MTA/5'-dAdo/Ado Deaminase 
gamma proteobacterium NOR51-B 254281621 Sg2 MTA/5'-dAdo/Ado Deaminase 
gamma proteobacterium NOR5-3 254515160 Sg2 MTA/5'-dAdo/Ado Deaminase 
Glaciecola psychrophila 170 410612095 Sg10 8-Oxoadenine Deaminase 
Hahella chejuensis KCTC 2396 83647052 Sg2 MTA/5'-dAdo/Ado Deaminase 
Haladaptatus paucihalophilus DX253 322368161 Sg1b SAH/MTA/5'-dAdo Deaminase 
Halalkalicoccus jeotgali B3 300709789 Sg1b SAH/MTA/5'-dAdo Deaminase 
Halalkalicoccus jeotgali B3 300711133 Sg9 Guanine Deaminase 
Haloarcula hispanica ATCC 33960 344210262 Sg9 Guanine Deaminase 
Haloarcula marismortui ATCC 43049 55376787 Sg9 Guanine Deaminase 
Halobacterium sp. DL1 354609692 Sg1b SAH/MTA/5'-dAdo Deaminase 
Halobacterium sp. DL1 354611609 Sg9 Guanine Deaminase 
Halobacterium sp. NRC-1 15791066 Sg1b SAH/MTA/5'-dAdo Deaminase 
Halobacterium sp. NRC-1 15790271 Sg9 Guanine Deaminase 
Halobiforma lacisalsi AJ5 383619876 Sg1b SAH/MTA/5'-dAdo Deaminase 
Halobiforma lacisalsi AJ5 383622348 Sg9 Guanine Deaminase 
Halococcus hamelinensis 100A6 409723629 Sg1b SAH/MTA/5'-dAdo Deaminase 
Haloferax mediterranei ATCC 33500 389845656 Sg1b SAH/MTA/5'-dAdo Deaminase 
Haloferax mediterranei ATCC 33500 389848339 Sg9 Guanine Deaminase 
Haloferax volcanii DS2 292654344 Sg1b SAH/MTA/5'-dAdo Deaminase 
Haloferax volcanii DS2 292657041 Sg9 Guanine Deaminase 
Halogeometricum borinquense DSM 11551 313124800 Sg1b SAH/MTA/5'-dAdo Deaminase 
Halogeometricum borinquense DSM 11551 313125853 Sg9 Guanine Deaminase 
Halogranum salarium B-1 399576134 Sg1b SAH/MTA/5'-dAdo Deaminase 
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Halogranum salarium B-1 399578642 Sg9 Guanine Deaminase 
Halomicrobium mukohataei DSM 12286 257386819 Sg1b SAH/MTA/5'-dAdo Deaminase 
Halomicrobium mukohataei DSM 12286 257388127 Sg9 Guanine Deaminase 
halophilic archaeon DL31 345005326 Sg1b SAH/MTA/5'-dAdo Deaminase 
halophilic archaeon DL31 345006111 Sg1b SAH/MTA/5'-dAdo Deaminase 
halophilic archaeon DL31 345005185 Sg9 Guanine Deaminase 
Halopiger xanaduensis SH-6 336252669 Sg1b SAH/MTA/5'-dAdo Deaminase 
Halopiger xanaduensis SH-6 336251757 Sg9 Guanine Deaminase 
Haloquadratum walsbyi C23 385804851 Sg1b SAH/MTA/5'-dAdo Deaminase 
Haloquadratum walsbyi C23 385803442 Sg9 Guanine Deaminase 
Haloquadratum walsbyi DSM 16790 110669287 Sg1b SAH/MTA/5'-dAdo Deaminase 
Haloquadratum walsbyi DSM 16790 110667994 Sg9 Guanine Deaminase 
Halorhabdus tiamatea SARL4B 335438625 Sg1b SAH/MTA/5'-dAdo Deaminase 
Halorhabdus utahensis DSM 12940 257052590 Sg1b SAH/MTA/5'-dAdo Deaminase 
Halorhodospira halophila SL1 121997375 Sg2 MTA/5'-dAdo/Ado Deaminase 
Halorubrum lacusprofundi ATCC 49239 222478500 Sg1b SAH/MTA/5'-dAdo Deaminase 
Halorubrum lacusprofundi ATCC 49239 222480611 Sg9 Guanine Deaminase 
Haloterrigena turkmenica DSM 5511 284163440 Sg1b SAH/MTA/5'-dAdo Deaminase 
Haloterrigena turkmenica DSM 5511 284167168 Sg9 Guanine Deaminase 
Heliobacterium modesticaldum Ice1 167630246 Sg1a SAH/MTA Deaminase 
Heliobacterium modesticaldum Ice1 167630730 Sg9 Guanine Deaminase 
Herpetosiphon aurantiacus DSM 785 159901377 Sg7 5'-dAdo/Ado Deaminase 
Hydrocarboniphaga effusa AP103 392954008 Sg2 MTA/5'-dAdo/Ado Deaminase 
Ignavibacterium album JCM 16511 385810930 Sg9 Guanine Deaminase 
Janthinobacterium sp. Marseille 152980942 Sg10 8-Oxoadenine Deaminase 
Kangiella koreensis DSM 16069 256822116 Sg2 MTA/5'-dAdo/Ado Deaminase 
Kyrpidia tusciae DSM 2912 295696295 Sg1a SAH/MTA Deaminase 
Kyrpidia tusciae DSM 2912 295696613 Sg9 Guanine Deaminase 
Laribacter hongkongensis HLHK9 226939880 Sg2 MTA/5'-dAdo/Ado Deaminase 
Lawsonia intracellularis PHE/MN1-00 94986921 Sg6 5'-dAdo Deaminase 
Lawsonia intracellularis PHE/MN1-00 162416190 Sg6 5'-dAdo Deaminase 
Limnobacter sp. MED105 149928285 Sg2 MTA/5'-dAdo/Ado Deaminase 
Mahella australiensis 50-1 BON 332980925 Sg1a SAH/MTA Deaminase 
Marichromatium purpuratum 984 344342370 Sg2 MTA/5'-dAdo/Ado Deaminase 
marine gamma proteobacterium HTCC2080 119505050 Sg2 MTA/5'-dAdo/Ado Deaminase 
marine gamma proteobacterium HTCC2143 119476908 Sg2 MTA/5'-dAdo/Ado Deaminase 
marine gamma proteobacterium HTCC2148 254481817 Sg2 MTA/5'-dAdo/Ado Deaminase 
Marinobacter adhaerens HP15 385330969 Sg2 MTA/5'-dAdo/Ado Deaminase 
Marinobacter algicola DG893 149374309 Sg2 MTA/5'-dAdo/Ado Deaminase 
Marinobacter aquaeolei VT8 120555405 Sg2 MTA/5'-dAdo/Ado Deaminase 
Marinobacter hydrocarbonoclasticus ATCC 49840 387814819 Sg2 MTA/5'-dAdo/Ado Deaminase 
Marinobacter manganoxydans MnI7-9 358448853 Sg2 MTA/5'-dAdo/Ado Deaminase 
Marinobacter sp. BSs20148 399544435 Sg2 MTA/5'-dAdo/Ado Deaminase 
Marinobacter sp. ELB17 126665969 Sg2 MTA/5'-dAdo/Ado Deaminase 
Marinomonas sp. MED121 87119283 Sg2 MTA/5'-dAdo/Ado Deaminase 
Megamonas hypermegale ART12/1 291533823 Sg1a SAH/MTA Deaminase 
Megasphaera elsdenii DSM 20460 348026976 Sg1a SAH/MTA Deaminase 
Megasphaera genomosp. type_1 str. 28L 290968533 Sg1a SAH/MTA Deaminase 
Megasphaera sp. UPII 135-E 342218412 Sg1a SAH/MTA Deaminase 
Methanobacterium formicicum DSM 3637 408381208 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanobacterium sp. AL-21 325957773 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanobacterium sp. Maddingley MBC34 410720785 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanobacterium sp. SWAN-1 333986326 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanobrevibacter ruminantium M1 288559345 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanobrevibacter smithii ATCC 35061 148643319 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanobrevibacter smithii DSM 2375 222445560 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanocaldococcus fervens AG86 256811411 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanocaldococcus infernus ME 296109783 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanocaldococcus jannaschii DSM 2661 15669736 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanocaldococcus sp. FS406-22 289192226 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanocaldococcus vulcanius M7 261402768 Sg1b SAH/MTA/5'-dAdo Deaminase 
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Methanococcoides burtonii DSM 6242 91773163 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanococcus aeolicus Nankai-3 150400987 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanococcus maripaludis C5 134045132 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanococcus maripaludis C6 159905566 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanococcus maripaludis C7 150402659 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanococcus maripaludis S2 45359054 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanococcus maripaludis X1 340624802 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanococcus vannielii SB 150399551 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanocorpusculum labreanum Z 124485874 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanoculleus bourgensis MS2 397780245 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanoculleus marisnigri JR1 126179037 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanofollis liminatans DSM 4140 395646173 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanohalobium evestigatum Z-7303 298674732 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanohalobium evestigatum Z-7303 298674749 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanohalophilus mahii DSM 5219 294495200 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanolinea tarda NOBI-1 355571893 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanolobus psychrophilus R15 410670209 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanoplanus limicola DSM 2279 374628529 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanoplanus petrolearius DSM 11571 307352986 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanoregula boonei 6A8 154150311 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanosalsum zhilinae DSM 4017 336476448 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanosarcina acetivorans C2A 20090140 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanosarcina acetivorans C2A 162416231 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanosarcina barkeri str. Fusaro 73670698 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanosarcina mazei Go1 21228381 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanosarcina mazei Go1 162416232 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanosphaera stadtmanae DSM 3091 84489028 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanosphaerula palustris E1-9c 219851668 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanospirillum hungatei JF-1 88603687 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanothermobacter marburgensis str. Marburg 304313866 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanothermobacter thermautotrophicus str. Delta H 15679502 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanothermococcus okinawensis IH1 336121909 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanothermus fervidus DSM 2088 312136929 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanotorris formicicus Mc-S-70 374635036 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methanotorris igneus Kol 5 333910056 Sg1b SAH/MTA/5'-dAdo Deaminase 
Methylobacillus flagellatus KT 91775930 Sg2 MTA/5'-dAdo/Ado Deaminase 
Methylobacter tundripaludum SV96 344943153 Sg2 MTA/5'-dAdo/Ado Deaminase 
Methylococcus capsulatus str. Bath 53804375 Sg2 MTA/5'-dAdo/Ado Deaminase 
Methylomicrobium album BG8 381151397 Sg2 MTA/5'-dAdo/Ado Deaminase 
Methylomicrobium alcaliphilum 20Z 357404855 Sg2 MTA/5'-dAdo/Ado Deaminase 
Methylomonas methanica MC09 333983431 Sg2 MTA/5'-dAdo/Ado Deaminase 
Methylophaga aminisulfidivorans MP 335043680 Sg2 MTA/5'-dAdo/Ado Deaminase 
Methylophaga sp. JAM1 387126837 Sg2 MTA/5'-dAdo/Ado Deaminase 
Methylophaga sp. JAM7 387129950 Sg2 MTA/5'-dAdo/Ado Deaminase 
Methylophaga thiooxidans DMS010 254492160 Sg2 MTA/5'-dAdo/Ado Deaminase 
Methylophilales bacterium HTCC2181 118594964 Sg2 MTA/5'-dAdo/Ado Deaminase 
Methylotenera mobilis JLW8 253996273 Sg2 MTA/5'-dAdo/Ado Deaminase 
Methylotenera versatilis 301 297538147 Sg2 MTA/5'-dAdo/Ado Deaminase 
Methyloversatilis universalis FAM5 334131892 Sg2 MTA/5'-dAdo/Ado Deaminase 
Methylovorus glucosetrophus SIP3-4 253999389 Sg2 MTA/5'-dAdo/Ado Deaminase 
Methylovorus sp. MP688 313201411 Sg2 MTA/5'-dAdo/Ado Deaminase 
Moorella thermoacetica ATCC 39073 83590072 Sg9 Guanine Deaminase 
Myxococcus fulvus HW-1 338536821 Sg9 Guanine Deaminase 
Myxococcus xanthus DK 1622 108760686 Sg9 Guanine Deaminase 
Natranaerobius thermophilus JW/NM-WN-LF 188586216 Sg1a SAH/MTA Deaminase 
Natranaerobius thermophilus JW/NM-WN-LF 188585774 Sg9 Guanine Deaminase 
Natrialba magadii ATCC 43099 289581520 Sg1b SAH/MTA/5'-dAdo Deaminase 
Natrialba magadii ATCC 43099 289582777 Sg9 Guanine Deaminase 
Natrinema sp. J7-2 397772383 Sg1b SAH/MTA/5'-dAdo Deaminase 
Natrinema sp. J7-2 397775256 Sg9 Guanine Deaminase 
Natronomonas pharaonis DSM 2160 76801137 Sg1b SAH/MTA/5'-dAdo Deaminase 
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Nitrococcus mobilis Nb-231 88810641 Sg2 MTA/5'-dAdo/Ado Deaminase 
Nitrosococcus halophilus Nc4 292492450 Sg2 MTA/5'-dAdo/Ado Deaminase 
Nitrosococcus oceani ATCC 19707 77165758 Sg2 MTA/5'-dAdo/Ado Deaminase 
Nitrosococcus watsonii C-113 300114707 Sg2 MTA/5'-dAdo/Ado Deaminase 
Nitrosomonas sp. AL212 325982084 Sg2 MTA/5'-dAdo/Ado Deaminase 
Nitrosomonas sp. Is79A3 339484010 Sg2 MTA/5'-dAdo/Ado Deaminase 
Nitrosospira multiformis ATCC 25196 82703305 Sg2 MTA/5'-dAdo/Ado Deaminase 
Oscillochloris trichoides DG-6 309790136 Sg7 5'-dAdo/Ado Deaminase 
Paenibacillus alvei DSM 29 402815300 Sg1a SAH/MTA Deaminase 
Paenibacillus curdlanolyticus YK9 304406901 Sg1a SAH/MTA Deaminase 
Paenibacillus curdlanolyticus YK9 304407468 Sg9 Guanine Deaminase 
Paenibacillus dendritiformis C454 374606202 Sg1a SAH/MTA Deaminase 
Paenibacillus dendritiformis C454 374606828 Sg1a SAH/MTA Deaminase 
Paenibacillus elgii B69 357014314 Sg1a SAH/MTA Deaminase 
Paenibacillus lactis 154 354582691 Sg1a SAH/MTA Deaminase 
Paenibacillus mucilaginosus 3016 379720955 Sg1a SAH/MTA Deaminase 
Paenibacillus mucilaginosus K02 386721945 Sg9 Guanine Deaminase 
Paenibacillus mucilaginosus KNP414 337747099 Sg1a SAH/MTA Deaminase 
Paenibacillus mucilaginosus KNP414 337745352 Sg9 Guanine Deaminase 
Paenibacillus peoriae KCTC 3763 390453515 Sg1a SAH/MTA Deaminase 
Paenibacillus polymyxa E681 308069468 Sg1a SAH/MTA Deaminase 
Paenibacillus polymyxa SC2 310642521 Sg1a SAH/MTA Deaminase 
Paenibacillus popilliae ATCC 14706 410831044 Sg1a SAH/MTA Deaminase 
Paenibacillus sp. Aloe-11 375308996 Sg1a SAH/MTA Deaminase 
Paenibacillus sp. HGF5 329929741 Sg1a SAH/MTA Deaminase 
Paenibacillus sp. HGF7 334137813 Sg1a SAH/MTA Deaminase 
Paenibacillus sp. HGF7 334133556 Sg4 5'-dAdo/Ado Deaminase 
Paenibacillus sp. JDR-2 251796461 Sg1a SAH/MTA Deaminase 
Paenibacillus sp. JDR-2 251797317 Sg9 Guanine Deaminase 
Paenibacillus sp. oral taxon 786 str. D14 253577521 Sg1a SAH/MTA Deaminase 
Paenibacillus sp. Y412MC10 261406089 Sg1a SAH/MTA Deaminase 
Paenibacillus terrae HPL-003 374324456 Sg1a SAH/MTA Deaminase 
Paenibacillus terrae HPL-003 374324681 Sg1a SAH/MTA Deaminase 
Paenibacillus vortex V453 315646469 Sg1a SAH/MTA Deaminase 
Pelosinus fermentans DSM 17108 392960171 Sg1a SAH/MTA Deaminase 
Pelosinus fermentans DSM 17108 392960651 Sg1a SAH/MTA Deaminase 
Pelosinus fermentans JBW45 392525916 Sg1a SAH/MTA Deaminase 
Pelotomaculum thermopropionicum SI 147678063 Sg1a SAH/MTA Deaminase 
Peptoniphilus harei ACS-146-V-Sch2b 313888086 Sg1a SAH/MTA Deaminase 
Peptoniphilus lacrimalis 315-B 282883342 Sg1a SAH/MTA Deaminase 
Peptoniphilus rhinitidis 1-13 399924014 Sg1a SAH/MTA Deaminase 
Peptoniphilus sp. oral taxon 375 str. F0436 342215639 Sg1a SAH/MTA Deaminase 
Peptoniphilus sp. oral taxon 386 str. F0131 299144487 Sg1a SAH/MTA Deaminase 
Peptoniphilus sp. oral taxon 836 str. F0141 300814796 Sg1a SAH/MTA Deaminase 
Phytophthora infestans T30-4 301110462 Sg2 MTA/5'-dAdo/Ado Deaminase 
Phytophthora infestans T30-4 301117868 Sg2 MTA/5'-dAdo/Ado Deaminase 
Phytophthora sojae 348667430 Sg2 MTA/5'-dAdo/Ado Deaminase 
Phytophthora sojae 348688636 Sg2 MTA/5'-dAdo/Ado Deaminase 
Picrophilus torridus DSM 9790 48477797 Sg11 SAH Deaminase 
Polysphondylium pallidum PN500 281202610 Sg2 MTA/5'-dAdo/Ado Deaminase 
Porphyromonas asaccharolytica DSM 20707 332299943 Sg1b SAH/MTA/5'-dAdo Deaminase 
Porphyromonas asaccharolytica PR426713P-I 313887254 Sg1b SAH/MTA/5'-dAdo Deaminase 
Porphyromonas endodontalis ATCC 35406 229495478 Sg1b SAH/MTA/5'-dAdo Deaminase 
Porphyromonas sp. oral taxon 279 str. F0450 402846236 Sg1b SAH/MTA/5'-dAdo Deaminase 
Porphyromonas uenonis 60-3 228470332 Sg1b SAH/MTA/5'-dAdo Deaminase 
Pseudogulbenkiania ferrooxidans 2002 224824519 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudogulbenkiania sp. NH8B 347538759 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas aeruginosa 138244 334835211 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas aeruginosa ATCC 700888 404537409 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas aeruginosa M18 386057869 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas aeruginosa PA7 152983730 Sg2 MTA/5'-dAdo/Ado Deaminase 
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Pseudomonas aeruginosa PACS2 107102700 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas aeruginosa PAO1 15598366 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas aeruginosa UCBPP-PA14 116051159 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas avellanae BPIC 631 407990790 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas brassicacearum subsp. brassicacearum NFM421 330808285 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas chlororaphis O6 389680971 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas chlororaphis subsp. aureofaciens 30-84 397883504 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas entomophila L48 104780666 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas extremaustralis 14-3 substr. 14-3b 395651183 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas fluorescens A506 387892902 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas fluorescens F113 378949565 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas fluorescens Pf0-1 77460301 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas fluorescens Q2-87 397889241 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas fluorescens R124 404305413 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas fluorescens SBW25 229589162 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas fluorescens SS101 387997677 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas fluorescens WH6 312959696 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas fragi A22 402699915 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas fulva 12-X 333900206 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas fuscovaginae UPB0736 404401721 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas geniculata N1 408825073 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas mandelii JR-1 407365600 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas mendocina DLHK 400345472 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas mendocina NK-01 330502866 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas mendocina ymp 146306877 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas protegens Pf-5 70731666 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas pseudoalcaligenes CECT 5344 399520031 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas psychrotolerans L19 359781487 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas putida W619 170722310 Sg10 8-Oxoadenine Deaminase 
Pseudomonas sp. Ag1 395798591 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. Chol1 409393717 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. GM102 398839969 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. GM17 399010547 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. GM18 399002584 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. GM21 398995407 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. GM24 398989436 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. GM25 398973358 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. GM30 398964531 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. GM33 398952126 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. GM41(2012) 398938561 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. GM49 398917336 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. GM50 398899111 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. GM55 398890629 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. GM60 398885429 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. GM67 398879366 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. GM74 398871471 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. GM78 398868653 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. GM79 398859092 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. GM80 398850871 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. GM84 398843691 Sg10 8-Oxoadenine Deaminase 
Pseudomonas sp. HYS 409426090 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. M47T1 388545952 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. PAMC 25886 395499790 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. R81 408482975 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas sp. S9 374702041 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas stutzeri A1501 146282666 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas stutzeri ATCC 14405 = CCUG 16156 379064775 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas stutzeri ATCC 17588 = LMG 11199 339494279 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas stutzeri CCUG 29243 392421516 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas stutzeri DSM 10701 397687516 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas stutzeri DSM 4166 386020950 Sg2 MTA/5'-dAdo/Ado Deaminase 
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Pseudomonas stutzeri KOS6 409778759 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas stutzeri TS44 387967423 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas synxantha BG33R 388470050 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas syringae Cit 7 330953526 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas syringae pv. aceris str. M302273 330972347 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas syringae pv. actinidiae str. M302091 330964795 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas syringae pv. aesculi str. NCPPB 3681 289623729 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas syringae pv. aptata str. DSM 50252 330980274 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas syringae pv. avellanae str. ISPaVe013 407996526 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas syringae pv. avellanae str. ISPaVe037 407996413 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas syringae pv. glycinea str. B076 320323354 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas syringae pv. lachrymans str. M301315 330986668 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas syringae pv. maculicola str. ES4326 330960548 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas syringae pv. mori str. 301020 330889349 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas syringae pv. morsprunorum str. M302280 330877043 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas syringae pv. phaseolicola 1448A 71733895 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas syringae pv. syringae 642 302187663 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas syringae pv. syringae B728a 66046878 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas syringae pv. tabaci str. ATCC 11528 257485851 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas syringae pv. tomato str. DC3000 28868949 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudomonas viridiflava UASWS0038 410092253 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudoxanthomonas spadix BD-a59 357417314 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pseudoxanthomonas suwonensis 11-1 319786813 Sg2 MTA/5'-dAdo/Ado Deaminase 
Pyrococcus abyssi GE5 14520861 Sg1b SAH/MTA/5'-dAdo Deaminase 
Pyrococcus furiosus DSM 3638 18977910 Sg1b SAH/MTA/5'-dAdo Deaminase 
Pyrococcus horikoshii OT3 14591297 Sg1b SAH/MTA/5'-dAdo Deaminase 
Pyrococcus horikoshii OT3 161789036 Sg1b SAH/MTA/5'-dAdo Deaminase 
Pyrococcus sp. NA2 332157744 Sg1b SAH/MTA/5'-dAdo Deaminase 
Pyrococcus sp. ST04 389852822 Sg1b SAH/MTA/5'-dAdo Deaminase 
Pyrococcus yayanosii CH1 337284243 Sg1b SAH/MTA/5'-dAdo Deaminase 
Reinekea blandensis MED297 88800757 Sg2 MTA/5'-dAdo/Ado Deaminase 
Rhodanobacter fulvus Jip2 389793007 Sg2 MTA/5'-dAdo/Ado Deaminase 
Rhodanobacter sp. 115 389721634 Sg2 MTA/5'-dAdo/Ado Deaminase 
Rhodanobacter sp. 116-2 389797714 Sg2 MTA/5'-dAdo/Ado Deaminase 
Rhodanobacter spathiphylli B39 389774472 Sg2 MTA/5'-dAdo/Ado Deaminase 
Rhodanobacter thiooxydans LCS2 389806384 Sg2 MTA/5'-dAdo/Ado Deaminase 
Ricinus communis 255594903 Sg2 MTA/5'-dAdo/Ado Deaminase 
Roseiflexus castenholzii DSM 13941 156744101 Sg7 5'-dAdo/Ado Deaminase 
Roseiflexus sp. RS-1 148658401 Sg7 5'-dAdo/Ado Deaminase 
Saccharophagus degradans 2-40 90021794 Sg2 MTA/5'-dAdo/Ado Deaminase 
Salinisphaera shabanensis E1L3A 335420684 Sg2 MTA/5'-dAdo/Ado Deaminase 
Selenomonas ruminantium subsp. lactilytica TAM6421 383754018 Sg1a SAH/MTA Deaminase 
Selenomonas sp. CM52 402833860 Sg1a SAH/MTA Deaminase 
Selenomonas sp. FOBRC6 401564592 Sg1a SAH/MTA Deaminase 
Selenomonas sp. FOBRC9 402301912 Sg1a SAH/MTA Deaminase 
Selenomonas sp. oral taxon 137 str. F0430 313895544 Sg1a SAH/MTA Deaminase 
Simiduia agarivorans SA1 = DSM 21679 410663080 Sg2 MTA/5'-dAdo/Ado Deaminase 
Sporolactobacillus inulinus CASD 374710320 Sg9 Guanine Deaminase 
Sporolactobacillus vineae DSM 21990 = SL153 404330030 Sg9 Guanine Deaminase 
Stenotrophomonas maltophilia D457 386719260 Sg2 MTA/5'-dAdo/Ado Deaminase 
Stenotrophomonas maltophilia JV3 344208162 Sg2 MTA/5'-dAdo/Ado Deaminase 
Stenotrophomonas maltophilia K279a 190575196 Sg2 MTA/5'-dAdo/Ado Deaminase 
Stenotrophomonas maltophilia R551-3 194366514 Sg2 MTA/5'-dAdo/Ado Deaminase 
Stenotrophomonas sp. SKA14 254522291 Sg2 MTA/5'-dAdo/Ado Deaminase 
Stigmatella aurantiaca DW4/3-1 115373684 Sg9 Guanine Deaminase 
Stigmatella aurantiaca DW4/3-1 310823592 Sg9 Guanine Deaminase 
Streptococcus anginosus 1_2_62CV 319939966 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus anginosus F0211 315222254 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus anginosus SK1138 400374374 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus anginosus SK52 = DSM 20563 335032486 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus anginosus subsp. whileyi CCUG 39159 383340131 Sg5 5'-dAdo/Ado Deaminase 
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Streptococcus cristatus ATCC 51100 322385066 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus gordonii str. Challis substr. CH1 157150044 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus infantis ATCC 700779 322388284 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus infantis SK1076 335029092 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus infantis SK970 343391918 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus infantis X 343400182 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus intermedius F0413 355363819 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus intermedius JTH08 392428100 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus mitis ATCC 6249 306829721 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus mitis B6 289167624 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus mitis bv. 2 str. F0392 340771138 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus mitis bv. 2 str. SK95 342833418 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus mitis NCTC 12261 307701897 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus mitis SK1073 339457332 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus mitis SK1080 339455936 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus mitis SK321 307706305 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus mitis SK564 307708937 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus mitis SK569 342837099 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus mitis SK575 383350029 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus mitis SK579 383353478 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus mitis SK597 307705065 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus mitis SK616 383344035 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus mitis SPAR10 395876851 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus oralis ATCC 35037 293365671 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus oralis SK10 383186488 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus oralis SK100 383184224 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus oralis SK1074 383347755 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus oralis SK255 334265937 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus oralis SK304 400367786 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus oralis SK313 343388443 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus oralis SK610 383183371 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus oralis Uo5 331266145 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus peroris ATCC 700780 322392322 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae 2061376 395594508 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae 2061617 395600874 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae 2070005 395573856 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae 2070035 395574791 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae 2070108 395579606 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae 2070335 395583699 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae 2070531 395587592 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae 2071004 395602303 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae 2080913 395607217 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae 2081074 395608263 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae 2082170 395613768 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae 2082239 395613286 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae 2090008 395575076 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae 459-5 381316034 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae 70585 225859123 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae ATCC 700669 221232098 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae CDC0288-04 183603522 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae CDC3059-06 168493257 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae CGSP14 182684315 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae D39 116515507 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae G54 194397682 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA05578 379637156 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA13224 379552008 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA13637 353812129 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA16531 353769117 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA17328 353827378 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA17570 332073663 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA40028 379574886 Sg5 5'-dAdo/Ado Deaminase 
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Streptococcus pneumoniae GA40410 379578678 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA41277 353838513 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA41301 332074936 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA41317 332200799 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA41437 353841597 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA43380 353849068 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA44452 353764072 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA47368 332201809 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA47461 379595656 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA47502 353748250 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA47522 379599992 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA47597 379599212 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA52306 353867138 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA54354 395889185 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA60080 395900240 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae GA60132 395909036 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae gamPNI0373 410476740 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae Hungary19A-6 169833999 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae INV104 387626615 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae JJA 225854804 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae MLV-016 183603825 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae Netherlands15B-37 353872354 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae P1031 225856991 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae R6 15458849 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae R6 161410744 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae SP11-BS70 148997592 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae SP14-BS69 149004511 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae SP18-BS74 149006995 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae SP19-BS75 149011588 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae SP23-BS72 149019308 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae SP3-BS71 148985696 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae SP6-BS73 148989473 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae SP9-BS68 148993087 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae SPNA45 405760708 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae TCH8431/19A 298502696 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pneumoniae TIGR4 111656887 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pseudopneumoniae IS7493 342163987 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus pseudopneumoniae SK674 383937960 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sanguinis ATCC 49296 315613384 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sanguinis SK1 327459442 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sanguinis SK1056 332358175 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sanguinis SK1057 327459045 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sanguinis SK1058 327490642 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sanguinis SK1059 332364739 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sanguinis SK1087 328945851 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sanguinis SK115 325689424 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sanguinis SK150 325693741 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sanguinis SK330 327468567 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sanguinis SK353 324990301 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sanguinis SK355 332364426 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sanguinis SK36 125717247 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sanguinis SK405 324992129 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sanguinis SK49 332363176 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sanguinis SK678 324994224 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sanguinis SK72 325688420 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sanguinis VMC66 323353448 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sp. 2_1_36FAA 262281915 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sp. AS14 401682181 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sp. BS35b 401684914 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sp. C300 322375454 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sp. F0441 410869346 Sg5 5'-dAdo/Ado Deaminase 
 
 
180 
 
Organism GI Number Sg Function 
Streptococcus sp. GMD1S 406587711 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sp. GMD2S 404468846 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sp. GMD6S 406576640 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sp. M143 270292519 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sp. oral taxon 056 str. F0418 339641238 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sp. oral taxon 058 str. F0407 358464559 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sp. oral taxon 071 str. 73H25AP 306825008 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sp. SK140 385260114 Sg5 5'-dAdo/Ado Deaminase 
Streptococcus sp. SK643 385262097 Sg5 5'-dAdo/Ado Deaminase 
Sulfobacillus acidophilus DSM 10332 379007998 Sg9 Guanine Deaminase 
Sulfobacillus acidophilus TPY 339627639 Sg9 Guanine Deaminase 
Sulfuricella denitrificans skB26 394989067 Sg2 MTA/5'-dAdo/Ado Deaminase 
Sutterella parvirubra YIT 11816 378822009 Sg2 MTA/5'-dAdo/Ado Deaminase 
Sutterella wadsworthensis 2_1_59BFAA 404657153 Sg2 MTA/5'-dAdo/Ado Deaminase 
Sutterella wadsworthensis 3_1_45B 319942536 Sg2 MTA/5'-dAdo/Ado Deaminase 
Symbiobacterium thermophilum IAM 14863 51892841 Sg1a SAH/MTA Deaminase 
Syntrophobotulus glycolicus DSM 8271 325290416 Sg1a SAH/MTA Deaminase 
Syntrophomonas wolfei subsp. wolfei str. Goettingen 114566319 Sg1a SAH/MTA Deaminase 
Syntrophothermus lipocalidus DSM 12680 297617458 Sg1a SAH/MTA Deaminase 
Tepidanaerobacter acetatoxydans Re1 332799863 Sg1a SAH/MTA Deaminase 
Teredinibacter turnerae T7901 254785507 Sg2 MTA/5'-dAdo/Ado Deaminase 
Thauera sp. MZ1T 217970136 Sg2 MTA/5'-dAdo/Ado Deaminase 
Thermacetogenium phaeum DSM 12270 410667372 Sg1a SAH/MTA Deaminase 
Thermaerobacter marianensis DSM 12885 317121933 Sg1a SAH/MTA Deaminase 
Thermincola potens JR 296133555 Sg1a SAH/MTA Deaminase 
Thermoanaerobacter ethanolicus CCSD1 256751722 Sg1a SAH/MTA Deaminase 
Thermoanaerobacter ethanolicus JW 200 326389977 Sg1a SAH/MTA Deaminase 
Thermoanaerobacter italicus Ab9 289578629 Sg1a SAH/MTA Deaminase 
Thermoanaerobacter mathranii subsp. mathranii str. A3 297544852 Sg1a SAH/MTA Deaminase 
Thermoanaerobacter pseudethanolicus ATCC 33223 167037289 Sg1a SAH/MTA Deaminase 
Thermoanaerobacter tengcongensis MB4 20808022 Sg1a SAH/MTA Deaminase 
Thermoanaerobacter wiegelii Rt8.B1 345017876 Sg1a SAH/MTA Deaminase 
Thermococcus barophilus MP 315231643 Sg1b SAH/MTA/5'-dAdo Deaminase 
Thermococcus gammatolerans EJ3 240102195 Sg1b SAH/MTA/5'-dAdo Deaminase 
Thermococcus kodakarensis KOD1 57641826 Sg1b SAH/MTA/5'-dAdo Deaminase 
Thermococcus litoralis DSM 5473 375084151 Sg1b SAH/MTA/5'-dAdo Deaminase 
Thermococcus onnurineus NA1 212224804 Sg1b SAH/MTA/5'-dAdo Deaminase 
Thermococcus sibiricus MM 739 242399953 Sg1b SAH/MTA/5'-dAdo Deaminase 
Thermococcus sp. 4557 341582507 Sg1b SAH/MTA/5'-dAdo Deaminase 
Thermococcus sp. AM4 223477357 Sg1b SAH/MTA/5'-dAdo Deaminase 
Thermococcus sp. CL1 390961208 Sg1b SAH/MTA/5'-dAdo Deaminase 
Thermococcus zilligii AN1 409096367 Sg1b SAH/MTA/5'-dAdo Deaminase 
Thermoplasma acidophilum 10640374 Sg11 SAH Deaminase 
Thermoplasma acidophilum DSM 1728 16082586 Sg11 SAH Deaminase 
Thermoplasma volcanium GSS1 13541346 Sg11 SAH Deaminase 
Thermosinus carboxydivorans Nor1 121535792 Sg1a SAH/MTA Deaminase 
Thermosipho africanus H17ap60334 407514376 Sg8 SAH/MTA Deaminase 
Thermosipho africanus TCF52B 217077947 Sg8 SAH/MTA Deaminase 
Thermosipho melanesiensis BI429 150021441 Sg8 SAH/MTA Deaminase 
Thermotoga lettingae TMO 157363801 Sg8 SAH/MTA Deaminase 
Thermotoga maritima MSB8 15643698 Sg8 SAH/MTA Deaminase 
Thermotoga naphthophila RKU-10 281413203 Sg8 SAH/MTA Deaminase 
Thermotoga neapolitana DSM 4359 222100614 Sg8 SAH/MTA Deaminase 
Thermotoga petrophila RKU-1 148270922 Sg8 SAH/MTA Deaminase 
Thermotoga sp. EMP 403252676 Sg8 SAH/MTA Deaminase 
Thermotoga sp. RQ2 170289617 Sg8 SAH/MTA Deaminase 
Thermotoga thermarum DSM 5069 338730352 Sg8 SAH/MTA Deaminase 
Thioalkalivibrio sp. K90mix 289208680 Sg2 MTA/5'-dAdo/Ado Deaminase 
Thioalkalivibrio sulfidophilus HL-EbGr7 220934703 Sg2 MTA/5'-dAdo/Ado Deaminase 
Thioalkalivibrio thiocyanoxidans ARh 4 350560955 Sg2 MTA/5'-dAdo/Ado Deaminase 
Thiobacillus denitrificans ATCC 25259 74316965 Sg2 MTA/5'-dAdo/Ado Deaminase 
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Thiocapsa marina 5811 344339504 Sg2 MTA/5'-dAdo/Ado Deaminase 
Thiocystis violascens DSM 198 390951578 Sg2 MTA/5'-dAdo/Ado Deaminase 
Thiorhodococcus drewsii AZ1 345869285 Sg2 MTA/5'-dAdo/Ado Deaminase 
Thiorhodospira sibirica ATCC 700588 350553685 Sg2 MTA/5'-dAdo/Ado Deaminase 
Thiorhodovibrio sp. 970 381157376 Sg2 MTA/5'-dAdo/Ado Deaminase 
Thiothrix nivea DSM 5205 386815608 Sg2 MTA/5'-dAdo/Ado Deaminase 
uncultured bacterium 407007146 Sg10 8-Oxoadenine Deaminase 
uncultured bacterium 406883814 Sg1b SAH/MTA/5'-dAdo Deaminase 
uncultured bacterium 406902473 Sg2 MTA/5'-dAdo/Ado Deaminase 
uncultured bacterium 406915765 Sg2 MTA/5'-dAdo/Ado Deaminase 
uncultured bacterium 406941479 Sg2 MTA/5'-dAdo/Ado Deaminase 
uncultured bacterium 406943346 Sg2 MTA/5'-dAdo/Ado Deaminase 
uncultured bacterium 406946171 Sg2 MTA/5'-dAdo/Ado Deaminase 
uncultured bacterium 406982005 Sg9 Guanine Deaminase 
uncultured haloarchaeon 148508286 Sg1b SAH/MTA/5'-dAdo Deaminase 
uncultured haloarchaeon 148508263 Sg9 Guanine Deaminase 
Veillonella atypica ACS-049-V-Sch6 303231426 Sg1a SAH/MTA Deaminase 
Veillonella atypica ACS-134-V-Col7a 303228970 Sg1a SAH/MTA Deaminase 
Veillonella parvula ACS-068-V-Sch12 333977040 Sg1a SAH/MTA Deaminase 
Veillonella parvula ATCC 17745 282850234 Sg1a SAH/MTA Deaminase 
Veillonella parvula DSM 2008 269798007 Sg1a SAH/MTA Deaminase 
Veillonella sp. 3_1_44 294793747 Sg1a SAH/MTA Deaminase 
Veillonella sp. 6_1_27 294791887 Sg1a SAH/MTA Deaminase 
Veillonella sp. ACP1 401679851 Sg1a SAH/MTA Deaminase 
Veillonella sp. oral taxon 158 str. F0412 313894498 Sg1a SAH/MTA Deaminase 
Veillonella sp. oral taxon 780 str. F0422 342214436 Sg1a SAH/MTA Deaminase 
Xanthomonas albilineans GPE PC73 285018688 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xanthomonas axonopodis pv. citri str. 306 21243112 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xanthomonas axonopodis pv. citrumelo F1 346725272 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xanthomonas axonopodis pv. malvacearum str. GSPB2388 410700374 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xanthomonas axonopodis pv. punicae str. LMG 859 390992333 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xanthomonas campestris pv. campestris str. ATCC 33913 21231708 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xanthomonas campestris pv. campestris str. B100 188991303 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xanthomonas campestris pv. musacearum NCPPB 4381 289671283 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xanthomonas campestris pv. raphani 756C 384428174 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xanthomonas campestris pv. vasculorum NCPPB 702 289665703 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xanthomonas campestris pv. vesicatoria str. 85-10 78048131 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xanthomonas citri pv. mangiferaeindicae LMG 941 381171484 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xanthomonas fuscans subsp. aurantifolii str. ICPB 11122 294624431 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xanthomonas gardneri ATCC 19865 325921158 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xanthomonas oryzae pv. oryzae KACC 10331 58582326 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xanthomonas oryzae pv. oryzae MAFF 311018 84624206 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xanthomonas oryzae pv. oryzae PXO99A 188576191 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xanthomonas oryzae pv. oryzicola BLS256 384419078 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xanthomonas perforans 91-118 325926496 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xanthomonas sacchari NCPPB 4393 380512828 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xanthomonas vesicatoria ATCC 35937 325918739 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xylella fastidiosa 9a5c 15839062 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xylella fastidiosa Dixon 71276240 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xylella fastidiosa M23 182682097 Sg2 MTA/5'-dAdo/Ado Deaminase 
Xylella fastidiosa Temecula1 28199370 Sg2 MTA/5'-dAdo/Ado Deaminase 
Yokenella regensburgei ATCC 43003 365847690 Sg10 8-Oxoadenine Deaminase 
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FUNCTIONAL ANNOTATIONS OF PTERIN DEAMINASES 
Organism  Gi Number Locus Tag 
Agrobacterium radiobacter K84 222086854 Arad_3529 
Agrobacterium tumefaciens 5A 358004348 AT5A_20871 
Agrobacterium vitis S4 222149611 Avi_3553 
Agrobacterium vitis S4 222106464 Avi_5410 
alpha proteobacterium BAL199 163793175 BAL199_25339 
Arthrospira maxima CS-328 209525534 AmaxDRAFT_2897 
Arthrospira platensis NIES-39 291567086 NIES39_C04920 
Arthrospira platensis str. Paraca 284051729 AplaP_010100009690 
Arthrospira sp. PCC 8005 376001956 ARTHRO_1140019 
Burkholderia multivorans CGD2M 221198870 BURMUCGD2M_6445 
Burkholderia xenovorans LB400 91780827 Bxe_C0802 
Chlorella variabilis 307110611 CHLNCDRAFT_34176 
Comamonas testosteroni ATCC 11996 371450227 CTATCC11996_23416 
Crocosphaera watsonii WH 0003 357261488 CWATWH0003_4509 
Crocosphaera watsonii WH 8501 67924588 CwatDRAFT_1740 
Cyanobium sp. PCC 7001 254432712 CPCC7001_2605 
Cyanothece sp. ATCC 51142 172038506 cce_3593 
Cyanothece sp. ATCC 51472 354554150 Cy51472DRAFT_2251 
Cyanothece sp. CCY0110 126659334 CY0110_06099 
Cyanothece sp. PCC 7424 218437242 PCC7424_0235 
Cyanothece sp. PCC 7822 307151773 Cyan7822_1898 
Cyanothece sp. PCC 8801 218246775 PCC8801_1952 
Cyanothece sp. PCC 8802 257059817 Cyan8802_1979 
Dinoroseobacter shibae DFL 12 159043930 Dshi_1381 
Erwinia billingiae Eb661 300717286 EbC_27110 
Gluconacetobacter oboediens 174Bp2 349687131 Gobo1_010100008018 
Gluconacetobacter sp. SXCC-1 330992835 SXCC_02737 
Hoeflea phototrophica DFL-43 163760226 HPDFL43_08189 
Hydrogenophaga sp. PBC 388566070 Q5W_0868 
Jannaschia sp. CCS1 89053965 Jann_1474 
Ketogulonicigenium vulgare Y25 310816506 EIO_2064 
Klebsiella oxytoca 10-5246 376395439 HMPREF9690_02815 
Klebsiella pneumoniae 342 206580486 KPK_2297 
Klebsiella pneumoniae KCTC 2242 386035174 KPN2242_13140 
Klebsiella pneumoniae subsp. pneumoniae 378979178 KPHS_30190 
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HS11286 
Klebsiella pneumoniae subsp. pneumoniae 
MGH 78578 152970585 KPN_02036 
Klebsiella pneumoniae subsp. pneumoniae 
NTUH-K2044 238895079 KP1_3111 
Klebsiella sp. 1_1_55 290509179 HMPREF0485_00950 
Klebsiella sp. 4_1_44FAA 365137953 HMPREF1024_00689 
Klebsiella sp. MS 92-3 330015330 HMPREF9538_05868 
Klebsiella variicola At-22 288935109 Kvar_2241 
Labrenzia aggregata IAM 12614 118592963 SIAM614_02036 
Labrenzia alexandrii DFL-11 254501071 ADFL11_1107 
Lyngbya sp. PCC 8106 119485483 L8106_10086 
Mesorhizobium alhagi CCNWXJ12-2 359791086 MAXJ12_16641 
Mesorhizobium amorphae CCNWGS0123 357026772 MEA186_18497 
Mesorhizobium australicum WSM2073 354569803  
Mesorhizobium ciceri biovar biserrulae 
WSM1271 319783022 Mesci_3325 
Mesorhizobium loti MAFF303099 14022090 mll1290 
Mesorhizobium loti MAFF303099 161621451 mll1290 
Mesorhizobium opportunistum WSM2075 337268293 Mesop_3816 
Methylobacterium chloromethanicum CM4 218530001 Mchl_2042 
Methylobacterium extorquens AM1 240138303 MexAM1_META1p1649 
Methylobacterium extorquens DM4 254560845 METDI2397 
Methylobacterium extorquens DSM 13060 373564592 MetexDRAFT_4416 
Methylobacterium extorquens PA1 163851150 Mext_1723 
Methylobacterium populi BJ001 188580356 Mpop_1091 
Microcoleus chthonoplastes PCC 7420 254410796 MC7420_274 
Microcoleus vaginatus FGP-2 334120965 MicvaDRAFT_2986 
Microcystis aeruginosa NIES-843 166363277 MAE_05360 
Microcystis aeruginosa PCC 7806 159026135 IPF_4829 
Microcystis aeruginosa PCC 7941 389764552 MICAD_400012 
Microcystis aeruginosa PCC 9432 389677661 MICCA_3050004 
Microcystis aeruginosa PCC 9443 389731332 MICAC_5760002 
Microcystis aeruginosa PCC 9701 389881376 MICAK_3820002 
Microcystis aeruginosa PCC 9717 389716015 MICAB_6620002 
Microcystis aeruginosa PCC 9806 389790346 MICAE_2140020 
Microcystis aeruginosa PCC 9807 389802797 MICAF_3630004 
Microcystis aeruginosa PCC 9808 389824008 MICAG_3490012 
Microcystis aeruginosa PCC 9809 389834001 MICAH_1010004 
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Organism  Gi Number Locus Tag 
Microcystis sp. T1-4 390441413 MICAI_4010001 
Micromonas pusilla CCMP1545 303279224 MICPUCDRAFT_58167 
Moorea producta 3L 332707052 LYNGBM3L_26730 
Ochrobactrum anthropi ATCC 49188 153011192 Oant_3872 
Octadecabacter antarcticus 307 254436998 OA307_1868 
omamonas testosteroni KF-1 221070037  
Opitutaceae bacterium TAV1 390121479 ObacTA_020100014809 
Opitutaceae bacterium TAV5 373851669  
Ostreococcus lucimarinus CCE9901 145349453 OSTLU_42867 
Ostreococcus tauri 308806984 Ot08g02330 
Pantoea sp. aB 304397339 PanABDRAFT_2477 
Pantoea sp. At-9b 317046647 Pat9b_0413 
Paulinella chromatophora 194476571 PCC_0086 
Polymorphum gilvum SL003B-26A1 328542414 SL003B_0794 
Prochlorococcus marinus str. MIT 9211 159903893 P9211_13521 
Prochlorococcus marinus str. MIT 9301 126696828 P9301_14901 
Prochlorococcus marinus str. MIT 9303 124023689 P9303_19891 
Prochlorococcus marinus str. MIT 9312 78779784 PMT9312_1400 
Prochlorococcus marinus str. MIT 9313 33862599 PMT0326 
Prochlorococcus marinus str. NATL1A 124026429 NATL1_17241 
Prochlorococcus marinus str. NATL2A 72382709 PMN2A_0870 
Prochlorococcus marinus subsp. marinus str. 
CCMP1375 33240827 Pro1378 
Pseudomonas sp. ADP 32455877 pADP-1_p093 
Rahnella aquatilis CIP 78.65 = ATCC 33071 383189811 Rahaq2_1935 
Rahnella sp. Y9602 322832607 Rahaq_1889 
Rhizobium etli CFN 42 86281764 RHE_CH02043 
Rhizobium etli CFN 42 162329640 RHE_CH02043 
Rhizobium etli CIAT 652 190894434 RHECIAT_PC0000096 
Rhizobium etli CNPAF512 327188280 RHECNPAF_9300154 
Rhizobium leguminosarum bv. trifolii 1439551  
Rhizobium leguminosarum bv. trifolii 
WSM1325 241113027 Rleg_4666 
Rhizobium leguminosarum bv. trifolii 
WSM2304 209549272 Rleg2_1675 
Rhizobium leguminosarum bv. trifolii 
WSM597 392850220 Rleg9DRAFT_1550 
Rhizobium leguminosarum bv. trifolii WU95 392515184 Rleg8DRAFT_0280 
Rhizobium leguminosarum bv. viciae 3841 116255810 pRL110609 
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Organism  Gi Number Locus Tag 
Rhizobium leguminosarum bv. viciae 3841 116248977 pRL120308 
Rhizobium sp. PDO1-076 375053111 PDO_3140 
Roseobacter denitrificans OCh 114 110678617 RD1_1293 
Ruegeria sp. TM1040 99078030 TM1040_3052 
Serratia odorifera 4Rx13 270262662 SOD_c02830 
Serratia sp. M24T3 383816172 SPM24T3_17475 
Starkeya novella DSM 506 298292809 Snov_2842 
Synechococcus elongatus PCC 6301 56750963 syc0954_d 
Synechococcus elongatus PCC 7942 81299379 Synpcc7942_0568 
Synechococcus sp. BL107 116072321 BL107_11056 
Synechococcus sp. CB0101 318040418 SCB01_010100001875 
Synechococcus sp. CB0205 317970568 SCB02_010100013621 
Synechococcus sp. CC9311 113953404 sync_0740 
Synechococcus sp. CC9605 78212398 Syncc9605_0854 
Synechococcus sp. CC9902 78185105 Syncc9902_1538 
Synechococcus sp. JA-2-3B'a(2-13) 86608541 CYB_1063 
Synechococcus sp. JA-3-3Ab 86606230 CYA_1567 
Synechococcus sp. PCC 7335 254421902 S7335_2052 
Synechococcus sp. RS9916 116073349  
Synechococcus sp. RS9917 87125519 RS9917_02061 
Synechococcus sp. WH 5701 87302978 WH5701_07386 
Synechococcus sp. WH 5701 87303856 WH5701_16173 
Synechococcus sp. WH 7803 148240087 SynWH7803_1751 
Synechococcus sp. WH 7805 88809157 WH7805_05676 
Synechococcus sp. WH 8016 352096259 Syn8016DRAFT_2486 
Synechococcus sp. WH 8102 33866172  
Synechococcus sp. WH 8109 260436186 SH8109_1371 
Synechocystis sp. PCC 6803 16330119 slr1237 
Trichodesmium erythraeum IMS101 113477958 Tery_4570 
Variovorax paradoxus EPS 319796039 Varpa_5413 
Variovorax paradoxus EPS 319796483 Varpa_5860 
Variovorax paradoxus S110 239817717 Vapar_4756 
Variovorax paradoxus S110 239818099 Vapar_5141 
Verminephrobacter eiseniae EF01-2 121610081 Veis_3139 
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APPENDIX C 
COMPOUNDS TESTED WITH YAHJ AND SSNA FOR DEAMINATION 
Compound Tested SsnA YahJ 
 
Adenine No-UV No-UV 
 
Guanine No-UV No-UV 
 
Cytosine No-UV No-UV 
 
Adenosine No-UV No-UV 
 
Guanosine No-UV No-UV 
 
Cytidine 
Back 
Ground No-UV 
 
8-mercaptoguanine No-UV No-UV 
 
Thioguanine No-UV No-UV 
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Compound Tested SsnA YahJ 
 
2,6-diaminopurine No-UV No-UV 
 
Xanthine No-UV No-UV 
 
8-oxoguanine No-UV No-UV 
 
Urate No-UV No-UV 
 
7-methylguanine No-UV 
False 
Positive 
 
9-methylguanine No-UV 
False 
Positive 
 
6-chloropurine No-UV No-UV 
 
8-oxoadenine No-UV No-UV 
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Compound Tested SsnA YahJ 
 
Isopentenyladenine No-UV No-UV 
 
N6-methyladenine No-UV No-UV 
 
1-methyladenine No-UV No-UV 
 
Cis-zeatin No-UV No-UV 
 
Trans-zeatin No-UV No-UV 
 
D2 
Benzyladenine B7 No-UV No-UV 
 
2-amino-6-benzylthiopurine No-UV No-UV 
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Compound Tested SsnA YahJ 
 
N-Ethenoadenine No-UV No-UV 
 
N6-acyladenine No-UV No-UV 
 
Kinetin 
Furfurly adenine No-UV No-UV 
 
N-dimethyladenine No-UV No-UV 
 
N-butyladenine No-UV No-UV 
 
Isoguanine No-UV No-UV 
 
6-methylthiopurine No-UV No-UV 
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Compound Tested SsnA YahJ 
 
2-chloroadenine No-UV No-UV 
 
6-methyoxyadenine No-UV No-UV 
 
6-mercaptopurine No-UV No-UV 
 
7-methyladenine No-UV No-UV 
 
2-dimethylaminoadenin No-UV No-UV 
 
2,4-diamino-6-hydroxymethylpteridine No-UV No-UV 
 
Biopterin No-UV No-UV 
 
Pterin No-UV No-UV 
 
D-(+)-neopterin No-UV No-UV 
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Compound Tested SsnA YahJ 
 
Isoxanthopterin No-UV No-UV 
 
Pterin-6-carboxylate No-UV No-UV 
 
Sepiapterin No-UV No-UV 
 
 
Folate No-UV No-UV 
 
3-iminiosoindolinone No-UV No-UV 
 
Acycloguanosine No-UV No-UV 
 
2’-deoxyguanosine No-UV No-UV 
 
Xanthosine No-UV No-UV 
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Compound Tested SsnA YahJ 
 
2’-deoxyadenosine 
Back 
Ground No-UV 
 
3’-deoxyadenosine No-UV No-UV 
 
5’-deoxyadenosine No-UV No-UV 
 
2’,5’-dideoxyadenosine No-UV No-UV 
 
 
5’-amino-5’-dAdo No-UV No-UV 
 
5’-chloro-5’-dAdo No-UV No-UV 
 
5’-deoxy-5’-methylthioaAdo No-UV No-UV 
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Compound Tested SsnA YahJ 
 
S-adenosylhomocysteine No-UV No-UV 
 
N6-methyl-2dAdo No-UV No-UV 
 
Isoguanosine No-UV No-UV 
 
2’-deoxyisoguanosine No-UV No-UV 
 
2’-deoxycytidine Background Background 
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Compound Tested SsnA YahJ 
 
Cytosine-B-D-arabinofuranose Background No-UV 
 
n-methylcytidine No-UV No-UV 
 
5-methylcytidine 
Back 
Ground No-UV 
 
5-methyl-2dCyt 
Back 
Ground No-UV 
 
5-hydroxymethylcytidine 
Back 
Ground No-UV 
 No-UV No-UV 
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Compound Tested SsnA YahJ 
2,4-diaminopyrimidine 
 
4,6-diaminopyrimidine No-UV No-UV 
 
4-amino-2,6-dihydroxypyrimidine No-UV No-UV 
 
2-amino-4,6-dihydroxypyrimidine  No-UV No-UV 
 
5-methylcytosine No-UV No-UV 
 
5-hydroxymethyl cytosine No-UV No-UV 
 
5-carboxy cytosine No-UV No-UV 
 
5-aminocytosine No-UV No-UV 
 
5-fluorocytosine No-UV No-UV 
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Compound Tested SsnA YahJ 
 
5-chlorocytosine No-UV No-UV 
 
4-OH-2,5,6-triaminopyrimidine No-UV No-UV 
 
FAPY Adenine No-UV No-UV 
 
FAPY Guanine No-UV No-UV 
 
n-methylcytosine 
Synthesized No-UV No-UV 
 
 
3-methylcytosine   
 
2,6-diaminopyrimidine No-UV No-UV 
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Compound Tested SsnA YahJ 
 
2,4,6-triaminopyrimidine No-UV No-UV 
 
Uracil No-UV No-UV 
 
5-aminouracil No-UV No-UV 
 
5-formyluracil No-UV No-UV 
 
5-fluorouracil A8 No-UV No-UV 
 
3-oxauracil B8 No-UV No-UV 
 
6-hydroxyaminouracil E4 No-UV No-UV 
Thiamin D8 No-UV No-UV 
Thiamin Pyrophosphate 20 No-UV No-UV 
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Compound Tested SsnA YahJ 
 
2-aminopyrimidine E8 No-UV No-UV 
 
4-aminopyrimidine  No-UV No-UV 
 
Toxopyrimidine No-UV No-UV 
 
Sulfamonomethoxine No-UV No-UV 
 
Thiamin Fragment No-UV No-UV 
 
4-thiouracil No-UV No-UV 
 
2-thiouracil No-UV No-UV 
 
Thymine No-UV No-UV 
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Compound Tested SsnA YahJ 
 
Melamine No-UV  
 
Ammeline No-UV  
 
 
Ammelide No-UV  
 
2-amino-4-hydroxy-6-chlorotriazine No-UV No-UV 
 
Cyromazin No-UV No-UV 
 
n-ethylammeline No-UV No-UV 
 
Desethylatrazine No-UV No-UV 
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Compound Tested SsnA YahJ 
 
6-azacytosine No-UV No-UV 
 
2-aminopyridine No-UV No-UV 
 
4,6-diamino-2-hydroxypyridine No-UV No-UV 
 
4-aminopyridine No-UV No-UV 
 
4-dimethylaminopyridine No-UV No-UV 
 
Creatinine F9 No-UV No-UV 
 
5-amino-4-imidazolecarboxyamide No-UV No-UV 
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Compound Tested SsnA YahJ 
 
2-guanidinobenzimidazole No-UV No-UV 
 
3-amino-5-mercapto-1,2,4-triazole No-UV No-UV 
 
3-amino-5-carboxy-1,2,4-triazole No-UV No-UV 
 
Barbiturate No-UV No-UV 
 
 
2-thiobarbiturate No-UV No-UV 
 
Nevirapine No-UV No-UV 
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Compound Tested SsnA YahJ 
 
7,8-dihydro-L-biopterin No-UV  
 
S-(5’-adenosyl)-3-thiopropylamine No-UV  
 
O6-methyl-2’-deoxyguanosine No-UV  
Cyclic adenosine diphosphate-ribose No-UV  
 
8-bromoadenosine No-UV  
 No-UV  
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Compound Tested SsnA YahJ 
8-azaadenosine 
 
Cycloguanilhydrochloride No-UV  
 
Propazine No-UV  
 
Cyanazine 
No-UV 
  
 
Adenosine 5’-diphosphoribose sodium salt 
No-UV 
  
 
Gemcitabine No-UV  
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Compound Tested SsnA YahJ 
Prometon No-UV  
Acyclovir No-UV  
 
Zeatin Riboside No-UV  
 
Isopentenyl Adenosine No-UV  
 
Adenosine beta-D arabinofuraose No-UV  
 
Maleamate  No-GLDH 
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Compound Tested SsnA YahJ 
 
Biuret  No-GLDH 
 
Oxalureate  No-GLDH 
 
Ureidoglycolate  No-GLDH 
 
